Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Vaccine

Retrieve available abstracts of 1108 articles:
HTML format

Single Articles

    September 2021
  1. LAW JLM, Logan M, Joyce MA, Landi A, et al
    SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1.
    Vaccine. 2021;39:5769-5779.
    PubMed     Abstract available

  2. LI L, Honda-Okubo Y, Huang Y, Jang H, et al
    Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection.
    Vaccine. 2021;39:5940-5953.
    PubMed     Abstract available

  3. PARK SJ, Kang YM, Cho HK, Kim DY, et al
    Cross-protective efficacy of inactivated whole influenza vaccines against Korean Y280 and Y439 lineage H9N2 viruses in mice.
    Vaccine. 2021 Sep 20. pii: S0264-410X(21)01207.
    PubMed     Abstract available

  4. SELL H, Assi A, Driedger SM, Dube E, et al
    Continuity of routine immunization programs in Canada during the COVID-19 pandemic.
    Vaccine. 2021;39:5532-5537.
    PubMed     Abstract available

  5. KIM DY, Kang YM, Cho HK, Park SJ, et al
    Development of a recombinant H9N2 influenza vaccine candidate against the Y280 lineage field virus and its protective efficacy.
    Vaccine. 2021 Sep 14. pii: S0264-410X(21)01149.
    PubMed     Abstract available

    Influenza vaccination at the workplace.
    Vaccine. 2021 Sep 14. pii: S0264-410X(21)01188.

  7. BENJAMIN-CHUNG J, Arnold BF, Mishra K, Kennedy CJ, et al
    City-wide school-located influenza vaccination: A retrospective cohort study.
    Vaccine. 2021 Sep 14. pii: S0264-410X(21)01161.
    PubMed     Abstract available

  8. PALACHE A, Rockman S, Taylor B, Akcay M, et al
    Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use.
    Vaccine. 2021 Sep 11. pii: S0264-410X(21)01157.
    PubMed     Abstract available

  9. THOMPSON MG, Soto G, Perez A, Newes-Adeyim G, et al
    Influenza vaccine effectiveness within prospective cohorts of healthcare personnel in Israel and Peru 2016-2019.
    Vaccine. 2021 Sep 8. pii: S0264-410X(21)00982.
    PubMed     Abstract available

  10. JOGI P, Soeorg H, Ingerainen D, Soots M, et al
    Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study).
    Vaccine. 2021;39:5376-5384.
    PubMed     Abstract available

  11. BARRY M, Temsah MH, Aljamaan F, Saddik B, et al
    COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout.
    Vaccine. 2021 Sep 1. pii: S0264-410X(21)01131.
    PubMed     Abstract available

    August 2021
  12. PRIVOR-DUMM LA, Poland GA, Barratt J, Durrheim DN, et al
    A global agenda for older adult immunization in the COVID-19 era: A roadmap for action.
    Vaccine. 2021;39:5240-5250.
    PubMed     Abstract available

  13. CANTARELLI P, Belle N, Quattrone F
    Nudging influenza vaccination among health care workers.
    Vaccine. 2021 Aug 31. pii: S0264-410X(21)01073.
    PubMed     Abstract available

  14. TROGSTAD L, Robertson AH, Mjaaland S, Magnus P, et al
    Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: Large population-based cohort study.
    Vaccine. 2021 Aug 31. pii: S0264-410X(21)01103.
    PubMed     Abstract available

  15. BROSH-NISSIMOV T, Sorek N, Yeshayahu M, Zherebovich I, et al
    Oropharyngeal shedding of herpesviruses before and after BNT162b2 mRNA vaccination against COVID-19.
    Vaccine. 2021 Aug 30. pii: S0264-410X(21)01148.
    PubMed     Abstract available

  16. O'LORCAIN P, Cotter S, Walsh C
    Influenza vaccine uptake among healthcare workers and residents in public health care facilities in Ireland over nine influenza seasons (2011-2012 to 2019-2020).
    Vaccine. 2021 Aug 27. pii: S0264-410X(21)00987.
    PubMed     Abstract available

  17. ROTENBERG S, Downer MB, Cooper J
    Making COVID-19 vaccinations accessible for people with disabilities.
    Vaccine. 2021 Aug 24. pii: S0264-410X(21)01110.

  18. PIERCE-RUIZ C, Santana WI, Sutton WJH, Fischler DA, et al
    Quantification of SARS-CoV-2 spike and nucleocapsid proteins using isotope dilution tandem mass spectrometry.
    Vaccine. 2021;39:5106-5115.
    PubMed     Abstract available

  19. WIEMKEN TL, Salas J, Hoft DF, Jacobs C, et al
    Dementia risk following influenza vaccination in a large veteran cohort running head: Influenza vaccination and dementia.
    Vaccine. 2021 Aug 19. pii: S0264-410X(21)01079.
    PubMed     Abstract available

  20. BRAEYE T, Cornelissen L, Catteau L, Haarhuis F, et al
    Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021.
    Vaccine. 2021 Aug 19. pii: S0264-410X(21)01108.
    PubMed     Abstract available

  21. DUDLEY MZ, Bernier R, Brewer J, Salmon DA, et al
    Walking the Tightrope: Reevaluating science communication in the era of COVID-19 vaccines.
    Vaccine. 2021 Aug 19. pii: S0264-410X(21)01070.
    PubMed     Abstract available

  22. PENG HK, Dombkowski KJ, Freed GL, Creary SE, et al
    Influenza immunization coverage of children with sickle cell disease.
    Vaccine. 2021 Aug 17. pii: S0264-410X(21)01072.
    PubMed     Abstract available

  23. LIU S, Liu J
    Public attitudes toward COVID-19 vaccines on English-language Twitter: A sentiment analysis.
    Vaccine. 2021 Aug 17. pii: S0264-410X(21)01106.
    PubMed     Abstract available

  24. LAUFER RS, Driscoll AJ, Baral R, Buchwald AG, et al
    Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisions.
    Vaccine. 2021;39:5037-5045.
    PubMed     Abstract available

  25. HAGAN LM, Dusseau C, Crockett M, Rodriguez T, et al
    COVID-19 vaccination in the Federal Bureau of Prisons, December 2020-April 2021.
    Vaccine. 2021 Aug 14. pii: S0264-410X(21)01078.
    PubMed     Abstract available

  26. LAIGLE V, Postma MJ, Pavlovic M, Cadeddu C, et al
    Vaccine market access pathways in the EU27 and the United Kingdom-analysis and recommendations for improvements.
    Vaccine. 2021 Aug 14. pii: S0264-410X(21)00918.
    PubMed     Abstract available

  27. CIAPPONI A, Bardach A, Mazzoni A, Alconada T, et al
    Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review.
    Vaccine. 2021 Aug 13. pii: S0264-410X(21)01067.
    PubMed     Abstract available

  28. PALLADINO G, Ferrari A, Music N, Settembre EC, et al
    Improved immunologic responses to heterologous influenza strains in children with low preexisting antibody response vaccinated with MF59-adjuvanted influenza vaccine.
    Vaccine. 2021 Aug 12. pii: S0264-410X(21)01041.
    PubMed     Abstract available

  29. STINSON JA, Boopathy AV, Cieslewicz BM, Zhang Y, et al
    Enhancing influenza vaccine immunogenicity and efficacy through infection mimicry using silk microneedles.
    Vaccine. 2021 Aug 11. pii: S0264-410X(21)00957.
    PubMed     Abstract available

  30. GRUPEL D, Gazit S, Schreiber L, Nadler V, et al
    Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination.
    Vaccine. 2021 Aug 11. pii: S0264-410X(21)01045.
    PubMed     Abstract available

  31. KANJI JN, Bailey A, Fenton J, Ling SH, et al
    Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests.
    Vaccine. 2021 Aug 11. pii: S0264-410X(21)01042.
    PubMed     Abstract available

  32. OKAMURA S, Ebina H
    Could live attenuated vaccines better control COVID-19?
    Vaccine. 2021 Aug 11. pii: S0264-410X(21)01038.
    PubMed     Abstract available

  33. PETRIE JG, Fligiel H, Lamerato L, Martin ET, et al
    Agreement between state registry, health record, and self-report of influenza vaccination.
    Vaccine. 2021 Aug 9. pii: S0264-410X(21)00995.
    PubMed     Abstract available

  34. LYTLE KL, Collins SP, Feldstein LR, Baughman AH, et al
    Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020.
    Vaccine. 2021 Aug 7. pii: S0264-410X(21)00948.
    PubMed     Abstract available

    Implementing vaccination policies based upon scientific evidence in Japan.
    Vaccine. 2021 Aug 7. pii: S0264-410X(21)00968.
    PubMed     Abstract available

  36. PHILLIPS A, Carlson S, Danchin M, Beard F, et al
    From program suspension to the pandemic: A qualitative examination of Australia's vaccine pharmacovigilance system over 10 years.
    Vaccine. 2021 Aug 7. pii: S0264-410X(21)00950.
    PubMed     Abstract available

  37. FENG J, Li Q
    How to ensure vaccine safety: An evaluation of China's vaccine regulation system.
    Vaccine. 2021 Aug 6. pii: S0264-410X(21)00986.
    PubMed     Abstract available

  38. TAYLOR SC, Hurst B, Martiszus I, Hausman MS, et al
    Semi-quantitative, high throughput analysis of SARS-CoV-2 neutralizing antibodies: Measuring the level and duration of immune response antibodies post infection/vaccination.
    Vaccine. 2021 Aug 6. pii: S0264-410X(21)01013.
    PubMed     Abstract available

  39. D'SOUZA MP, Palin AC, Calder T, Golding H, et al
    Mind the gap from research laboratory to clinic: Challenges and opportunities for next-generation assays in human diseases.
    Vaccine. 2021 Aug 5. pii: S0264-410X(21)00964.
    PubMed     Abstract available

  40. HAUPT RE, Harberts EM, Kitz RJ, Strohmeier S, et al
    Novel TLR4 adjuvant elicits protection against homologous and heterologous Influenza A infection.
    Vaccine. 2021 Aug 3. pii: S0264-410X(21)00847.
    PubMed     Abstract available

  41. SAKALA IG, Honda-Okubo Y, Li L, Baldwin J, et al
    A M2 protein-based universal influenza vaccine containing Advax-SM adjuvant provides newborn protection via maternal or neonatal immunization.
    Vaccine. 2021 Aug 3. pii: S0264-410X(21)00914.
    PubMed     Abstract available

  42. HAYMAN B, Dennehy M
    Developing-country vaccine manufacturers' technical capabilities can make a difference in global immunization.
    Vaccine. 2021 Aug 3. pii: S0264-410X(21)00922.
    PubMed     Abstract available

    July 2021
  43. REDONDO E, Drago G, Lopez-Belmonte JL, Guillen JM, et al
    Cost-utility analysis of influenza vaccination in a population aged 65 years or older in Spain with a high-dose vaccine versus an adjuvanted vaccine.
    Vaccine. 2021 Jul 31. pii: S0264-410X(21)00926.
    PubMed     Abstract available

  44. KONTOPOULOU K, Ainatzoglou A, Nakas CT, Ifantidou A, et al
    Second dose of the BNT162b2 mRNA vaccine: Value of timely administration but questionable necessity among the seropositive.
    Vaccine. 2021 Jul 31. pii: S0264-410X(21)00958.
    PubMed     Abstract available

  45. SIDDIQUI A, Ahmed A, Tanveer M, Saqlain M, et al
    An overview of procurement, pricing, and uptake of COVID-19 vaccines in Pakistan.
    Vaccine. 2021 Jul 31. pii: S0264-410X(21)00965.

  46. MAHAJAN A, Kaur J, Sidana C, Shivam S, et al
    Geo-prioritization framework for COVID-19 vaccine allocation in India.
    Vaccine. 2021 Jul 31. pii: S0264-410X(21)00989.
    PubMed     Abstract available

  47. RAGHUNANDAN R, Higgins D, Hosken N
    RSV neutralization assays - Use in immune response assessment.
    Vaccine. 2021;39:4591-4597.
    PubMed     Abstract available

  48. DIACO M, Yin K, Seet B, Samson S, et al
    Author response to a Letter to the Editor on "Introductory paper: High dose influenza vaccine".
    Vaccine. 2021 Jul 28. pii: S0264-410X(21)00917.

  49. YU VG, Lasco G, David CC
    Fear, mistrust, and vaccine hesitancy: Narratives of the dengue vaccine controversy in the Philippines.
    Vaccine. 2021 Jul 27. pii: S0264-410X(21)00929.
    PubMed     Abstract available

  50. GEORGIADIS GP, Georgiadis MC
    Optimal planning of the COVID-19 vaccine supply chain.
    Vaccine. 2021 Jul 27. pii: S0264-410X(21)00961.
    PubMed     Abstract available

  51. RAJAN S, Akhtar N, Sharma S, Chakrabarti D, et al
    COVID-19 vaccination for cancer patients: Evidence, priority, and practice.
    Vaccine. 2021 Jul 24. pii: S0264-410X(21)00956.

  52. MICHOS A, Tatsi EB, Filippatos F, Dellis C, et al
    Association of total and neutralizing SARS-CoV-2 spike -receptor binding domain antibodies with epidemiological and clinical characteristics after immunization with the 1(st) and 2(nd) doses of the BNT162b2 vaccine.
    Vaccine. 2021 Jul 24. pii: S0264-410X(21)00960.
    PubMed     Abstract available

  53. CALLAHAN AG, Coleman-Cowger VH, Schulkin J, Power ML, et al
    Racial disparities in influenza immunization during pregnancy in the United States: A narrative review of the evidence for disparities and potential interventions.
    Vaccine. 2021 Jul 23. pii: S0264-410X(21)00905.
    PubMed     Abstract available

  54. BURKE PF, Masters D, Massey G
    Enablers and barriers to COVID-19 vaccine uptake: An international study of perceptions and intentions.
    Vaccine. 2021 Jul 23. pii: S0264-410X(21)00947.
    PubMed     Abstract available

  55. TEASDALE CA, Borrell LN, Shen Y, Kimball S, et al
    Parental plans to vaccinate children for COVID-19 in New York city.
    Vaccine. 2021 Jul 23. pii: S0264-410X(21)00949.
    PubMed     Abstract available

  56. SUNDARAM M, Nasreen S, Calzavara A, He S, et al
    Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments.
    Vaccine. 2021 Jul 23. pii: S0264-410X(21)00951.
    PubMed     Abstract available

  57. SCHEIBLHOFER S, Drothler S, Braun W, Braun R, et al
    Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding.
    Vaccine. 2021;39:4399-4403.
    PubMed     Abstract available

  58. ARIAS-FERNANDEZ L, San-Roman Montero J, Gil-Prieto R, Walter S, et al
    Burden of pneumonia in patients with viral and bacterial coinfection in Spain during six consecutive influenza seasons, from 2009-10 to 2014-15.
    Vaccine. 2021 Jul 22. pii: S0264-410X(21)00912.
    PubMed     Abstract available

  59. HERVE PL, Dhelft V, Zuniga A, Ghasparian A, et al
    Epicutaneous immunization using synthetic virus-like particles efficiently boosts protective immunity to respiratory syncytial virus.
    Vaccine. 2021;39:4555-4563.
    PubMed     Abstract available

    Will COVID-19 vaccine equity be possible in India?
    Vaccine. 2021 Jul 22. pii: S0264-410X(21)00927.

  61. TISSOT N, Brunel AS, Bozon F, Rosolen B, et al
    Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine.
    Vaccine. 2021 Jul 22. pii: S0264-410X(21)00925.
    PubMed     Abstract available

  62. CHUA H, Kwan MYW, Chan ELY, Wong JSC, et al
    Influenza vaccine effectiveness against influenza-associated hospitalization in children in Hong Kong, 2010-2020.
    Vaccine. 2021 Jul 20. pii: S0264-410X(21)00873.
    PubMed     Abstract available

  63. INGROLE RSJ, Tao W, Joshi G, Gill HS, et al
    M2e conjugated gold nanoparticle influenza vaccine displays thermal stability at elevated temperatures and confers protection to ferrets.
    Vaccine. 2021 Jul 20. pii: S0264-410X(21)00909.
    PubMed     Abstract available

  64. PAUL E, Brown GW, Kalk A, Ridde V, et al
    Playing vaccine roulette: Why the current strategy of staking everything on Covid-19 vaccines is a high-stakes wager.
    Vaccine. 2021 Jul 20. pii: S0264-410X(21)00923.

  65. FLUCKIGER AC, Ontsouka B, Bozic J, Diress A, et al
    An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity.
    Vaccine. 2021 Jul 16. pii: S0264-410X(21)00911.
    PubMed     Abstract available

  66. INSERRA F, Tajer C, Antonietti L, Mariani J, et al
    Vitamin D supplementation: An alternative to enhance the effectiveness of vaccines against SARS-CoV-2?
    Vaccine. 2021 Jul 16. pii: S0264-410X(21)00908.

  67. JAIN R, Chopra A, Falezan C, Patel M, et al
    COVID-19 related immunization disruptions in Rajasthan, India: A retrospective observational study.
    Vaccine. 2021;39:4343-4350.
    PubMed     Abstract available

  68. PICHE-RENAUD PP, Ji C, Farrar DS, Friedman JN, et al
    Impact of the COVID-19 pandemic on the provision of routine childhood immunizations in Ontario, Canada.
    Vaccine. 2021;39:4373-4382.
    PubMed     Abstract available

  69. MOGAJI E
    Marketing the COVID-19 vaccine and the implications for public health.
    Vaccine. 2021 Jul 13. pii: S0264-410X(21)00874.
    PubMed     Abstract available

  70. HAYMAN B, Suri R, Prasad SD
    COVID-19 vaccine capacity: Challenges and mitigation - The DCVMN perspective.
    Vaccine. 2021 Jul 13. pii: S0264-410X(21)00866.
    PubMed     Abstract available

  71. LAZAROS G, Klein AL, Hatziantoniou S, Tsioufis C, et al
    The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying Mechanism.
    Vaccine. 2021 Jul 13. pii: S0264-410X(21)00875.

  72. CLARKE M, Goodchild LM, Evans S, Giles LC, et al
    Body mass index and vaccine responses following influenza vaccination during pregnancy.
    Vaccine. 2021 Jul 12. pii: S0264-410X(21)00826.
    PubMed     Abstract available

  73. MACINTYRE CR, Veness B, Berger D, Hamad N, et al
    Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-benefit analysis for people < 60 years in Australia.
    Vaccine. 2021 Jul 10. pii: S0264-410X(21)00872.
    PubMed     Abstract available

  74. MATEO-URDIALES A, Del Manso M, Andrianou X, Spuri M, et al
    Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy- Update on the 28th of March 2021.
    Vaccine. 2021 Jul 7. pii: S0264-410X(21)00862.
    PubMed     Abstract available

  75. BELLIER L, Petitjean A, Sarazu T, Tresierra J, et al
    Cost-effectiveness analysis of switching from a trivalent to a quadrivalent inactivated influenza vaccine in the Peruvian immunisation programme.
    Vaccine. 2021;39:4144-4152.
    PubMed     Abstract available

  76. LO CY, Misplon JA, Li X, Price GE, et al
    Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice.
    Vaccine. 2021 Jul 2. pii: S0264-410X(21)00833.
    PubMed     Abstract available

  77. RAHAMIMOV N, Baturov V, Shani A, Ben Zoor I, et al
    Inadequate deltoid muscle penetration and concerns of improper COVID mRNA vaccine administration can be avoided by injection technique modification.
    Vaccine. 2021 Jul 2. pii: S0264-410X(21)00843.
    PubMed     Abstract available

    June 2021
  78. HINES AM, Murphy N, Mullin C, Barillas J, et al
    Henoch-Schonlein purpura presenting post COVID-19 vaccination.
    Vaccine. 2021 Jun 30. pii: S0264-410X(21)00841.

  79. YOUSSEF Y, Chmaisse A, Boutros C, Chamseddine S, et al
    The burden of Respiratory Syncytial Virus (RSV) infection in the Middle East and North Africa (MENA) region across age groups: A systematic review.
    Vaccine. 2021;39:3803-3813.
    PubMed     Abstract available

  80. AL-SHAIKH A, Muthu N, Aidyralieva C, Profili MC, et al
    COVID-19 vaccine roll-out in middle-income countries: Lessons learned from the Jordan experience.
    Vaccine. 2021 Jun 29. pii: S0264-410X(21)00840.

  81. BANKS C, Portnoy A, Moi F, Boonstoppel L, et al
    Cost of vaccine delivery strategies in low- and middle-income countries during the COVID-19 pandemic.
    Vaccine. 2021 Jun 29. pii: S0264-410X(21)00838.
    PubMed     Abstract available

  82. FUJIMOTO AB, Keskinocak P, Yildirim I
    Significance of SARS-CoV-2 specific antibody testing during COVID-19 vaccine allocation.
    Vaccine. 2021 Jun 26. pii: S0264-410X(21)00828.
    PubMed     Abstract available

  83. MYLES IA, Vinciguerra JS, Premus RT
    Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site.
    Vaccine. 2021 Jun 25. pii: S0264-410X(21)00811.
    PubMed     Abstract available

  84. GUAN L, Yu Y, Wu X, Nie J, et al
    The first Chinese national standards for SARS-CoV-2 neutralizing antibody.
    Vaccine. 2021;39:3724-3730.
    PubMed     Abstract available

  85. DESAI AP, Desai AP, Loomis GJ
    Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00808.
    PubMed     Abstract available

  86. BALDOLLI A, Michon J, Appia F, Galimard C, et al
    Tolerance of BNT162b2 mRNA COVI-19 vaccine in patients with a medical history of COVID-19 disease: A case control study.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00804.
    PubMed     Abstract available

  87. GOOCH KE, Smith TRF, Salguero FJ, Fotheringham SA, et al
    One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00807.
    PubMed     Abstract available

  88. CHEN IH, Ahorsu DK, Ko NY, Yen CF, et al
    Adapting the Motors of Influenza Vaccination Acceptance Scale into the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students.
    Vaccine. 2021 Jun 22. pii: S0264-410X(21)00794.
    PubMed     Abstract available

  89. LUNDBERG L, Bygdell M, Stukat von Feilitzen G, Woxenius S, et al
    Recent MMR vaccination in health care workers and Covid-19: A test negative case-control study.
    Vaccine. 2021 Jun 22. pii: S0264-410X(21)00795.
    PubMed     Abstract available

  90. SMITH KJ, Wateska AR, Nowalk MP, Lin CJ, et al
    Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis.
    Vaccine. 2021 Jun 21. pii: S0264-410X(21)00773.
    PubMed     Abstract available

  91. FOGEL B, Schaefer EW, Hicks SD
    Early influenza vaccination rates decline in children during the COVID-19 pandemic.
    Vaccine. 2021 Jun 17. pii: S0264-410X(21)00777.
    PubMed     Abstract available

  92. BROWN CC, Young SG, Pro GC
    COVID-19 vaccination rates vary by community vulnerability: A county-level analysis.
    Vaccine. 2021 Jun 17. pii: S0264-410X(21)00774.
    PubMed     Abstract available

  93. BIFULCO M, Pisanti S, Fusco I
    Lessons from the 1656 Neapolitan Plague: Something to learn for the current coronavirus Pandemic?
    Vaccine. 2021;39:3641-3643.
    PubMed     Abstract available

  94. JETHWA H, Wong R, Abraham S
    Covid-19 vaccine trials: Ethnic diversity and immunogenicity.
    Vaccine. 2021;39:3541-3543.

  95. PRASAD N, Read JM, Jewell C, Waite B, et al
    Modelling the impact of respiratory syncytial virus (RSV) vaccine and immunoprophylaxis strategies in New Zealand.
    Vaccine. 2021 Jun 16. pii: S0264-410X(21)00708.
    PubMed     Abstract available

    Helping patients with ethical concerns about COVID-19 vaccines in light of fetal cell lines used in some COVID-19 vaccines.
    Vaccine. 2021 Jun 15. pii: S0264-410X(21)00763.
    PubMed     Abstract available

  97. POLAND GA, Ovsyannikova IG, Kennedy RB
    The need for broadly protective COVID-19 vaccines: Beyond S-only approaches.
    Vaccine. 2021 Jun 14. pii: S0264-410X(21)00764.

  98. IVANOV V, Oomens AGP, Papin JF, Staats R, et al
    Intranasal and intrapulmonary vaccination with an M protein-deficient respiratory syncytial virus (RSV) vaccine improves clinical signs and reduces viral replication in infant baboons after an RSV challenge infection.
    Vaccine. 2021 Jun 14. pii: S0264-410X(21)00737.
    PubMed     Abstract available

  99. FERRARI D, Di Resta C, Tomaiuolo R, Sabetta E, et al
    Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects.
    Vaccine. 2021 Jun 12. pii: S0264-410X(21)00756.
    PubMed     Abstract available

  100. LIPSITCH M, Kahn R
    Interpreting vaccine efficacy trial results for infection and transmission.
    Vaccine. 2021 Jun 12. pii: S0264-410X(21)00735.
    PubMed     Abstract available

  101. MCFADDEN K, Heywood A, Dyda A, Kaufman J, et al
    Minimising missed opportunities to promote and deliver immunization services to middle and older age adults: Can hospital-based programs be a solution?
    Vaccine. 2021;39:3467-3472.
    PubMed     Abstract available

  102. BEAU RENEER Z, Abreu RB, Jamal US, Corn MR, et al
    Seasonal influenza vaccination does not effectively expand H2 cross-reactive antibodies in humans.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00659.
    PubMed     Abstract available

  103. HSIA J, Zhao G, Lu PJ, Town M, et al
    Estimating bias from internet non-use for a hybrid web vaccination survey - 2013-2017 Behavioral Risk Factor Surveillance System.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00675.
    PubMed     Abstract available

  104. LUTZ CS, Biggerstaff M, Rolfes MA, Lafond KE, et al
    Estimating the number of averted illnesses and deaths as a result of vaccination against an influenza pandemic in nine low- and middle-income countries.
    Vaccine. 2021 Jun 9. pii: S0264-410X(21)00557.
    PubMed     Abstract available

  105. GUNTUKU SC, Buttenheim AM, Sherman G, Merchant RM, et al
    Twitter discourse reveals geographical and temporal variation in concerns about COVID-19 vaccines in the United States.
    Vaccine. 2021 Jun 9. pii: S0264-410X(21)00738.
    PubMed     Abstract available

  106. IKILEZI G, Bachmeier SD, Cogswell IE, Maddison ER, et al
    Tracking government spending on immunization: The joint reporting forms, national health accounts, comprehensive multi-year plans and co-financing data.
    Vaccine. 2021;39:3410-3418.
    PubMed     Abstract available

  107. NUZHATH T, Ajayi KV, Fan Q, Hotez P, et al
    Childhood immunization during the COVID-19 pandemic in Texas.
    Vaccine. 2021;39:3333-3337.
    PubMed     Abstract available

  108. SILVEIRA MF, Tonial CT, Goretti K Maranhao A, Teixeira AMS, et al
    Missed childhood immunizations during the COVID-19 pandemic in Brazil: Analyses of routine statistics and of a national household survey.
    Vaccine. 2021;39:3404-3409.
    PubMed     Abstract available

  109. JENSEN A, A F Simoes E, Bohn Christiansen C, Graff Stensballe L, et al
    Respiratory syncytial virus and influenza hospitalizations in Danish children 2010-2016.
    Vaccine. 2021 Jun 8. pii: S0264-410X(21)00705.
    PubMed     Abstract available

  110. HOEHL S, Ciesek S, Graf J, Wicker S, et al
    A new group at increased risk of a SARS-CoV-2 infection emerges: The recently vaccinated.
    Vaccine. 2021 Jun 8. pii: S0264-410X(21)00736.

  111. ANDAYI F, Emukule GO, Osoro E, Ndegwa LK, et al
    Knowledge and attitude of Kenyan healthcare workers towards pandemic influenza disease and vaccination: 9 years after the last influenza pandemic.
    Vaccine. 2021 Jun 7. pii: S0264-410X(21)00643.
    PubMed     Abstract available

  112. RAZ A, Keshet Y, Popper-Giveon A, Karkabi MS, et al
    One size does not fit all: Lessons from Israel's Covid-19 vaccination drive and hesitancy.
    Vaccine. 2021 Jun 5. pii: S0264-410X(21)00714.

  113. DAL-RE R, Launay O
    Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label.
    Vaccine. 2021 Jun 4. pii: S0264-410X(21)00703.

  114. STUURMAN AL, Biccler J, Carmona A, Descamps A, et al
    Brand-specific influenza vaccine effectiveness estimates during 2019/20 season in Europe - Results from the DRIVE EU study platform.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00654.
    PubMed     Abstract available

  115. GATES A, Rahman S, Sim S, Pillay J, et al
    Health inequities related to vaccination: An evidence map of potentially influential factors and systematic review of interventions.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00640.
    PubMed     Abstract available

  116. FERDINANDS JM, Thompson MG, Blanton L, Spencer S, et al
    Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research.
    Vaccine. 2021 Jun 2. pii: S0264-410X(21)00562.
    PubMed     Abstract available

  117. SHINGAI M, Nomura N, Sekiya T, Ohno M, et al
    Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells.
    Vaccine. 2021 Jun 2. pii: S0264-410X(21)00660.
    PubMed     Abstract available

  118. LASKY T, McMahon AW, Hua W, Forshee R, et al
    Methodologic approaches in studies using real-world data (RWD) to measure pediatric safety and effectiveness of vaccines administered to pregnant women: A scoping review.
    Vaccine. 2021 Jun 2. pii: S0264-410X(21)00666.
    PubMed     Abstract available

  119. WANG Y, Zhang Y, Wu H, Huang L, et al
    Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine: A randomized, double-blind, active-controlled phase 1 clinical trial.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00665.
    PubMed     Abstract available

  120. DEY A, Chozhavel Rajanathan TM, Chandra H, Pericherla HPR, et al
    Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00706.
    PubMed     Abstract available

  121. PATEL MK, Bergeri I, Bresee JS, Cowling BJ, et al
    Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00707.
    PubMed     Abstract available

    May 2021
  122. ZIPFEL CM, Colizza V, Bansal S
    The missing season: The impacts of the COVID-19 pandemic on influenza.
    Vaccine. 2021 May 30. pii: S0264-410X(21)00635.
    PubMed     Abstract available

  123. LEWIS NS, Banyard AC, Essen S, Whittard E, et al
    Antigenic evolution of contemporary clade HPAI H5 influenza A viruses and impact on vaccine use for mitigation and control.
    Vaccine. 2021 May 29. pii: S0264-410X(21)00655.
    PubMed     Abstract available

  124. BARDENHEIER BH, Gravenstein S, Blackman C, Gutman R, et al
    Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents.
    Vaccine. 2021 May 28. pii: S0264-410X(21)00683.
    PubMed     Abstract available

  125. ABU MOUCH S, Roguin A, Hellou E, Ishai A, et al
    Myocarditis following COVID-19 mRNA vaccination.
    Vaccine. 2021 May 28. pii: S0264-410X(21)00682.
    PubMed     Abstract available

  126. GURWITZ D
    COVID-19 vaccine hesitancy: Lessons from Israel.
    Vaccine. 2021 May 27. pii: S0264-410X(21)00680.

  127. KESSELS R, Luyten J, Tubeuf S
    Willingness to get vaccinated against Covid-19 and attitudes toward vaccination in general.
    Vaccine. 2021 May 26. pii: S0264-410X(21)00664.
    PubMed     Abstract available

  128. VANHEMS P
    A breath of humanity in the era of Covid-19 vaccine.
    Vaccine. 2021 May 24. pii: S0264-410X(21)00638.

  129. EARLE KA, Ambrosino DM, Fiore-Gartland A, Goldblatt D, et al
    Evidence for antibody as a protective correlate for COVID-19 vaccines.
    Vaccine. 2021 May 24. pii: S0264-410X(21)00658.
    PubMed     Abstract available

  130. SAM IC, Ahmad Jaafar N, Wong LP, Nathan AM, et al
    Socioeconomic costs of children <5 years hospitalised with acute respiratory infections in Kuala Lumpur, Malaysia.
    Vaccine. 2021;39:2983-2988.
    PubMed     Abstract available

  131. VOGEL TP, Top KA, Karatzios C, Hilmers DC, et al
    Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Vaccine. 2021;39:3037-3049.
    PubMed     Abstract available

  132. SERAZIN NA, Edem B, Williams SR, Ortiz JR, et al
    Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Vaccine. 2021;39:3028-3036.
    PubMed     Abstract available

  133. AIZAWA Y, Katsuta T, Sakiyama H, Tanaka-Taya K, et al
    Changes in childhood vaccination during the coronavirus disease 2019 pandemic in Japan.
    Vaccine. 2021 May 21. pii: S0264-410X(21)00636.
    PubMed     Abstract available

  134. NICHOLLS LAB, Gallant AJ, Cogan N, Rasmussen S, et al
    Older adults' vaccine hesitancy: Psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake.
    Vaccine. 2021 May 19. pii: S0264-410X(21)00544.
    PubMed     Abstract available

  135. KIM S, Williams TC, Viboud C, Campbell H, et al
    RSV genomic diversity and the development of a globally effective RSV intervention.
    Vaccine. 2021;39:2811-2820.
    PubMed     Abstract available

  136. NAG K, Chandra Baray J, Rahman Khan M, Mahmud A, et al
    An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose.
    Vaccine. 2021 May 18. pii: S0264-410X(21)00607.
    PubMed     Abstract available

  137. LUK TT, Zhao S, Wu Y, Wong JY, et al
    Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: A population-based survey.
    Vaccine. 2021 May 18. pii: S0264-410X(21)00608.
    PubMed     Abstract available

  138. CHAN YW, Wong ML, Kwok FY, Au AK, et al
    The effect of seasonal influenza vaccine on medically-attended influenza and non-influenza respiratory viruses infections at primary care level, Hong Kong SAR, 2017/18 to 2019/20.
    Vaccine. 2021 May 17. pii: S0264-410X(21)00541.
    PubMed     Abstract available

  139. GUBERNOT D, Jazwa A, Niu M, Baumblatt J, et al
    U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines.
    Vaccine. 2021 May 14. pii: S0264-410X(21)00578.
    PubMed     Abstract available

  140. WOOD RM, Murch BJ, Moss SJ, Tyler JMB, et al
    Operational research for the safe and effective design of COVID-19 mass vaccination centres.
    Vaccine. 2021 May 14. pii: S0264-410X(21)00588.

  141. CHUNG JR, Flannery B, Kim SS, Gaglani M, et al
    Sample size considerations for mid-season estimates from a large influenza vaccine effectiveness network in the United States.
    Vaccine. 2021 May 13. pii: S0264-410X(21)00555.
    PubMed     Abstract available

  142. KIM TH, Choi JH, Park SH, Yoo JH, et al
    Safety and immunogenicity of a seasonal quadrivalent influenza vaccine (GC3110A) in healthy participants aged >/= 65 years.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00551.
    PubMed     Abstract available

  143. KRAIGSLEY AM, Moore KA, Bolster A, Peters M, et al
    Barriers and activities to implementing or expanding influenza vaccination programs in low- and middle-income countries: A global survey.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00502.
    PubMed     Abstract available

  144. AFIFI TO, Salmon S, Taillieu T, Stewart-Tufescu A, et al
    Older adolescents and young adults willingness to receive the COVID-19 vaccine: Implications for informing public health strategies.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00590.
    PubMed     Abstract available

  145. LONGCHAMPS C, Ducarroz S, Crouzet L, Vignier N, et al
    COVID-19 vaccine hesitancy among persons living in homeless shelters in France.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00563.
    PubMed     Abstract available

  146. LEUNG VKY, Fox A, Carolan LA, Aban M, et al
    Impact of prior vaccination on antibody response and influenza-like illness among Australian healthcare workers after influenza vaccination in 2016.
    Vaccine. 2021 May 10. pii: S0264-410X(21)00483.
    PubMed     Abstract available

  147. POWELL H, Liu H, Pekosz A
    Changes in sialic acid binding associated with egg adaptation decrease live attenuated influenza virus replication in human nasal epithelial cell cultures.
    Vaccine. 2021 May 10. pii: S0264-410X(21)00535.
    PubMed     Abstract available

  148. PASTORINO R, Villani L, La Milia DI, Ieraci R, et al
    Influenza and pneumococcal vaccinations are not associated to COVID-19 outcomes among patients admitted to a university hospital.
    Vaccine. 2021 May 9. pii: S0264-410X(21)00566.
    PubMed     Abstract available

  149. HUANG JM, Wang SY, Lai MR, Tseng YK, et al
    Development of a respiratory syncytial virus vaccine using human hepatitis B core-based virus-like particles to induce mucosal immunity.
    Vaccine. 2021 May 7. pii: S0264-410X(21)00485.
    PubMed     Abstract available

  150. CORREIA R, Meneses L, Richheimer C, Alves PM, et al
    Improved storage of influenza HA-VLPs using a trehalose-glycerol natural deep eutectic solvent system.
    Vaccine. 2021 May 6. pii: S0264-410X(21)00480.
    PubMed     Abstract available

  151. SOMIYA M, Mine S, Yasukawa K, Ikeda S, et al
    Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines.
    Vaccine. 2021 May 6. pii: S0264-410X(21)00548.

    April 2021
  152. EYAL N, Gerhard T, Strom BL
    Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests.
    Vaccine. 2021 Apr 30. pii: S0264-410X(21)00526.

  153. WELSH KJ, Baumblatt J, Chege W, Goud R, et al
    Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).
    Vaccine. 2021 Apr 30. pii: S0264-410X(21)00524.
    PubMed     Abstract available

  154. KINI A, Morgan R, Kuo H, Shea P, et al
    Differences and disparities in seasonal influenza vaccine, acceptance, adverse reactions, and coverage by age, sex, gender, and race.
    Vaccine. 2021 Apr 28. pii: S0264-410X(21)00448.
    PubMed     Abstract available

  155. SAITOH A, Okabe N
    Changes and remaining challenges for the Japanese immunization program: Closing the vaccine gap.
    Vaccine. 2021 Apr 27. pii: S0264-410X(21)00460.
    PubMed     Abstract available

  156. KWON JH, Criado MF, Killmaster L, Ali MZ, et al
    Efficacy of two vaccines against recent emergent antigenic variants of clade highly pathogenic avian influenza viruses in Bangladesh.
    Vaccine. 2021 Apr 25. pii: S0264-410X(21)00459.
    PubMed     Abstract available

  157. KREPS SE, Kriner DL
    Factors influencing Covid-19 vaccine acceptance across subgroups in the United States: Evidence from a conjoint experiment.
    Vaccine. 2021 Apr 24. pii: S0264-410X(21)00503.
    PubMed     Abstract available

  158. OLATUNJI EA, Ogunsola AS, Khodakarami N, Callaghan T, et al
    Who receives influenza vaccinations at the Pharmacy? An analysis of the Texas Behavioral Risk Factor Surveillance System.
    Vaccine. 2021 Apr 22. pii: S0264-410X(21)00451.
    PubMed     Abstract available

  159. DADARI I, Higgins-Steele A, Sharkey A, Charlet D, et al
    Pro-equity immunization and health systems strengthening strategies in select Gavi-supported countries.
    Vaccine. 2021;39:2434-2444.
    PubMed     Abstract available

  160. WANG C, Han B, Zhao T, Liu H, et al
    Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study.
    Vaccine. 2021 Apr 13. pii: S0264-410X(21)00455.
    PubMed     Abstract available

  161. LEVIN Y, Balakirski NM, Caraco Y, Ben-Ami E, et al
    Ethics and execution of developing a 2nd wave COVID vaccine - Our interim phase I/II VSV-SARS-CoV2 vaccine experience.
    Vaccine. 2021 Apr 13. pii: S0264-410X(21)00452.

  162. HAMILTON RA, Krockow EM, Vekria P
    Attitudes towards influenza and uptake of the flu vaccine: A survey of pharmacy staff working in English hospitals.
    Vaccine. 2021 Apr 9. pii: S0264-410X(21)00407.
    PubMed     Abstract available

  163. PU J, Yu Q, Yin Z, Zhang Y, et al
    The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial.
    Vaccine. 2021 Apr 9. pii: S0264-410X(21)00431.
    PubMed     Abstract available

  164. POLUEKTOV Y, George M, Daftarian P, Delcommenne MC, et al
    Assessment of SARS-CoV-2 specific CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers.
    Vaccine. 2021;39:2110-2116.
    PubMed     Abstract available

  165. HOGAN AB, Winskill P, Watson OJ, Walker PGT, et al
    Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis.
    Vaccine. 2021 Apr 8. pii: S0264-410X(21)00427.
    PubMed     Abstract available

  166. PAGLIUSI S, Hayman B, Jarrett S
    Vaccines for a healthy future: 21st DCVMN Annual General Meeting 2020 report.
    Vaccine. 2021 Apr 7. pii: S0264-410X(21)00293.
    PubMed     Abstract available

  167. DANIELS V, Saxena K, Roberts C, Kothari S, et al
    Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis.
    Vaccine. 2021 Apr 6. pii: S0264-410X(21)00428.
    PubMed     Abstract available

  168. GRAMACHO WG, Turgeon M
    When politics collides with public health: COVID-19 vaccine country of origin and vaccination acceptance in Brazil.
    Vaccine. 2021 Apr 6. pii: S0264-410X(21)00396.
    PubMed     Abstract available

  169. HATZIANTONIOU S, Maltezou HC, Tsakris A, Poland GA, et al
    Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study.
    Vaccine. 2021 Apr 6. pii: S0264-410X(21)00377.

    March 2021
  170. PELTON SI, Divino V, Postma MJ, Shah D, et al
    A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United States during the 2018-19 influenza season.
    Vaccine. 2021 Mar 30. pii: S0264-410X(21)00347.
    PubMed     Abstract available

  171. GUR-ARIE R, Katz MA, Hirsch A, Greenberg D, et al
    "You Have to Die Not to Come to Work": A Mixed Methods Study of Attitudes and Behaviors regarding Presenteeism, Absenteeism and Influenza Vaccination among Healthcare Personnel with Respiratory Illness in Israel, 2016-2019.
    Vaccine. 2021 Mar 29. pii: S0264-410X(21)00361.
    PubMed     Abstract available

  172. KUTER BJ, Offit PA, Poland GA
    The development of COVID-19 vaccines in the United States: Why and how so fast?
    Vaccine. 2021 Mar 26. pii: S0264-410X(21)00383.

  173. RUSSO AG, Decarli A, Valsecchi MG
    Strategy to identify priority groups for COVID-19 vaccination: A population based cohort study.
    Vaccine. 2021 Mar 26. pii: S0264-410X(21)00382.
    PubMed     Abstract available

  174. GKENTZI D, Aggelopoulos K, Karatza A, Sinopidis X, et al
    Influenza vaccination among caregivers and household contacts of children with asthma.
    Vaccine. 2021 Mar 25. pii: S0264-410X(21)00325.
    PubMed     Abstract available

  175. SALMON DA, Dudley MZ, Brewer J, Kan L, et al
    COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization.
    Vaccine. 2021 Mar 24. pii: S0264-410X(21)00315.
    PubMed     Abstract available

  176. ROSA SS, Prazeres DMF, Azevedo AM, Marques MPC, et al
    mRNA vaccines manufacturing: Challenges and bottlenecks.
    Vaccine. 2021 Mar 23. pii: S0264-410X(21)00319.
    PubMed     Abstract available

  177. HAEDER SF
    Joining the herd? U.S. public opinion and vaccination requirements across educational settings during the COVID-19 pandemic.
    Vaccine. 2021 Mar 23. pii: S0264-410X(21)00348.
    PubMed     Abstract available

  178. KOCHHAR S, Dube E, Graham J, Jee Y, et al
    COVID-19 vaccine safety questions and answers for healthcare providers (CONSIDER).
    Vaccine. 2021 Mar 22. pii: S0264-410X(21)00364.

  179. ZHANG Y, Li D, Zhao H, Wang L, et al
    The role of multiple SARS-CoV-2 viral antigens in a vaccine-induced integrated immune response.
    Vaccine. 2021 Mar 22. pii: S0264-410X(21)00371.

  180. ANTONELLI INCALZI R, Trevisan C, Del Signore S, Volpato S, et al
    Are vaccines against COVID-19 tailored to the most vulnerable people?
    Vaccine. 2021 Mar 22. pii: S0264-410X(21)00370.

  181. ANGELIS A, Darrow J
    Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines.
    Vaccine. 2021 Mar 22. pii: S0264-410X(21)00346.

  182. KENDAL A
    Safety monitoring of COVID-19 vaccines - Lessons learned from the 1976 national influenza immunization program about detecting rare vaccine-related severe adverse events in emergency mass-vaccination programs.
    Vaccine. 2021 Mar 20. pii: S0264-410X(21)00283.

  183. CHEN D, Ye Z, Pi Z, Mizukami S, et al
    Cost-effectiveness of dual influenza and pneumococcal vaccination among the elderly in Shenzhen, China.
    Vaccine. 2021 Mar 20. pii: S0264-410X(21)00324.
    PubMed     Abstract available

  184. VILCHES TN, Zhang K, Van Exan R, Langley JM, et al
    Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada.
    Vaccine. 2021 Mar 20. pii: S0264-410X(21)00362.
    PubMed     Abstract available

  185. CAMBOU MC, Copeland TP, Nielsen-Saines K, Macinko J, et al
    Insurance status predicts self-reported influenza vaccine coverage among pregnant women in the United States: A cross-sectional analysis of the National Health Interview Study Data from 2012 to 2018.
    Vaccine. 2021 Mar 17. pii: S0264-410X(21)00294.
    PubMed     Abstract available

  186. GRAUPENSPERGER S PHD, Abdallah DA, Lee CM
    Social norms and vaccine uptake: College students' COVID vaccination intentions, attitudes, and estimated peer norms and comparisons with influenza vaccine.
    Vaccine. 2021 Mar 17. pii: S0264-410X(21)00286.
    PubMed     Abstract available

  187. SZIGETI R, Kellermayer R
    Natural unblinding of BCG vaccination trials.
    Vaccine. 2021 Mar 17. pii: S0264-410X(21)00320.
    PubMed     Abstract available

  188. ALLINGTON D, McAndrew S, Moxham-Hall VL, Duffy B, et al
    Media usage predicts intention to be vaccinated against SARS-CoV-2 in the US and the UK.
    Vaccine. 2021 Mar 16. pii: S0264-410X(21)00234.
    PubMed     Abstract available

  189. CHOI UY, Kim KH, Lee KY, Kim JH, et al
    Active-controlled phase III study of an egg-cultivated quadrivalent inactivated split-virion influenza vaccine (GC3110A) in healthy Korean children aged 6-35 months.
    Vaccine. 2021 Mar 15. pii: S0264-410X(21)00273.
    PubMed     Abstract available

  190. NET P, Colrat F, Nascimento Costa M, Bianic F, et al
    Estimating public health and economic benefits along 10 years of Fluzone(R) High Dose in the United States.
    Vaccine. 2021;39 Suppl 1:A56-A69.
    PubMed     Abstract available

    Developing standard safety outcomes for COVID-19 vaccines.
    Vaccine. 2021 Mar 12. pii: S0264-410X(21)00272.

  192. LEE J, Li Y, Li Y, Cino-Ozuna AG, et al
    Bat influenza vectored NS1-truncated live vaccine protects pigs against heterologous virus challenge.
    Vaccine. 2021 Mar 11. pii: S0264-410X(21)00268.
    PubMed     Abstract available

  193. BERTRAN K, Kassa A, Criado MF, Nunez IA, et al
    Efficacy of recombinant Marek's disease virus vectored vaccines with computationally optimized broadly reactive antigen (COBRA) hemagglutinin insert against genetically diverse H5 high pathogenicity avian influenza viruses.
    Vaccine. 2021 Mar 11. pii: S0264-410X(21)00266.
    PubMed     Abstract available

  194. EBAMA MS, Chu SY, Azziz-Baumgartner E, Lafond KE, et al
    Ancillary benefits of seasonal influenza vaccination in middle-income countries.
    Vaccine. 2021 Mar 10. pii: S0264-410X(21)00228.
    PubMed     Abstract available

  195. LATKIN C, Dayton LA, Yi G, Konstantopoulos A, et al
    COVID-19 vaccine intentions in the United States, a social-ecological framework.
    Vaccine. 2021 Mar 10. pii: S0264-410X(21)00238.
    PubMed     Abstract available

  196. REPERANT LA, Osterhaus ADME
    COVID-19 vaccination and critical care capacity: Perilous months ahead.
    Vaccine. 2021 Mar 10. pii: S0264-410X(21)00316.

  197. WENTZELL E, Racila AM
    The social experience of participation in a COVID-19 vaccine trial: Subjects' motivations, others' concerns, and insights for vaccine promotion.
    Vaccine. 2021 Mar 10. pii: S0264-410X(21)00317.
    PubMed     Abstract available

  198. GUIDRY JPD, Perrin PB, Laestadius LI, Vraga EK, et al
    U.S. public support for COVID-19 vaccine donation to low- and middle-income countries during the COVID-19 pandemic.
    Vaccine. 2021 Mar 9. pii: S0264-410X(21)00306.
    PubMed     Abstract available

  199. SADARANGANI M, Abu Raya B, Conway JM, Iyaniwura SA, et al
    Importance of COVID-19 vaccine efficacy in older age groups.
    Vaccine. 2021 Mar 8. pii: S0264-410X(21)00288.
    PubMed     Abstract available

  200. KISZEWSKI AE, Cleary EG, Jackson MJ, Ledley FD, et al
    NIH funding for vaccine readiness before the COVID-19 pandemic.
    Vaccine. 2021 Mar 8. pii: S0264-410X(21)00290.
    PubMed     Abstract available

  201. PULLAN S, Dey M
    Vaccine hesitancy and anti-vaccination in the time of COVID-19: A Google Trends analysis.
    Vaccine. 2021 Mar 6. pii: S0264-410X(21)00287.
    PubMed     Abstract available

  202. BLACK SB, Law B, Chen RT, Dekker CL, et al
    The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety.
    Vaccine. 2021 Mar 6. pii: S0264-410X(21)00284.
    PubMed     Abstract available

  203. GASPAR EB, De Gaspari E
    Avidity assay to test functionality of anti-SARS-Cov-2 antibodies.
    Vaccine. 2021;39:1473-1475.

  204. YOKOMICHI H, Kojima R, Horiuchi S, Ooka T, et al
    Effectiveness of influenza vaccination in infants and toddlers with and without prior infection history: The Japan Environment and Children's Study.
    Vaccine. 2021 Mar 5. pii: S0264-410X(21)00224.
    PubMed     Abstract available

  205. DU Y, Xu Y, Feng J, Hu L, et al
    Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse.
    Vaccine. 2021 Mar 5. pii: S0264-410X(21)00274.
    PubMed     Abstract available

  206. KUO H, Shapiro JR, Dhakal S, Morgan R, et al
    Sex-specific effects of age and body mass index on antibody responses to seasonal influenza vaccines in healthcare workers.
    Vaccine. 2021 Mar 4. pii: S0264-410X(21)00227.
    PubMed     Abstract available

  207. WOO EJ, Moro PL
    Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: Reports to the vaccine adverse event reporting system.
    Vaccine. 2021 Mar 4. pii: S0264-410X(21)00232.
    PubMed     Abstract available

  208. STURM L, Kasting ML, Head KJ, Hartsock JA, et al
    Influenza vaccination in the time of COVID-19: A national U.S. survey of adults.
    Vaccine. 2021 Mar 4. pii: S0264-410X(21)00271.
    PubMed     Abstract available

  209. HELMKAMP LJ, Szilagyi PG, Zimet G, Saville AW, et al
    A validated modification of the vaccine hesitancy scale for childhood, influenza and HPV vaccines.
    Vaccine. 2021 Mar 3. pii: S0264-410X(21)00206.
    PubMed     Abstract available

  210. FELL DB, Dimitris MC, Hutcheon JA, Ortiz JR, et al
    Guidance for design and analysis of observational studies of fetal and newborn outcomes following COVID-19 vaccination during pregnancy.
    Vaccine. 2021 Mar 2. pii: S0264-410X(21)00261.
    PubMed     Abstract available

    February 2021
  211. WANG J, Lyu Y, Zhang H, Jing R, et al
    Willingness to pay and financing preferences for COVID-19 vaccination in China.
    Vaccine. 2021 Feb 27. pii: S0264-410X(21)00240.
    PubMed     Abstract available

  212. SHEN M, Zu J, Fairley CK, Pagan JA, et al
    Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use.
    Vaccine. 2021 Feb 27. pii: S0264-410X(21)00236.
    PubMed     Abstract available

  213. SELL TK, Gastfriend D, Watson M, Watson C, et al
    Building the global vaccine manufacturing capacity needed to respond to pandemics.
    Vaccine. 2021 Feb 24. pii: S0264-410X(21)00165.

  214. MUNOZ FM, Cramer JP, Dekker CL, Dudley MZ, et al
    Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Vaccine. 2021 Feb 23. pii: S0264-410X(21)00094.
    PubMed     Abstract available

  215. VERELST F, Beutels P, Hens N, Willem L, et al
    Workplace influenza vaccination to reduce employee absenteeism: An economic analysis from the employers' perspective.
    Vaccine. 2021 Feb 22. pii: S0264-410X(21)00168.
    PubMed     Abstract available

  216. SU QD, Zou YN, Yi Y, Shen LP, et al
    Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response.
    Vaccine. 2021;39:1241-1247.
    PubMed     Abstract available

  217. BLUNCK BN, Aideyan L, Ye X, Avadhanula V, et al
    A prospective surveillance study on the kinetics of the humoral immune response to the respiratory syncytial virus fusion protein in adults in Houston, Texas.
    Vaccine. 2021;39:1248-1256.
    PubMed     Abstract available

    How COVID exposed the hypocrisy within me.
    Vaccine. 2021;39:1178-1179.

  219. ORTIZ JR, Robertson J, Hsu JS, Yu SL, et al
    The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region.
    Vaccine. 2021 Feb 19. pii: S0264-410X(21)00204.
    PubMed     Abstract available

  220. CHANG LJ, Anderson EJ, Jeanfreau R, He Y, et al
    Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6months through<18years of age: A randomized controlled phase II dose-finding trial.
    Vaccine. 2021 Feb 18. pii: S0264-410X(21)00162.
    PubMed     Abstract available

  221. KUTER BJ, Browne S, Momplaisir FM, Feemster KA, et al
    Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia.
    Vaccine. 2021 Feb 16. pii: S0264-410X(21)00185.
    PubMed     Abstract available

  222. WU MJ, Chung JR, Kim SS, Jackson ML, et al
    Influenza vaccination coverage among persons seeking outpatient medical care for acute respiratory illness in five states in the United States, 2011-2012 through 2018-2019.
    Vaccine. 2021 Feb 15. pii: S0264-410X(21)00106.
    PubMed     Abstract available

  223. GURWITZ D
    Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries.
    Vaccine. 2021;39:1027.

  224. RID A, Shah SK, Miller FG, Danis M, et al
    Ethical trade-offs in vaccine development and distribution-Response to Gurwitz.
    Vaccine. 2021;39:1028-1029.

  225. WARD BJ, Seguin A, Couillard J, Trepanier S, et al
    Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18-49 years of age.
    Vaccine. 2021 Feb 10. pii: S0264-410X(21)00004.
    PubMed     Abstract available

  226. POLAND CM, Matthews AKS, Poland GA
    Improving COVID-19 vaccine acceptance: Including insights from human decision-making under conditions of uncertainty and human-centered design.
    Vaccine. 2021 Feb 10. pii: S0264-410X(21)00154.

  227. BRUCE-STASKAL PJ, Woods RM, Borisov OV, Massare MJ, et al
    Corrigendum to "Hemagglutinin from multiple divergent influenza A and B viruses bind to a distinct branched, sialylated poly-LacNAc glycan by surface plasmon resonance" [Vaccine 38(43) (2020) 6757-6765].
    Vaccine. 2021 Feb 9. pii: S0264-410X(21)00105.

  228. CHU L, McPhee R, Huang W, Bennett H, et al
    A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine.
    Vaccine. 2021 Feb 9. pii: S0264-410X(21)00153.
    PubMed     Abstract available

  229. ROBINSON E, Jones A, Lesser I, Daly M, et al
    International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples.
    Vaccine. 2021 Feb 6. pii: S0264-410X(21)00140.
    PubMed     Abstract available

  230. KUMAR N, Bhartiya S, Singh T
    Duration of anti-SARS-CoV-2 antibodies much shorter in India.
    Vaccine. 2021;39:886-888.
    PubMed     Abstract available

  231. DIACO M, Chang LJ, Seet B, Robertson CA, et al
    Introductory paper: High dose influenza vaccine.
    Vaccine. 2021 Feb 3. pii: S0264-410X(20)31147.
    PubMed     Abstract available

  232. WILCK MB, Jin Xu Z, Stek JE, Goveia MG, et al
    Protective immune responses against Haemophilus influenza type B elicited by a fully-liquid DTaP-IPV-Hib-HepB vaccine (VAXELIS).
    Vaccine. 2021 Feb 1. pii: S0264-410X(21)00073.
    PubMed     Abstract available

    January 2021
  233. AXELSEN PH, Poland GA
    Vaccines, masks, distancing and credibility: An urgent warning for pandemic management.
    Vaccine. 2021 Jan 31. pii: S0264-410X(21)00079.

  234. COLRAT F, Thommes E, Largeron N, Alvarez FP, et al
    Economic evaluation of high-dose inactivated influenza vaccine in adults aged >/=65 years: A systematic literature review.
    Vaccine. 2021 Jan 29. pii: S0264-410X(20)31603.
    PubMed     Abstract available

  235. HAMPTON LM, Aggarwal R, Evans SJW, Law B, et al
    General determination of causation between Covid-19 vaccines and possible adverse events.
    Vaccine. 2021 Jan 29. pii: S0264-410X(21)00096.

  236. BERMAN L, Riedel M
    Coping with COVID.
    Vaccine. 2021;39:777-778.

  237. KIM SH, Paldurai A, Xiao S, Collins PL, et al
    Retraction notice to "Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens" [Vaccine 32(35) (2014) 4428-4435].
    Vaccine. 2021;39:775.

  238. WANG Y, Chen L, Cheng F, Biggerstaff M, et al
    Economic burden of influenza illness among children under 5 years in Suzhou, China: Report from the cost surveys during 2011/12 to 2016/17 influenza seasons.
    Vaccine. 2021 Jan 22. pii: S0264-410X(20)31672.
    PubMed     Abstract available

  239. OKOLI GN, Racovitan F, Abdulwahid T, Righolt CH, et al
    Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studie
    Vaccine. 2021 Jan 22. pii: S0264-410X(21)00048.
    PubMed     Abstract available

  240. BHUIYAN MU, Stiboy E, Hassan MZ, Chan M, et al
    Epidemiology of COVID-19 infection in young children under five years: A systematic review and meta-analysis.
    Vaccine. 2021;39:667-677.
    PubMed     Abstract available

  241. JAMROZIK E, Littler K, Bull S, Emerson C, et al
    Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.
    Vaccine. 2021;39:633-640.
    PubMed     Abstract available

  242. BALASUBRAMANI GK, Zimmerman RK, Eng H, Lyons J, et al
    Comparison of local influenza vaccine effectiveness using two methods.
    Vaccine. 2021 Jan 20. pii: S0264-410X(21)00017.
    PubMed     Abstract available

  243. DAL-RE R
    US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine.
    Vaccine. 2021 Jan 20. pii: S0264-410X(21)00077.

  244. POLAND EG, McGuire DK, Ratishvili T, Poland GA, et al
    The economics of global COVID vaccine administration during a pandemic - Why continue skin alcohol preparation as a costly but ineffective practice?
    Vaccine. 2021 Jan 20. pii: S0264-410X(20)31694.

  245. WINOKUR P, El Sahly HM, Mulligan MJ, Frey SE, et al
    Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older.
    Vaccine. 2021 Jan 20. pii: S0264-410X(20)31504.
    PubMed     Abstract available

  246. CAO L, Lou J, Zhao S, Chan RWY, et al
    In silico prediction of influenza vaccine effectiveness by sequence analysis.
    Vaccine. 2021 Jan 19. pii: S0264-410X(21)00006.
    PubMed     Abstract available

  247. REEMERS S, Verstegen I, Basten S, Hubers W, et al
    A broad spectrum HVT-H5 avian influenza vector vaccine which induces a rapid onset of immunity.
    Vaccine. 2021 Jan 19. pii: S0264-410X(21)00022.
    PubMed     Abstract available

  248. FATOBA AJ, Maharaj L, Adeleke VT, Okpeku M, et al
    Immunoinformatics prediction of overlapping CD8(+) T-cell, IFN-gamma and IL-4 inducer CD4(+) T-cell and linear B-cell epitopes based vaccines against COVID-19 (SARS-CoV-2).
    Vaccine. 2021 Jan 18. pii: S0264-410X(21)00003.
    PubMed     Abstract available

  249. SCOTT EM, Stein R, Brown MF, Hershberger J, et al
    Vaccination patterns of the northeast Ohio Amish revisited.
    Vaccine. 2021 Jan 18. pii: S0264-410X(21)00026.
    PubMed     Abstract available

  250. WHITAKER JA, Parikh SA, Shanafelt TD, Kay NE, et al
    The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL).
    Vaccine. 2021 Jan 15. pii: S0264-410X(21)00001.
    PubMed     Abstract available

  251. GUALANO MR, Corradi A, Voglino G, Catozzi D, et al
    Healthcare Workers' (HCWs) attitudes towards mandatory influenza vaccination: A systematic review and meta-analysis.
    Vaccine. 2021 Jan 12. pii: S0264-410X(20)31655.
    PubMed     Abstract available

  252. AKMATOV MK, Holstiege J, Steffen A, Batzing J, et al
    Utilization of influenza vaccination among chronically ill individuals in Germany: A nationwide claims-based analysis.
    Vaccine. 2021 Jan 12. pii: S0264-410X(20)31693.
    PubMed     Abstract available

  253. BURGER AE, Reither EN, Mamelund SE, Lim S, et al
    Black-white disparities in 2009 H1N1 vaccination among adults in the United States: A cautionary tale for the COVID-19 pandemic.
    Vaccine. 2021 Jan 11. pii: S0264-410X(20)31666.
    PubMed     Abstract available

  254. WIEMKEN TL, Rutschman AS
    Development of vaccines for influenza disease: Opportunity costs of the COVID-19 pandemic.
    Vaccine. 2021 Jan 9. pii: S0264-410X(21)00018.

  255. SINGH J, Malik D, Raina A
    Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus.
    Vaccine. 2021 Jan 9. pii: S0264-410X(21)00015.
    PubMed     Abstract available

  256. RUIZ JB, Bell RA
    Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey.
    Vaccine. 2021 Jan 9. pii: S0264-410X(21)00014.
    PubMed     Abstract available

  257. BEIGI RH, Krubiner C, Jamieson DJ, Lyerly AD, et al
    The need for inclusion of pregnant women in COVID-19 vaccine trials.
    Vaccine. 2021 Jan 8. pii: S0264-410X(20)31671.

  258. GOLD MS, Lincoln G, Cashman P, Braunack-Mayer A, et al
    Efficacy of m-Health for the detection of adverse events following immunization - The stimulated telephone assisted rapid safety surveillance (STARSS) randomised control trial.
    Vaccine. 2021;39:332-342.
    PubMed     Abstract available

  259. CALDERA F, Mercer M, Samson SI, Pitt JM, et al
    Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity.
    Vaccine. 2021 Jan 7. pii: S0264-410X(20)31490.
    PubMed     Abstract available

  260. WILLIAMS J, Degeling C, McVernon J, Dawson A, et al
    How should we conduct pandemic vaccination?
    Vaccine. 2021 Jan 7. pii: S0264-410X(20)31639.
    PubMed     Abstract available

  261. KELSO JM
    Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines.
    Vaccine. 2021 Jan 6. pii: S0264-410X(20)31696.

  262. KOHLI M, Maschio M, Becker D, Weinstein MC, et al
    The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization.
    Vaccine. 2021 Jan 6. pii: S0264-410X(20)31690.
    PubMed     Abstract available

  263. MIDDELDORP M, van Lier A, van der Maas N, Veldhuijzen I, et al
    Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020.
    Vaccine. 2021 Jan 6. pii: S0264-410X(20)31692.
    PubMed     Abstract available

  264. WONG MCS, Wong ELY, Huang J, Cheung AWL, et al
    Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong.
    Vaccine. 2021 Jan 6. pii: S0264-410X(20)31695.
    PubMed     Abstract available

  265. SU JR, McNeil MM, Welsh KJ, Marquez PL, et al
    Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018.
    Vaccine. 2021 Jan 6. pii: S0264-410X(20)31614.
    PubMed     Abstract available

  266. GODINOT LD, Sicsic J, Lachatre M, Bouvet E, et al
    Quantifying preferences around vaccination against frequent, mild disease with risk for vulnerable persons: A discrete choice experiment among French hospital health care workers.
    Vaccine. 2021 Jan 5. pii: S0264-410X(20)31637.
    PubMed     Abstract available

    December 2020
  267. JIANG X, Shang X, Lin J, Zhao Y, et al
    Impacts of free vaccination policy and associated factors on influenza vaccination behavior of the elderly in China: A quasi-experimental study.
    Vaccine. 2020 Dec 31. pii: S0264-410X(20)31608.
    PubMed     Abstract available

  268. DAMJANOVSKA S, Smith C, Sayin I, Burant CJ, et al
    Adjuvant effect of type I interferon induced by many but not all commercial influenza vaccines.
    Vaccine. 2020 Dec 31. pii: S0264-410X(20)31631.
    PubMed     Abstract available

  269. ZHONG Y, Clapham HE, Aishworiya R, Chua YX, et al
    Childhood vaccinations: Hidden impact of COVID-19 on children in Singapore.
    Vaccine. 2020 Dec 26. pii: S0264-410X(20)31634.
    PubMed     Abstract available

  270. MORO PL, Marquez P
    Reports of cell-based influenza vaccine administered during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2013-2020.
    Vaccine. 2020 Dec 24. pii: S0264-410X(20)31613.
    PubMed     Abstract available

  271. THANGARAJAH D, Malo JA, Field E, Andrews R, et al
    Effectiveness of quadrivalent influenza vaccination in the first year of a funded childhood program in Queensland, Australia, 2018.
    Vaccine. 2020 Dec 23. pii: S0264-410X(20)31579.
    PubMed     Abstract available

  272. MCFADDEN K, Seale H
    A review of hospital-based interventions to improve inpatient influenza vaccination uptake for high-risk adults.
    Vaccine. 2020 Dec 21. pii: S0264-410X(20)31610.
    PubMed     Abstract available

  273. SCHMIT T, Kuntz M, Patel D, Nadeem Khan M, et al
    Anti-capsular immunity to Streptococcus pneumoniae serotype 22F prevents bacterial transmission in murine colonization and influenza virus co-infection models.
    Vaccine. 2020 Dec 18. pii: S0264-410X(20)31558.
    PubMed     Abstract available

  274. SPARROW E, Wood JG, Chadwick C, Newall AT, et al
    Global production capacity of seasonal and pandemic influenza vaccines in 2019.
    Vaccine. 2020 Dec 16. pii: S0264-410X(20)31585.
    PubMed     Abstract available

  275. FULVINI AA, Tuteja A, Le J, Pokorny BA, et al
    HA1 (Hemagglutinin) quantitation for influenza A H1N1 and H3N2 high yield reassortant vaccine candidate seed viruses by RP-UPLC.
    Vaccine. 2020 Dec 16. pii: S0264-410X(20)31563.
    PubMed     Abstract available

  276. BORRIELLO A, Master D, Pellegrini A, Rose JM, et al
    Preferences for a COVID-19 vaccine in Australia.
    Vaccine. 2020 Dec 16. pii: S0264-410X(20)31599.
    PubMed     Abstract available

  277. BOKEMPER SE, Huber GA, Gerber AS, James EK, et al
    Timing of COVID-19 vaccine approval and endorsement by public figures.
    Vaccine. 2020 Dec 16. pii: S0264-410X(20)31616.
    PubMed     Abstract available

  278. SANFTENBERG L, Kuehne F, Anraad C, Jung-Sievers C, et al
    Assessing the impact of shared decision making processes on influenza vaccination rates in adult patients in outpatient care: A systematic review and meta-analysis.
    Vaccine. 2020 Dec 14. pii: S0264-410X(20)31581.
    PubMed     Abstract available

  279. BROOCKMAN D, Kalla J, Guerrero A, Budolfson M, et al
    Broad cross-national public support for accelerated COVID-19 vaccine trial designs.
    Vaccine. 2020 Dec 14. pii: S0264-410X(20)31555.
    PubMed     Abstract available

  280. BRAVO-GRANDE JL, Asuncion Blanco-Gonzalez M, de la Torre-Robles JM, Asmat-Inostrosa MP, et al
    Vaccination adjuvated against hepatitis B in Spanish National Healthcare System (SNS) workers typed as non-responders to conventional vaccines.
    Vaccine. 2020 Dec 14. pii: S0264-410X(20)31571.
    PubMed     Abstract available

  281. SARINHO E, Goudouris E, Sole D
    BCG vaccine: Worrying proposal for COVID-19.
    Vaccine. 2020 Dec 13. pii: S0264-410X(20)31593.
    PubMed     Abstract available

  282. DEGELING C, Williams J, Carter SM, Moss R, et al
    Priority allocation of pandemic influenza vaccines in Australia - Recommendations of 3 community juries.
    Vaccine. 2020 Dec 11. pii: S0264-410X(20)31577.
    PubMed     Abstract available

  283. RASTEGAR M, Tavana M, Meraj A, Mina H, et al
    An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic.
    Vaccine. 2020 Dec 9. pii: S0264-410X(20)31589.
    PubMed     Abstract available

  284. HOLM MR, Poland GA
    Critical aspects of packaging, storage, preparation, and administration of mRNA and adenovirus-vectored COVID-19 vaccines for optimal efficacy.
    Vaccine. 2020 Dec 9. pii: S0264-410X(20)31584.

  285. CARIAS C, Pawaskar M, Nyaku M, Conway JH, et al
    Potential impact of COVID-19 pandemic on vaccination coverage in children: A case study of measles-containing vaccine administration in the United States (US).
    Vaccine. 2020 Dec 9. pii: S0264-410X(20)31557.
    PubMed     Abstract available

  286. DHAKAL S, Deshpande S, McMahon M, Strohmeier S, et al
    Female-biased effects of aging on a chimeric hemagglutinin stalk-based universal influenza virus vaccine in mice.
    Vaccine. 2020 Dec 5. pii: S0264-410X(20)31510.
    PubMed     Abstract available

  287. LENG A, Maitland E, Wang S, Nicholas S, et al
    Individual preferences for COVID-19 vaccination in China.
    Vaccine. 2020 Dec 5. pii: S0264-410X(20)31576.
    PubMed     Abstract available

  288. GHIGA I, Richardson S, Alvarez AMR, Kato M, et al
    PIPDeploy: Development and implementation of a gamified table top simulation exercise to strengthen national pandemic vaccine preparedness and readiness.
    Vaccine. 2020 Dec 5. pii: S0264-410X(20)31500.
    PubMed     Abstract available

  289. WENZEL NS, Atkins KE, van Leeuwen E, Halloran ME, et al
    Cost-effectiveness of live-attenuated influenza vaccination among school-age children.
    Vaccine. 2020 Dec 4. pii: S0264-410X(20)31282.
    PubMed     Abstract available

  290. MAYKIN MM, Heuser C, Feltovich H
    Pregnant people deserve the protection offered by SARS-CoV-2 vaccines.
    Vaccine. 2020 Dec 4. pii: S0264-410X(20)31572.

  291. BOTHUN LS
    COVID-19: The worst date to the senior dance.
    Vaccine. 2020;38:8066-8067.

    November 2020
  292. EDOKA I, Kohli-Lynch C, Fraser H, Hofman K, et al
    A cost-effectiveness analysis of South Africa's seasonal influenza vaccination programme.
    Vaccine. 2020 Nov 30. pii: S0264-410X(20)31468.
    PubMed     Abstract available

  293. HAVERI A, Ikonen N, Savolainen-Kopra C, Julkunen I, et al
    Long-lasting heterologous antibody responses after sequential vaccination with A/Indonesia/5/2005 and A/Vietnam/1203/2004 pre-pandemic influenza A(H5N1) virus vaccines.
    Vaccine. 2020 Nov 24. pii: S0264-410X(20)31494.
    PubMed     Abstract available

  294. VANDER STICHELE RH, Hay C, Fladvad M, Sturkenboom MCJM, et al
    How to ensure we can track and trace global use of COVID-19 vaccines?
    Vaccine. 2020 Nov 24. pii: S0264-410X(20)31508.

  295. KITANO T, Aoki H
    A model for the incremental burden of invasive Haemophilus influenzae type b due to a decline of childhood vaccination during the COVID-19 outbreak: A dynamic transmission model in Japan.
    Vaccine. 2020 Nov 24. pii: S0264-410X(20)31506.
    PubMed     Abstract available

  296. URA T, Yamashita A, Mizuki N, Okuda K, et al
    New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Vaccine. 2020 Nov 24. pii: S0264-410X(20)31507.
    PubMed     Abstract available

  297. KITTIKRAISAK W, Phadungkiatwatana P, Ditsungnoen D, Kaoiean S, et al
    Comparison of influenza antibody titers among women who were vaccinated in the 2(nd) and the 3(rd) trimesters of pregnancy.
    Vaccine. 2020 Nov 23. pii: S0264-410X(20)31472.
    PubMed     Abstract available

  298. DRORI Y, Pando R, Sefty H, Rosenberg A, et al
    Influenza vaccine effectiveness against laboratory-confirmed influenza in a vaccine-mismatched influenza B-dominant season.
    Vaccine. 2020 Nov 23. pii: S0264-410X(20)31394.
    PubMed     Abstract available

  299. GANGULY M, Yeolekar L, Tyagi P, Sagar U, et al
    Evaluation of manufacturing feasibility and safety of an MDCK cell-based live attenuated influenza vaccine (LAIV) platform.
    Vaccine. 2020 Nov 20. pii: S0264-410X(20)31424.
    PubMed     Abstract available

  300. TUCKERMAN JL, Kaufman J, Danchin M, Marshall HS, et al
    Influenza vaccination: A qualitative study of practice level barriers from medical practitioners caring for children with special risk medical conditions.
    Vaccine. 2020;38:7806-7814.
    PubMed     Abstract available

  301. GARCIA LY, Cerda AA
    Acceptance of a COVID-19 vaccine: A multifactorial consideration.
    Vaccine. 2020;38:7587.

  302. GRAFFIGNA G, Palamenghi L, Barello S, Stefania B, et al
    "Cultivating" acceptance of a COVID-19 vaccination program: Lessons from Italy.
    Vaccine. 2020;38:7585-7586.

  303. COUDEVILLE L, Gomez GB, Jollivet O, Harris RC, et al
    Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry.
    Vaccine. 2020;38:7588-7595.

  304. ZHANG W, Gao J, Chen L, Tian J, et al
    Estimated influenza illnesses and hospitalizations averted by influenza vaccination among children aged 6-59 months in Suzhou, China, 2011/12 to 2015/16 influenza seasons.
    Vaccine. 2020 Nov 8. pii: S0264-410X(20)31389.
    PubMed     Abstract available

  305. CHIU SS, Chua H, Kwan MYW, Chan ELY, et al
    Influenza vaccination effectiveness in preventing influenza hospitalization in children, Hong Kong, winter 2019/20.
    Vaccine. 2020 Nov 6. pii: S0264-410X(20)31401.
    PubMed     Abstract available

  306. SARASTY O, Carpio CE, Hudson D, Guerrero-Ochoa PA, et al
    The demand for a COVID-19 vaccine in Ecuador.
    Vaccine. 2020 Nov 6. pii: S0264-410X(20)31439.
    PubMed     Abstract available

  307. KESKE S, Mutters NT, Tsioutis C, Ergonul O, et al
    Influenza vaccination among infection control teams: A EUCIC survey prior to COVID-19 pandemic.
    Vaccine. 2020 Nov 5. pii: S0264-410X(20)31427.
    PubMed     Abstract available

  308. CHEN WH, Tao X, Agrawal AS, Algaissi A, et al
    Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement.
    Vaccine. 2020;38:7533-7541.
    PubMed     Abstract available

    October 2020
  309. VESIKARI T, Ramsey K, Pitisuttithum P, Capeding R, et al
    Repeated exposure to an MF-59 adjuvanted quadrivalent subunit influenza vaccine (aQIV) in children: Results of two revaccination studies.
    Vaccine. 2020 Oct 30. pii: S0264-410X(20)31330.
    PubMed     Abstract available

  310. BONANNI P, Angelillo IF, Villani A, Biasci P, et al
    Maintain and increase vaccination coverage in children, adolescents, adults and elderly people: Let's avoid adding epidemics to the pandemic: Appeal from the Board of the Vaccination Calendar for Life in Italy: Maintain and increase coverage also by r
    Vaccine. 2020 Oct 30. pii: S0264-410X(20)31318.
    PubMed     Abstract available

  311. CARCELEN AC, Vilajeliu A, Malik F, Gilman RH, et al
    Perceptions and attitudes towards vaccination during pregnancy in a peri urban area of Lima, Peru.
    Vaccine. 2020 Oct 30. pii: S0264-410X(20)31325.
    PubMed     Abstract available

  312. LIU B, Shi P, Wang T, Zhao Y, et al
    Recombinant H7 hemagglutinin expressed in glycoengineered Pichia pastoris forms nanoparticles that protect mice from challenge with H7N9 influenza virus.
    Vaccine. 2020 Oct 29. pii: S0264-410X(20)31370.
    PubMed     Abstract available

  313. SCHNEIKART G, Tavarini S, Sammicheli C, Torricelli G, et al
    The respiratory syncytial virus fusion protein-specific B cell receptor repertoire reshaped by post-fusion subunit vaccination.
    Vaccine. 2020 Oct 29. pii: S0264-410X(20)31371.
    PubMed     Abstract available

  314. SCHOCH-SPANA M, Brunson EK, Long R, Ruth A, et al
    The public's role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States.
    Vaccine. 2020 Oct 29. pii: S0264-410X(20)31368.
    PubMed     Abstract available

  315. LIU X, Drelich A, Li W, Chen C, et al
    Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice.
    Vaccine. 2020;38:7205-7212.
    PubMed     Abstract available

  316. GUEBRE-XABIER M, Patel N, Tian JH, Zhou B, et al
    NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge.
    Vaccine. 2020 Oct 23. pii: S0264-410X(20)31373.
    PubMed     Abstract available

  317. CHANDIR S, Siddiqi DA, Mehmood M, Setayesh H, et al
    Impact of COVID-19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: An analysis of provincial electronic immunization registry data.
    Vaccine. 2020;38:7146-7155.
    PubMed     Abstract available

  318. RUSCIO BA, Hotez P
    Expanding global and national influenza vaccine systems to match the COVID-19 pandemic response.
    Vaccine. 2020 Oct 21. pii: S0264-410X(20)31364.

  319. BELL S, Clarke R, Mounier-Jack S, Walker JL, et al
    Parents' and guardians' views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England.
    Vaccine. 2020 Oct 19. pii: S0264-410X(20)31321.
    PubMed     Abstract available

  320. ZHAI Y, Santibanez TA, Kahn KE, Srivastav A, et al
    Rural, urban, and suburban differences in influenza vaccination coverage among children.
    Vaccine. 2020 Oct 15. pii: S0264-410X(20)31324.
    PubMed     Abstract available

  321. GARCIA PJ, George PE, Romero C, Soto G, et al
    "The flu... is a little more complicated than a cold": Knowledge, beliefs, and practices related to influenza and influenza vaccination among at-risk populations and health professionals in Peru.
    Vaccine. 2020 Oct 15. pii: S0264-410X(20)31236.
    PubMed     Abstract available

  322. VERGKIZI S, Nikolakakis I
    Bacillus Calmette-Guerin (BCG) vaccine generates immunoregulatory cells in the cervical lymph nodes in guinea pigs injected intra dermally.
    Vaccine. 2020 Oct 15. pii: S0264-410X(20)31284.
    PubMed     Abstract available

  323. MALTEZOU HC, Theodoridou K, Tseroni M, Raftopoulos V, et al
    Influenza vaccination policies for health workers in low-income and middle-income countries: A cross-sectional survey, January-March 2020.
    Vaccine. 2020 Oct 12. pii: S0264-410X(20)31276.
    PubMed     Abstract available

  324. MO Y, Zeng J, Xiao C, Zhang, et al
    Effectiveness and safety of pneumococcal vaccines used alone or combined with influenza vaccination in dialysis patients: A systematic review and meta-analysis.
    Vaccine. 2020 Oct 12. pii: S0264-410X(20)31262.
    PubMed     Abstract available

  325. GOLDMAN RD, Yan TD, Seiler M, Parra Cotanda C, et al
    Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey.
    Vaccine. 2020 Oct 10. pii: S0264-410X(20)31317.
    PubMed     Abstract available

  326. SAFAVI A, Kefayat A, Mahdevar E, Abiri A, et al
    Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
    Vaccine. 2020 Oct 9. pii: S0264-410X(20)31307.
    PubMed     Abstract available

  327. RONCATI L, Vadala M, Corazzari V, Palmieri B, et al
    COVID-19 vaccine and boosted immunity: Nothing ad interim to do?
    Vaccine. 2020 Oct 9. pii: S0264-410X(20)31303.
    PubMed     Abstract available

  328. SINGH JA
    COVID-19 vaccine trials: Duty of care and standard of prevention considerations.
    Vaccine. 2020 Oct 9. pii: S0264-410X(20)31302.

  329. MACIAS AE, McElhaney JE, Chaves SS, Nealon J, et al
    The disease burden of influenza beyond respiratory illness.
    Vaccine. 2020 Oct 8. pii: S0264-410X(20)31209.
    PubMed     Abstract available

  330. GUILFOYLE K, Major D, Skeldon S, James H, et al
    Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model.
    Vaccine. 2020 Oct 6. pii: S0264-410X(20)31233.
    PubMed     Abstract available

  331. LEE JKH, Lam GKL, Shin T, Samson SI, et al
    Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis.
    Vaccine. 2020 Oct 6. pii: S0264-410X(20)31146.
    PubMed     Abstract available

  332. WOLF J, Hansen R, Hassis K, Lapps W, et al
    The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases.
    Vaccine. 2020 Oct 5. pii: S0264-410X(20)31228.

  333. CUSTERS J, Kim D, Leyssen M, Gurwith M, et al
    Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment.
    Vaccine. 2020 Oct 3. pii: S0264-410X(20)31160.
    PubMed     Abstract available

  334. HOSHI SL, Shono A, Seposo X, Okubo I, et al
    Cost-effectiveness analysis of influenza vaccination during pregnancy in Japan.
    Vaccine. 2020 Oct 2. pii: S0264-410X(20)31180.
    PubMed     Abstract available

  335. NIANG M, Deming ME, Goudiaby D, Diop OM, et al
    Immunogenicity of seasonal inactivated influenza and inactivated polio vaccines among children in Senegal: Results from a cluster-randomized trial.
    Vaccine. 2020 Oct 1. pii: S0264-410X(20)31230.
    PubMed     Abstract available

    September 2020
  336. TEMPIA S, Moyes J, Cohen AL, Walaza S, et al
    Influenza economic burden among potential target risk groups for immunization in South Africa, 2013-2015.
    Vaccine. 2020 Sep 23. pii: S0264-410X(20)31193.
    PubMed     Abstract available

  337. ANDREW MK, McNeil SA
    Influenza vaccination and the evolution of evidence-based recommendations for older adults: A Canadian perspective.
    Vaccine. 2020 Sep 18. pii: S0264-410X(20)31153.
    PubMed     Abstract available

  338. DETOC M, Bruel S, Frappe P, Tardy B, et al
    Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic.
    Vaccine. 2020 Sep 17. pii: S0264-410X(20)31201.
    PubMed     Abstract available

  339. ALHALASEH L, Fayoumi H, Khalil B
    The Health Belief Model in predicting healthcare workers' intention for influenza vaccine uptake in Jordan.
    Vaccine. 2020 Sep 16. pii: S0264-410X(20)31128.
    PubMed     Abstract available

  340. MCMAHON M, Strohmeier S, Rajendran M, Capuano C, et al
    Correctly folded - but not necessarily functional - influenza virus neuraminidase is required to induce protective antibody responses in mice.
    Vaccine. 2020 Sep 15. pii: S0264-410X(20)31119.
    PubMed     Abstract available

  341. DEAN NE, Pastore Y Piontti A, Madewell ZJ, Cummings DAT, et al
    Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials.
    Vaccine. 2020 Sep 15. pii: S0264-410X(20)31191.
    PubMed     Abstract available

  342. BRUCE-STASKAL PJ, Woods RM, Borisov OV, Massare MJ, et al
    Hemagglutinin from multiple divergent influenza A and B viruses bind to a distinct branched, sialylated poly-LacNAc glycan by surface plasmon resonance.
    Vaccine. 2020 Sep 11. pii: S0264-410X(20)31078.
    PubMed     Abstract available

  343. WANG K, Wong ELY, Ho KF, Cheung AWL, et al
    Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: A cross-sectional survey.
    Vaccine. 2020 Sep 10. pii: S0264-410X(20)31175.
    PubMed     Abstract available

  344. OTIENO NA, Nyawanda B, Otiato F, Adero M, et al
    Knowledge and attitudes towards influenza and influenza vaccination among pregnant women in Kenya.
    Vaccine. 2020 Sep 3. pii: S0264-410X(20)31046.
    PubMed     Abstract available

  345. LAU LHW, Lee SS, Wong NS
    The continuum of influenza vaccine hesitancy among nursing professionals in Hong Kong.
    Vaccine. 2020 Sep 2. pii: S0264-410X(20)31079.
    PubMed     Abstract available

    August 2020
  346. KASE T, Inoue M, Morikawa S, Kumashiro H, et al
    Comparison of immunogenicity between candidate influenza A(H3N2) virus vaccine strains in Japan: A randomized controlled trial using a monovalent vaccine of A/Saitama/103/2014 (CEXP-002) and A/Hong Kong/4801/2014 (X-263).
    Vaccine. 2020 Aug 29. pii: S0264-410X(20)31066.
    PubMed     Abstract available

  347. TALAYEV V, Zaichenko I, Svetlova M, Matveichev A, et al
    Low-dose influenza vaccine Grippol Quadrivalent with adjuvant Polyoxidonium induces a T helper-2 mediated humoral immune response and increases NK cell activity.
    Vaccine. 2020 Aug 29. pii: S0264-410X(20)30984.
    PubMed     Abstract available

  348. HOWE AS, Pointon L, Gauld N, Paynter J, et al
    Pertussis and influenza immunisation coverage of pregnant women in New Zealand.
    Vaccine. 2020 Aug 28. pii: S0264-410X(20)31071.
    PubMed     Abstract available

  349. AMIN AB, Nunes MC, Tapia MD, Madhi SA, et al
    Immunogenicity of influenza vaccines administered to pregnant women in randomized clinical trials in Mali and South Africa.
    Vaccine. 2020 Aug 28. pii: S0264-410X(20)30933.
    PubMed     Abstract available

  350. TOMITA Y, Sato R, Ikeda T, Sakagami T, et al
    BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.
    Vaccine. 2020 Aug 20. pii: S0264-410X(20)31086.
    PubMed     Abstract available

  351. REITER PL, Pennell ML, Katz ML
    Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?
    Vaccine. 2020 Aug 20. pii: S0264-410X(20)31084.
    PubMed     Abstract available

  352. PAGET J, Caini S, Cowling B, Esposito S, et al
    The impact of influenza vaccination on the COVID-19 pandemic? Evidence and lessons for public health policies.
    Vaccine. 2020 Aug 19. pii: S0264-410X(20)31065.

  353. GALILI U
    Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present alpha-gal epitopes.
    Vaccine. 2020 Aug 19. pii: S0264-410X(20)31073.
    PubMed     Abstract available

  354. ZHOU F, Lindley MC
    Variability in influenza vaccination opportunities and coverage among privately insured children.
    Vaccine. 2020 Aug 18. pii: S0264-410X(20)30992.
    PubMed     Abstract available

  355. HUNG MC, Lu PJ, Srivastav A, Cheng YJ, et al
    Influenza vaccination coverage among adults with diabetes, United States, 2007-08 through 2017-18 seasons.
    Vaccine. 2020 Aug 17. pii: S0264-410X(20)31029.
    PubMed     Abstract available

  356. NEWMAN KL, Stewart LM, Scott EM, Tielsch JM, et al
    Assessment of indirect protection from maternal influenza immunization among non-vaccinated household family members in a randomized controlled trial in Sarlahi, Nepal.
    Vaccine. 2020 Aug 17. pii: S0264-410X(20)31045.
    PubMed     Abstract available

  357. BENNETT N, Crouch S, Hoskins A, Malloy MJ, et al
    'Closing the gap': Evaluating the success of non-mandatory strategies for influenza vaccination of Victorian healthcare workers.
    Vaccine. 2020 Aug 12. pii: S0264-410X(20)31044.
    PubMed     Abstract available

  358. BALASUBRAMANI GK, Choi WS, Nowalk MP, Zimmerman RK, et al
    Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19.
    Vaccine. 2020 Aug 12. pii: S0264-410X(20)31032.
    PubMed     Abstract available

  359. GRADY C, Shah S, Miller F, Danis M, et al
    So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development.
    Vaccine. 2020 Aug 11. pii: S0264-410X(20)31048.
    PubMed     Abstract available

  360. KASSIANOS G, MacDonald P, Aloysius I, Reynolds A, et al
    Implementation of the United Kingdom's childhood influenza national vaccination programme: A review of clinical impact and lessons learned over six influenza seasons.
    Vaccine. 2020;38:5747-5758.
    PubMed     Abstract available

  361. FREW PM, Paine MB, Rouphael N, Schamel J, et al
    Acceptability of an inactivated influenza vaccine delivered by microneedle patch: Results from a phase I clinical trial of safety, reactogenicity, and immunogenicity.
    Vaccine. 2020 Aug 10. pii: S0264-410X(20)31006.
    PubMed     Abstract available

  362. YITBAREK K, Abraham G, Girma T, Tilahun T, et al
    The effect of Bacillus Calmette-Guerin (BCG) vaccination in preventing sever infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.
    Vaccine. 2020 Aug 10. pii: S0264-410X(20)31049.
    PubMed     Abstract available

  363. STUURMAN AL, Bollaerts K, Alexandridou M, Biccler J, et al
    Vaccine effectiveness against laboratory-confirmed influenza in Europe - Results from the DRIVE network during season 2018/19.
    Vaccine. 2020 Aug 7. pii: S0264-410X(20)31005.
    PubMed     Abstract available

  364. CHAN MS, Jamieson KH, Albarracin D
    Prospective associations of regional social media messages with attitudes and actual vaccination: A big data and survey study of the influenza vaccine in the United States.
    Vaccine. 2020 Aug 6. pii: S0264-410X(20)30985.
    PubMed     Abstract available

  365. MARELLAPUDI A, King AR, Bednarczyk RA
    Presentation of caregiver-specific vaccine-related information on National Cancer Institute designated cancer center websites.
    Vaccine. 2020 Aug 1. pii: S0264-410X(20)30983.
    PubMed     Abstract available

    July 2020
  366. REN W, Sun H, Gao GF, Chen J, et al
    Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates.
    Vaccine. 2020;38:5653-5658.
    PubMed     Abstract available

  367. WANG S, Zheng Y, Jin X, Gan Z, et al
    Efficacy and safety of a live attenuated influenza vaccine in Chinese healthy children aged 3-17 years in one study center of a randomized, double-blind, placebo-controlled phase 3 clinical trial, 2016/17 season.
    Vaccine. 2020 Jul 31. pii: S0264-410X(20)30932.
    PubMed     Abstract available

  368. FORMAN R, Anderson M, Jit M, Mossialos E, et al
    Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines.
    Vaccine. 2020 Jul 31. pii: S0264-410X(20)31012.

  369. KOCHHAR S, Excler JL, Kim D, Robertson JS, et al
    The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines.
    Vaccine. 2020 Jul 31. pii: S0264-410X(20)30944.
    PubMed     Abstract available

  370. YEOLEKAR LR, Guilfoyle K, Ganguly M, Tyagi P, et al
    Immunogenicity and efficacy comparison of MDCK cell-based and egg-based live attenuated influenza vaccines of H5 and H7 subtypes in ferrets.
    Vaccine. 2020 Jul 30. pii: S0264-410X(20)30972.
    PubMed     Abstract available

  371. MAZAGATOS C, Godoy P, Munoz Almagro C, Pozo F, et al
    Effectiveness of influenza vaccination during pregnancy to prevent severe infection in children under 6 months of age, Spain, 2017-2019.
    Vaccine. 2020 Jul 30. pii: S0264-410X(20)30914.
    PubMed     Abstract available

  372. ELLISON TJ, Talbott GC, Henderson DR
    VaxiPatch, a novel vaccination system comprised of subunit antigens, adjuvants and microneedle skin delivery: An application to influenza B/Colorado/06/2017.
    Vaccine. 2020 Jul 30. pii: S0264-410X(20)30958.
    PubMed     Abstract available

  373. DIVINO V, Krishnarajah G, Pelton SI, Mould-Quevedo J, et al
    A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017-18 influenza season.
    Vaccine. 2020 Jul 29. pii: S0264-410X(20)30936.
    PubMed     Abstract available

  374. KIM YH, Bang YJ, Park HJ, Li Ko H, et al
    Inactivated influenza vaccine formulated with single-stranded RNA-based adjuvant confers mucosal immunity and cross-protection against influenza virus infection.
    Vaccine. 2020 Jul 29. pii: S0264-410X(20)30935.
    PubMed     Abstract available

  375. MALTEZOU HC, Theodoridou K, Poland G
    Influenza immunization and COVID-19.
    Vaccine. 2020 Jul 29. pii: S0264-410X(20)30989.

  376. KIM HM, Kim DY, Kang YM, Cho HK, et al
    Immunogenicity and protective efficacy of clade and clade H5Nx avian influenza antigen bank vaccines in mice, Korea.
    Vaccine. 2020 Jul 27. pii: S0264-410X(20)30951.

  377. CHU K, Xu K, Tang R, Tian X, et al
    Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: A randomized, double-blind, controlled phase III study in healthy population aged >/=3 years.
    Vaccine. 2020 Jul 27. pii: S0264-410X(20)30872.
    PubMed     Abstract available

  378. VERDIJK P, van der Plas JL, van Brummelen EMJ, Jeeninga RE, et al
    First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial.
    Vaccine. 2020 Jul 25. pii: S0264-410X(20)30947.
    PubMed     Abstract available

  379. KAVIAN N, Hachim A, Poon LLM, Valkenburg SA, et al
    Vaccination with ADCC activating HA peptide epitopes provides 1 partial protection from influenza infection.
    Vaccine. 2020 Jul 24. pii: S0264-410X(20)30908.
    PubMed     Abstract available

  380. WEI J, Li Z, Yang Y, Ma X, et al
    A biomimetic VLP influenza vaccine with interior NP/exterior M2e antigens constructed through a temperature shift-based encapsulation strategy.
    Vaccine. 2020 Jul 23. pii: S0264-410X(20)30915.
    PubMed     Abstract available

  381. LEBRUN-HARRIS LA, Mendel Van Alstyne JA, Sripipatana A
    Influenza vaccination among U.S. pediatric patients receiving care from federally funded health centers.
    Vaccine. 2020 Jul 23. pii: S0264-410X(20)30934.
    PubMed     Abstract available

  382. MORO PL, Woo EJ, Marquez P, Cano M, et al
    Monitoring the safety of high-dose, trivalent inactivated influenza vaccine in the vaccine adverse event reporting system (VAERS), 2011 - 2019.
    Vaccine. 2020 Jul 21. pii: S0264-410X(20)30907.
    PubMed     Abstract available

  383. SAUNIER F, Berthelot P, Mottet-Auselo B, Pelissier C, et al
    Impact of a decision-aid tool on influenza vaccine coverage among HCW in two French hospitals: A cluster-randomized trial.
    Vaccine. 2020 Jul 16. pii: S0264-410X(20)30911.
    PubMed     Abstract available

  384. SKARLUPKA AL, Handel A, Ross TM
    Influenza hemagglutinin antigenic distance measures capture trends in HAI differences and infection outcomes, but are not suitable predictive tools.
    Vaccine. 2020 Jul 15. pii: S0264-410X(20)30828.
    PubMed     Abstract available

  385. JUNG YJ, Kim KH, Ko EJ, Lee Y, et al
    Adjuvant effects of killed Lactobacillus casei DK128 on enhancing T helper type 1 immune responses and the efficacy of influenza vaccination in normal and CD4-deficient mice.
    Vaccine. 2020 Jul 13. pii: S0264-410X(20)30878.
    PubMed     Abstract available

  386. HASHEMZADEH A, Avan A, Ferns GA, Khazaei M, et al
    Vaccines based on virus-like nano-particles for use against Middle East Respiratory Syndrome (MERS) coronavirus.
    Vaccine. 2020 Jul 11. pii: S0264-410X(20)30903.
    PubMed     Abstract available

  387. KOCHHAR S, Salmon DA
    Planning for COVID-19 vaccines safety surveillance.
    Vaccine. 2020 Jul 10. pii: S0264-410X(20)30913.

  388. SU QD, Yi Y, Zou YN, Jia ZY, et al
    The biological characteristics of SARS-CoV-2 spike protein Pro330-Leu650.
    Vaccine. 2020;38:5071-5075.
    PubMed     Abstract available

  389. OSAMA EL-GENDY A, Saeed H, Ali AMA, Zawbaa HM, et al
    Bacillus Calmette-Guerin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality.
    Vaccine. 2020 Jul 3. pii: S0264-410X(20)30886.
    PubMed     Abstract available

  390. MELIDOU A, Hungnes O, Pereyaslov D, Adlhoch C, et al
    Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018-2019.
    Vaccine. 2020 Jul 2. pii: S0264-410X(20)30804.
    PubMed     Abstract available

    June 2020
  391. BALZARINI F, Frascella B, Oradini-Alacreu A, Gaetti G, et al
    Does the use of personal electronic health records increase vaccine uptake? A systematic review.
    Vaccine. 2020 Jun 30. pii: S0264-410X(20)30738.
    PubMed     Abstract available

  392. RAJARAM S, Wojcik R, Moore C, Ortiz de Lejarazu R, et al
    The impact of candidate influenza virus and egg-based manufacture on vaccine effectiveness: Literature review and expert consensus.
    Vaccine. 2020 Jun 26. pii: S0264-410X(20)30794.
    PubMed     Abstract available

  393. LEE H, Kim HJ, Choe YJ, Shin JY, et al
    Signals and trends of Guillain-Barre syndrome after the introduction of live-attenuated vaccines for influenza in the US and South Korean adverse event reporting systems.
    Vaccine. 2020 Jun 26. pii: S0264-410X(20)30824.
    PubMed     Abstract available

  394. PAGUIO JA, Yao JS, Dee EC
    Silver lining of COVID-19: Heightened global interest in pneumococcal and influenza vaccines, an infodemiology study.
    Vaccine. 2020 Jun 25. pii: S0264-410X(20)30855.
    PubMed     Abstract available

  395. GARCIA LY, Cerda AA
    Contingent assessment of the COVID-19 vaccine.
    Vaccine. 2020 Jun 25. pii: S0264-410X(20)30854.
    PubMed     Abstract available

  396. GUIDRY JPD, Coman IA, Vraga EK, O'Donnell NH, et al
    (S)pin the flu vaccine: Recipes for concern.
    Vaccine. 2020 Jun 24. pii: S0264-410X(20)30773.
    PubMed     Abstract available

  397. KARTOGLU UH, Moore KL, Lloyd JS
    Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers.
    Vaccine. 2020 Jun 23. pii: S0264-410X(20)30842.

  398. HENN W
    Allocation criteria for an initial shortage of a future SARS-CoV-2 vaccine and necessary measures for global immunity.
    Vaccine. 2020 Jun 23. pii: S0264-410X(20)30844.

  399. BARAL R, Li X, Willem L, Antillon M, et al
    The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models.
    Vaccine. 2020 Jun 22. pii: S0264-410X(20)30822.
    PubMed     Abstract available

  400. MOEHLING KK, Zimmerman RK, Nowalk MP, Jeng Lin C, et al
    A randomized controlled trial of antibody response to 2018-19 cell-based vs. egg-based quadrivalent inactivated influenza vaccine in children.
    Vaccine. 2020 Jun 21. pii: S0264-410X(20)30796.
    PubMed     Abstract available

  401. GRIECO L, Panovska-Griffiths J, van Leeuwen E, Grove P, et al
    Exploring the role of mass immunisation in influenza pandemic preparedness: A modelling study for the UK context.
    Vaccine. 2020 Jun 20. pii: S0264-410X(20)30805.
    PubMed     Abstract available

  402. VAN AALST R, Russo EM, Neupane N, Mahmud SM, et al
    Comparing the impact of high-dose versus standard dose influenza vaccines on hospitalization cost for cardiovascular and respiratory diseases: Economic assessment in the US Veteran population during 5 respiratory seasons using an instrumental variable
    Vaccine. 2020 Jun 20. pii: S0264-410X(20)30735.
    PubMed     Abstract available

  403. ULYTE A, Wei W, Gruebner O, Bahler C, et al
    Insights into the protective effects of influenza vaccination: More hospitalizations but lower follow-up mortality during the 2014/15 influenza season in a Swiss cohort.
    Vaccine. 2020 Jun 19. pii: S0264-410X(20)30791.
    PubMed     Abstract available

  404. MUNOZ FM, Patel SM, Jackson LA, Swamy GK, et al
    Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants.
    Vaccine. 2020 Jun 19. pii: S0264-410X(20)30704.
    PubMed     Abstract available

  405. THINDWA D, Garcia Quesada M, Liu Y, Bennett J, et al
    Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality.
    Vaccine. 2020 Jun 19. pii: S0264-410X(20)30833.

  406. WOLFF GG
    Letter to the Editor.
    Vaccine. 2020;38:4651.

  407. LAYTON JB, McGrath LJ, Sahrmann JM, Ma Y, et al
    Comparative safety of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease.
    Vaccine. 2020 Jun 18. pii: S0264-410X(20)30793.
    PubMed     Abstract available

  408. KELLY MK, Grundmeier RW, Stephens-Shields AJ, Localio R, et al
    Missed opportunities for human papillomavirus vaccination at office visits during which influenza vaccine was administered: An AAP pediatric research in office settings (PROS) national primary care research network study.
    Vaccine. 2020 Jun 12. pii: S0264-410X(20)30757.
    PubMed     Abstract available

  409. COOKENHAM T, Lanzer KG, Gage E, Lorenzo EC, et al
    Vaccination of aged mice with adjuvanted recombinant influenza nucleoprotein enhances protective immunity.
    Vaccine. 2020 Jun 12. pii: S0264-410X(20)30752.
    PubMed     Abstract available

  410. AIDOUD A, Marlet J, Angoulvant D, Debacq C, et al
    Influenza vaccination as a novel means of preventing coronary heart disease: Effectiveness in older adults.
    Vaccine. 2020 Jun 11. pii: S0264-410X(20)30725.
    PubMed     Abstract available

  411. PAGLIUSI S, Jarrett S, Hayman B, Kreysa U, et al
    Emerging manufacturers engagements in the COVID -19 vaccine research, development and supply.
    Vaccine. 2020 Jun 11. pii: S0264-410X(20)30795.
    PubMed     Abstract available

  412. CHOI EJ, Park JH, Chun BC
    Cost effectiveness of trivalent and quadrivalent influenza vaccines in 50- to 64-year-old adults in Korea.
    Vaccine. 2020 Jun 9. pii: S0264-410X(20)30710.
    PubMed     Abstract available

  413. SCHAEFER GO, Tam CC, Savulescu J, Voo TC, et al
    COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies?
    Vaccine. 2020 Jun 4. pii: S0264-410X(20)30768.
    PubMed     Abstract available

  414. MORALES KF, Menning L, Lambach P
    The faces of influenza vaccine recommendation: A Literature review of the determinants and barriers to health providers' recommendation of influenza vaccine in pregnancy.
    Vaccine. 2020 Jun 2. pii: S0264-410X(20)30513.
    PubMed     Abstract available

  415. GLOVER C, Crawford N, Leeb A, Wood N, et al
    Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety.
    Vaccine. 2020 Jun 1. pii: S0264-410X(20)30560.
    PubMed     Abstract available

    May 2020
  416. POWELL AM, Luo Z, Martin L, Wan Z, et al
    Corrigendum to "The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals
    Vaccine. 2020 May 27. pii: S0264-410X(20)30673.

  417. LAMBERT PH, Ambrosino DM, Andersen SR, Baric RS, et al
    Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Vaccine. 2020 May 25. pii: S0264-410X(20)30709.
    PubMed     Abstract available

  418. PAUDEL M, Mahmud S, Buikema A, Korrer S, et al
    Relative vaccine efficacy of high-dose versus standard-dose influenza vaccines in preventing probable influenza in a Medicare Fee-for-Service population.
    Vaccine. 2020 May 20. pii: S0264-410X(20)30638.
    PubMed     Abstract available

  419. PLOTKIN SA, Caplan A
    Extraordinary diseases require extraordinary solutions.
    Vaccine. 2020;38:3987-3988.

  420. KOPSIDAS I, Tsopela GC, Maroudi-Manta S, Kourkouni E, et al
    Increasing healthcare workers' uptake of seasonal influenza vaccination in a tertiary-care pediatric hospital in Greece with a low-cost, tailor-made, multifaceted strategy.
    Vaccine. 2020 May 16. pii: S0264-410X(20)30639.
    PubMed     Abstract available

  421. ORTA OR, Hatch EE, Regan AK, Perkins R, et al
    A prospective study of influenza vaccination and time to pregnancy.
    Vaccine. 2020 May 11. pii: S0264-410X(20)30548.
    PubMed     Abstract available

  422. MALTEZOU HC, Asimakopoulos G, Stavrou S, Daskalakis G, et al
    Effectiveness of quadrivalent influenza vaccine in pregnant women and infants, 2018-2019.
    Vaccine. 2020 May 8. pii: S0264-410X(20)30564.
    PubMed     Abstract available

  423. WON G, Senevirathne A, Lee JH
    Salmonella Enteritidis ghost vaccine carrying the hemagglutinin globular head (HA1) domain from H1N1 virus protects against salmonellosis and influenza in chickens.
    Vaccine. 2020 May 8. pii: S0264-410X(20)30594.
    PubMed     Abstract available

  424. WRAITH S, Nachbagauer R, Balmaseda A, Stadlbauer D, et al
    Antibody responses to influenza A(H1N1)pdm infection.
    Vaccine. 2020 May 7. pii: S0264-410X(20)30586.
    PubMed     Abstract available

  425. TEMPIA S, Walaza S, Moyes J, McMorrow ML, et al
    Influenza disease burden among potential target risk groups for immunization in South Africa, 2013-2015.
    Vaccine. 2020 May 7. pii: S0264-410X(20)30539.
    PubMed     Abstract available

  426. LIAO Q, Ng TWY, Cowling BJ
    What influenza vaccination programmes are preferred by healthcare personnel? A discrete choice experiment.
    Vaccine. 2020 May 7. pii: S0264-410X(20)30630.
    PubMed     Abstract available

  427. WAGNER AL, Gordon A, Tallo VL, Simaku A, et al
    Intent to obtain pediatric influenza vaccine among mothers in four middle income countries.
    Vaccine. 2020 May 6. pii: S0264-410X(20)30508.
    PubMed     Abstract available

    A Veterinary Vaccine Development Process Map to assist in the development of new vaccines.
    Vaccine. 2020 May 6. pii: S0264-410X(20)30613.
    PubMed     Abstract available

  429. SMITH LE, Amlot R, Weinman J, Yiend J, et al
    Why do parents not re-vaccinate their child for influenza? A prospective cohort study.
    Vaccine. 2020 May 5. pii: S0264-410X(20)30509.
    PubMed     Abstract available

  430. BELL S, Chantler T, Paterson P, Mounier-Jack S, et al
    Is flu vaccination opt-out feasible? Evidence from vaccination programme implementers and managers in the English National Health Service.
    Vaccine. 2020 May 4. pii: S0264-410X(20)30506.
    PubMed     Abstract available

  431. HAWKSWORTH A, Lockhart R, Crowe J, Maeso R, et al
    Replication of live attenuated influenza vaccine viruses in human nasal epithelial cells is associated with H1N1 vaccine effectiveness.
    Vaccine. 2020 May 3. pii: S0264-410X(20)30462.
    PubMed     Abstract available

    April 2020
  432. NGUYEN VH, Vizzotti C, Uruena A, Giglio N, et al
    Cost-effectiveness of introducing an MF59-adjuvanted trivalent influenza vaccine for older adults in Argentina.
    Vaccine. 2020;38:3682-3689.
    PubMed     Abstract available

  433. HERST CV, Burkholz S, Sidney J, Sette A, et al
    An effective CTL peptide vaccine for Ebola Zaire Based on Survivors' CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design.
    Vaccine. 2020 Apr 28. pii: S0264-410X(20)30518.
    PubMed     Abstract available

  434. WANG SH, Chen J, Smith D, Cao Z, et al
    A novel combination of intramuscular vaccine adjuvants, nanoemulsion and CpG produces an effective immune response against influenza A virus.
    Vaccine. 2020;38:3537-3544.
    PubMed     Abstract available

  435. HOSANGADI D, Warmbrod KL, Martin EK, Adalja A, et al
    Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic.
    Vaccine. 2020 Apr 20. pii: S0264-410X(20)30530.

  436. KAUFMAN J, Attwell K, Tuckerman J, O'Sullivan J, et al
    Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: A pilot study.
    Vaccine. 2020 Apr 19. pii: S0264-410X(20)30469.
    PubMed     Abstract available

  437. CROSS JW, Joy M, McGee C, Akinyemi O, et al
    Adverse events of interest vary by influenza vaccine type and brand: Sentinel network study of eight seasons (2010-2018).
    Vaccine. 2020 Apr 13. pii: S0264-410X(20)30402.
    PubMed     Abstract available

  438. STAPLETON JT, Wagner N, Tuetken R, Bellamy AR, et al
    High dose trivalent influenza vaccine compared to standard dose vaccine in patients with rheumatoid arthritis receiving TNF-alpha inhibitor therapy and healthy controls: Results of the DMID 10-0076 randomized clinical trial.
    Vaccine. 2020 Apr 12. pii: S0264-410X(20)30459.
    PubMed     Abstract available

  439. CHANG CY, Cho CY, Lai CC, Lu CY, et al
    Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in healthy subjects aged 3 to 17 years old: A phase III, open label, single-arm study.
    Vaccine. 2020 Apr 10. pii: S0264-410X(20)30437.
    PubMed     Abstract available

  440. SUGISHITA Y, Nakayama T, Sugawara T, Ohkusa Y, et al
    Negative effect on immune response of repeated influenza vaccination and waning effectiveness in interseason for elderly people.
    Vaccine. 2020 Apr 7. pii: S0264-410X(20)30378.
    PubMed     Abstract available

  441. SURAGH TA, Hibbs B, Marquez P, McNeil MM, et al
    Age inappropriate influenza vaccination in infants less than 6 months old, 2010-2018.
    Vaccine. 2020 Apr 6. pii: S0264-410X(20)30418.
    PubMed     Abstract available

    March 2020
  442. AHMED MA, Naus M, Singer J, Valiquette L, et al
    Investigating the association of receipt of seasonal influenza vaccine with occurrence of anesthesia/paresthesia and severe headaches, Canada 2012/13-2016/17, the Canadian Vaccine Safety Network.
    Vaccine. 2020 Mar 27. pii: S0264-410X(20)30371.
    PubMed     Abstract available

  443. O'LEARY ST, Cataldi JR, Lindley MC, Hurley LP, et al
    Impact of media reports regarding influenza vaccine on obstetricians' vaccination practices.
    Vaccine. 2020 Mar 21. pii: S0264-410X(20)30263.
    PubMed     Abstract available

  444. LANE MC, Gordon JL, Jiang C, Leitner WW, et al
    Workshop report: Optimization of animal models to better predict influenza vaccine efficacy.
    Vaccine. 2020;38:2751-2757.
    PubMed     Abstract available

  445. NEUMANN G, Kawaoka Y
    Optimization of animal models to better predict influenza vaccine efficacy (VA).
    Vaccine. 2020;38:2749-2750.

  446. RUSCIO B, Bolster A, Bresee J
    Shaping meeting to explore the value of a coordinated work plan for epidemic and pandemic influenza vaccine preparedness.
    Vaccine. 2020 Mar 11. pii: S0264-410X(20)30247.
    PubMed     Abstract available

  447. BRAEYE T, Emborg HD, Llorente-Garcia A, Huerta C, et al
    Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries - The ADVANCE project.
    Vaccine. 2020 Mar 11. pii: S0264-410X(20)30326.
    PubMed     Abstract available

  448. CHO HK, Kang YM, Kim HM, Lee CH, et al
    Sales and immunogenicity of commercial vaccines to H9N2 low pathogenic avian influenza virus in Korea from 2007 to 2017.
    Vaccine. 2020 Mar 10. pii: S0264-410X(20)30328.
    PubMed     Abstract available

  449. MOUNIER-JACK S, Bell S, Chantler T, Edwards A, et al
    Organisational factors affecting performance in delivering influenza vaccination to staff in NHS Acute Hospital Trusts in England: A qualitative study.
    Vaccine. 2020 Mar 5. pii: S0264-410X(20)30321.
    PubMed     Abstract available

  450. BELONGIA EA, Levine MZ, Olaiya O, Gross FL, et al
    Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018.
    Vaccine. 2020 Mar 4. pii: S0264-410X(20)30278.
    PubMed     Abstract available

  451. DRISCOLL AJ, Arshad SH, Bont L, Brunwasser SM, et al
    Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting.
    Vaccine. 2020;38:2435-2448.
    PubMed     Abstract available

    February 2020
  452. POLAND GA
    Another coronavirus, another epidemic, another warning.
    Vaccine. 2020;38:v-vi.

  453. NABER SK, Bruijning-Verhagen PCJL, de Hoog MLA, van Giessen A, et al
    Cost-effectiveness of inactivated influenza vaccination in children with medical risk conditions in the Netherlands.
    Vaccine. 2020 Feb 27. pii: S0264-410X(20)30084.
    PubMed     Abstract available

  454. KALLIGEROS M, Shehadeh F, Mylona EK, Dapaah-Afriyie C, et al
    Influenza vaccine effectiveness against influenza-associated hospitalization in children: A systematic review and meta-analysis.
    Vaccine. 2020 Feb 27. pii: S0264-410X(20)30261.
    PubMed     Abstract available

  455. BLYTH CC, Cheng AC, Crawford NW, Clark JE, et al
    The impact of new universal child influenza programs in Australia: Vaccine coverage, effectiveness and disease epidemiology in hospitalised children in 2018.
    Vaccine. 2020 Feb 24. pii: S0264-410X(20)30228.
    PubMed     Abstract available

  456. MUELLER S, Stauft CB, Kalkeri R, Koidei F, et al
    A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates.
    Vaccine. 2020 Feb 24. pii: S0264-410X(20)30279.
    PubMed     Abstract available

  457. MOHAMMED H, Roberts CT, Grzeskowiak LE, Giles L, et al
    Psychosocial determinants of pertussis and influenza vaccine uptake in pregnant women: A prospective study.
    Vaccine. 2020 Feb 15. pii: S0264-410X(20)30217.
    PubMed     Abstract available

  458. HOSCHLER K, Maharjan S, Whitaker H, Southern J, et al
    Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2-16 years after successive annual vaccinations with LAIV.
    Vaccine. 2020 Feb 15. pii: S0264-410X(20)30221.
    PubMed     Abstract available

  459. SAMY N, Reichhardt D, Schmidt D, Chen LM, et al
    Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial.
    Vaccine. 2020 Feb 11. pii: S0264-410X(20)30081.
    PubMed     Abstract available

  460. FAN J, Cong S, Wang N, Bao H, et al
    Influenza vaccination rate and its association with chronic diseases in China: Results of a national cross-sectional study.
    Vaccine. 2020 Feb 8. pii: S0264-410X(20)30146.
    PubMed     Abstract available

  461. SICCA F, Martinuzzi D, Montomoli E, Huckriede A, et al
    Comparison of influenza-specific neutralizing antibody titers determined using different assay readouts and hemagglutination inhibition titers: good correlation but poor agreement.
    Vaccine. 2020 Feb 7. pii: S0264-410X(20)30141.
    PubMed     Abstract available

  462. PULLAGURA GR, Violette R, Houle SKD, Waite NM, et al
    Shades of gray in vaccination decisions - Understanding community pharmacists' perspectives of, and experiences with, influenza vaccine hesitancy in Ontario, Canada.
    Vaccine. 2020 Feb 6. pii: S0264-410X(20)30137.
    PubMed     Abstract available

  463. VANDERVEN HA, Barr I, Reynaldi A, Wheatley AK, et al
    Fc functional antibody responses to adjuvanted versus unadjuvanted seasonal influenza vaccination in community-dwelling older adults.
    Vaccine. 2020 Feb 5. pii: S0264-410X(20)30104.
    PubMed     Abstract available

  464. HALES C, Jochems SP, Robinson R, Solorzano C, et al
    Symptoms associated with influenza vaccination and experimental human pneumococcal colonisation of the nasopharynx.
    Vaccine. 2020 Feb 4. pii: S0264-410X(20)30112.
    PubMed     Abstract available

  465. MOURATIDOU E, Lambrou A, Andreopoulou A, Gioula G, et al
    Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.
    Vaccine. 2020 Feb 4. pii: S0264-410X(20)30135.
    PubMed     Abstract available

  466. BAKER MA, Jankosky C, Yih WK, Gruber S, et al
    The risk of febrile seizures following influenza and 13-valent pneumococcal conjugate vaccines.
    Vaccine. 2020 Feb 1. pii: S0264-410X(20)30072.
    PubMed     Abstract available

    January 2020
  467. LU Y, Landreth S, Liu G, Brownlie R, et al
    Innate immunemodulator containing adjuvant formulated HA based vaccine protects mice from lethal infection of highly pathogenic avian influenza H5N1 virus.
    Vaccine. 2020 Jan 31. pii: S0264-410X(20)30077.
    PubMed     Abstract available

  468. AKPALU Y, Sullivan SJ, Regan AK
    Association between health insurance coverage and uptake of seasonal influenza vaccine in Brazos County, Texas.
    Vaccine. 2020 Jan 31. pii: S0264-410X(20)30044.
    PubMed     Abstract available

  469. AVALOS LA, Ferber J, Zerbo O, Naleway AL, et al
    Trivalent inactivated influenza vaccine (IIV3) during pregnancy and six-month infant development.
    Vaccine. 2020 Jan 29. pii: S0264-410X(20)30086.
    PubMed     Abstract available

  470. NGUYEN TTM, Lafond KE, Nguyen TX, Tran PD, et al
    Acceptability of seasonal influenza vaccines among health care workers in Vietnam in 2017.
    Vaccine. 2020 Jan 27. pii: S0264-410X(19)31699.
    PubMed     Abstract available

  471. KING JP, Hanson KE, Donahue JG, Glanz JM, et al
    Survey of influenza vaccine knowledge, attitudes, and beliefs among pregnant women in the 2016-17 season.
    Vaccine. 2020 Jan 25. pii: S0264-410X(20)30054.
    PubMed     Abstract available

  472. KAZAKOVA A, Kakkola L, Ziegler T, Syrjanen R, et al
    Pandemic influenza A(H1N1pdm09) vaccine induced high levels of influenza-specific IgG and IgM antibodies as analyzed by enzyme immunoassay and dual-mode multiplex microarray immunoassay methods.
    Vaccine. 2020 Jan 24. pii: S0264-410X(20)30037.
    PubMed     Abstract available

  473. LAI E, Tan HY, Kunasekaran M, Chughtai AA, et al
    Influenza vaccine coverage and predictors of vaccination among aged care workers in Sydney Australia.
    Vaccine. 2020 Jan 23. pii: S0264-410X(20)30008.
    PubMed     Abstract available

  474. CASTILLA J, Portillo ME, Casado I, Pozo F, et al
    Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019.
    Vaccine. 2020 Jan 22. pii: S0264-410X(20)30043.
    PubMed     Abstract available

  475. MCDONALD JU, Rigsby P, Atkinson E, Engelhardt OG, et al
    Expansion of the 1st WHO international standard for antiserum to respiratory syncytial virus to include neutralisation titres against RSV subtype B: An international collaborative study.
    Vaccine. 2020;38:800-807.
    PubMed     Abstract available

  476. CHROMIKOVA V, Tan J, Aslam S, Rajabhathor A, et al
    Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay.
    Vaccine. 2020 Jan 17. pii: S0264-410X(20)30012.
    PubMed     Abstract available

  477. MA P, Luo Z, Qian J, Yan Z, et al
    Decreased ratio of influenza-specific IgG versus IgM in response to influenza vaccination in antiretroviral-treated HIV-infected African Americans compared to Caucasians, and its direct correlation with the percentages of peripheral Tfh cells.
    Vaccine. 2020 Jan 13. pii: S0264-410X(20)30004.
    PubMed     Abstract available

  478. HUANG C, Fu X, Zhou Y, Mi F, et al
    Comparison of the immunogenicity and safety of quadrivalent and tetravalent influenza vaccines in children and adolescents.
    Vaccine. 2020 Jan 13. pii: S0264-410X(19)31625.
    PubMed     Abstract available

  479. XU L, Qin Z, Qiao L, Wen J, et al
    Characterization of thermostable Newcastle disease virus recombinants expressing the hemagglutinin of H5N1 avian influenza virus as bivalent vaccine candidates.
    Vaccine. 2020 Jan 11. pii: S0264-410X(19)31718.
    PubMed     Abstract available

  480. JARVIS JR, Dorey RB, Warricker FDM, Alwan NA, et al
    The effectiveness of influenza vaccination in pregnancy in relation to child health outcomes: Systematic review and meta-analysis.
    Vaccine. 2020 Jan 10. pii: S0264-410X(19)31720.
    PubMed     Abstract available

  481. SANDHU SK, Hua W, MaCurdy TE, Franks RL, et al
    Comparison of alpha-spending plans for near real-time monitoring for Guillain-Barre after influenza vaccination during the 2010/11 influenza season.
    Vaccine. 2020 Jan 10. pii: S0264-410X(19)31674.
    PubMed     Abstract available

  482. RAINISCH G, Adhikari B, Meltzer MI, Langley G, et al
    Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants.
    Vaccine. 2020;38:251-257.
    PubMed     Abstract available

    December 2019
  483. LUTZ CS, Fink RV, Cloud AJ, Stevenson J, et al
    Factors associated with perceptions of influenza vaccine safety and effectiveness among adults, United States, 2017-2018.
    Vaccine. 2019 Dec 27. pii: S0264-410X(19)31644.
    PubMed     Abstract available

  484. BEYER WEP, Palache AM, Reperant LA, Boulfich M, et al
    Association between vaccine adjuvant effect and pre-seasonal immunity. Systematic review and meta-analysis of randomised immunogenicity trials comparing squalene-adjuvanted and aqueous inactivated influenza vaccines.
    Vaccine. 2019 Dec 23. pii: S0264-410X(19)31679.
    PubMed     Abstract available

  485. GIESE H, Neth H, Moussaid M, Betsch C, et al
    The echo in flu-vaccination echo chambers: Selective attention trumps social influence.
    Vaccine. 2019 Dec 18. pii: S0264-410X(19)31563.
    PubMed     Abstract available

  486. RAO S, Ziniel SI, Khan I, Dempsey A, et al
    Be inFLUential: Evaluation of a multifaceted intervention to increase influenza vaccination rates among pediatric inpatients.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31652.
    PubMed     Abstract available

  487. BERTRAN K, Criado MF, Lee DH, Killmaster L, et al
    Protection of White Leghorn chickens by recombinant fowlpox vector vaccine with an updated H5 insert against Mexican H5N2 avian influenza viruses.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31626.
    PubMed     Abstract available

  488. DHAMAYANTI M, Tarigan R, Fadlyana E, Prasetyo D, et al
    Immunogenicity and safety of Quadrivalent Influenza HA vaccine in Indonesian children: An open-labeled, bridging, clinical study.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31650.
    PubMed     Abstract available

  489. OFFEDDU V, Low MSF, Surendran S, Kembhavi G, et al
    Acceptance and feasibility of school-based seasonal influenza vaccination in Singapore: A qualitative study.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31662.
    PubMed     Abstract available

  490. DE HOOG MLA, Venekamp RP, Meijer A, Sanders EAM, et al
    Inactivated influenza vaccine does not reduce all cause respiratory illness in children with pre-existing medical conditions.
    Vaccine. 2019 Dec 16. pii: S0264-410X(19)31640.
    PubMed     Abstract available

  491. PORTER RM, Goldin S, Lafond KE, Hedman L, et al
    Does having a seasonal influenza program facilitate pandemic preparedness? An analysis of vaccine deployment during the 2009 pandemic.
    Vaccine. 2019 Dec 12. pii: S0264-410X(19)31548.
    PubMed     Abstract available

  492. GAO Z, Robinson K, Skowronski DM, De Serres G, et al
    Quantification of the total neuraminidase content of recent commercially-available influenza vaccines: Introducing a neuraminidase titration reagent.
    Vaccine. 2019 Dec 6. pii: S0264-410X(19)31570.
    PubMed     Abstract available

  493. DUONG TN, Thiem VD, Anh DD, Cuong NP, et al
    A Phase 2/3 double blinded, randomized, placebo-controlled study in healthy adult participants in Vietnam to examine the safety and immunogenicity of an inactivated whole virion, alum adjuvanted, A(H5N1) influenza vaccine (IVACFLU-A/H5N1).
    Vaccine. 2019 Dec 4. pii: S0264-410X(19)31601.
    PubMed     Abstract available

  494. PAN SC, Hsu WT, Lee WS, Wang NC, et al
    A double-blind, randomized controlled trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with the adjuvant LTh(alphaK): A phase II study.
    Vaccine. 2019 Dec 4. pii: S0264-410X(19)31589.
    PubMed     Abstract available

  495. WILSON R, Zaytseva A, Bocquier A, Nokri A, et al
    Vaccine hesitancy and self-vaccination behaviors among nurses in southeastern France.
    Vaccine. 2019 Dec 3. pii: S0264-410X(19)31541.
    PubMed     Abstract available

  496. LAMA Y, Hancock GR, Freimuth VS, Jamison AM, et al
    Using classification and regression tree analysis to explore parental influenza vaccine decisions.
    Vaccine. 2019 Dec 2. pii: S0264-410X(19)31568.
    PubMed     Abstract available

    November 2019
  497. MALLORY RM, Nyborg A, Kalyani RN, Yuan Y, et al
    A study to evaluate the immunogenicity and shedding of live attenuated influenza vaccine strains in children 24-<48 months of age.
    Vaccine. 2019 Nov 30. pii: S0264-410X(19)31597.
    PubMed     Abstract available

  498. LEE WN, Stuck D, Konty K, Rivers C, et al
    Large-scale influenza vaccination promotion on a mobile app platform: A randomized controlled trial.
    Vaccine. 2019 Nov 29. pii: S0264-410X(19)31595.
    PubMed     Abstract available

  499. JIANG M, Li P, Wang W, Zhao M, et al
    Cost-effectiveness of quadrivalent versus trivalent influenza vaccine for elderly population in China.
    Vaccine. 2019 Nov 28. pii: S0264-410X(19)31587.
    PubMed     Abstract available

  500. REINDERS S, Romero C, Carcamo C, Tinoco Y, et al
    A community-based survey on influenza and vaccination knowledge, perceptions and practices in Peru.
    Vaccine. 2019 Nov 28. pii: S0264-410X(19)31539.
    PubMed     Abstract available

  501. PENTA MA, Craciun IC, Baban A
    The power of anticipated regret: Predictors of HPV vaccination and seasonal influenza vaccination acceptability among young Romanians.
    Vaccine. 2019 Nov 27. pii: S0264-410X(19)31571.
    PubMed     Abstract available

  502. HIBBS BF, Ng CS, Museru O, Moro PL, et al
    Reports of atypical shoulder pain and dysfunction following inactivated influenza vaccine, Vaccine Adverse Event Reporting System (VAERS), 2010-2017.
    Vaccine. 2019 Nov 26. pii: S0264-410X(19)31546.
    PubMed     Abstract available

  503. GOSS MD, Temte JL, Barlow S, Temte E, et al
    An assessment of parental knowledge, attitudes, and beliefs regarding influenza vaccination.
    Vaccine. 2019 Nov 25. pii: S0264-410X(19)31569.
    PubMed     Abstract available

  504. FURER V, Zisman D, Kaufman I, Arad U, et al
    Immunogenicity and safety of vaccination against seasonal influenza vaccine in patients with psoriatic arthritis treated with secukinumab.
    Vaccine. 2019 Nov 22. pii: S0264-410X(19)31470.
    PubMed     Abstract available

  505. NOWAK GJ, Evans NJ, Wojdynski BW, Ahn SJG, et al
    Using immersive virtual reality to improve the beliefs and intentions of influenza vaccine avoidant 18-to-49-year-olds: Considerations, effects, and lessons learned.
    Vaccine. 2019 Nov 21. pii: S0264-410X(19)31516.
    PubMed     Abstract available

  506. WELLIVER RC, Papin JF, Preno A, Ivanov V, et al
    Maternal immunization with RSV fusion glycoprotein vaccine and substantial protection of neonatal baboons against respiratory syncytial virus pulmonary challenge.
    Vaccine. 2019 Nov 21. pii: S0264-410X(19)31510.
    PubMed     Abstract available

  507. FLOREK K, Mutschler J, McLean HQ, King JP, et al
    Antibody-dependent cell-mediated cytotoxicity antibody responses to inactivated and live-attenuated influenza vaccination in children during 2014-15.
    Vaccine. 2019 Nov 18. pii: S0264-410X(19)31440.
    PubMed     Abstract available

  508. PATEL MM, Davis W, Beacham L, Spencer S, et al
    Priming with MF59 adjuvanted versus nonadjuvanted seasonal influenza vaccines in children - A systematic review and a meta-analysis.
    Vaccine. 2019 Nov 14. pii: S0264-410X(19)31433.
    PubMed     Abstract available

  509. SMATTI MK, Nasrallah GK, Al Thani AA, Yassine HM, et al
    Measuring influenza hemagglutinin (HA) stem-specific antibody-dependent cellular cytotoxicity (ADCC) in human sera using novel stabilized stem nanoparticle probes.
    Vaccine. 2019 Nov 14. pii: S0264-410X(19)31493.
    PubMed     Abstract available

  510. TSUZUKI S, Baguelin M, Pebody R, van Leeuwen E, et al
    Modelling the optimal target age group for seasonal influenza vaccination in Japan.
    Vaccine. 2019 Nov 14. pii: S0264-410X(19)31508.
    PubMed     Abstract available

  511. NUNEZ IA, Ross TM
    Human COBRA 2 vaccine contains two major epitopes that are responsible for eliciting neutralizing antibody responses against heterologous clades of viruses.
    Vaccine. 2019 Nov 13. pii: S0264-410X(19)31497.
    PubMed     Abstract available

  512. KLAUSBERGER M, Leneva IA, Egorov A, Strobl F, et al
    Off-target effects of an insect cell-expressed influenza HA-pseudotyped Gag-VLP preparation in limiting postinfluenza Staphylococcus aureus infections.
    Vaccine. 2019 Nov 9. pii: S0264-410X(19)31472.
    PubMed     Abstract available

  513. TADOUNT F, Doyon-Plourde P, Quach C
    Is there a difference in the immune response, efficacy, effectiveness and safety of seasonal influenza vaccine in males and females? - A systematic review.
    Vaccine. 2019 Nov 8. pii: S0264-410X(19)31480.
    PubMed     Abstract available

  514. HAWKSWORTH A, Jayachander M, Hester S, Mohammed S, et al
    Proteomics as a tool for live attenuated influenza vaccine characterisation.
    Vaccine. 2019 Nov 7. pii: S0264-410X(19)31471.
    PubMed     Abstract available

  515. KONGCHANAGUL A, Samnuan K, Wirachwong P, Surichan S, et al
    A live attenuated H5N2 prime- inactivated H5N1 boost vaccination induces influenza virus hemagglutinin stalk specific antibody responses.
    Vaccine. 2019 Nov 7. pii: S0264-410X(19)31473.
    PubMed     Abstract available

  516. GANCZAK M, Kalinowski P, Drozd-Dabrowska M, Biesiada D, et al
    School life and influenza immunization: A cross-sectional study on vaccination coverage and influencing determinants among Polish teachers.
    Vaccine. 2019 Nov 6. pii: S0264-410X(19)31447.
    PubMed     Abstract available

  517. BROWNE SK, Beeler JA, Roberts JN
    Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naive infants.
    Vaccine. 2019 Nov 6. pii: S0264-410X(19)31428.
    PubMed     Abstract available

  518. MANTEL C, Chu SY, Hyde TB, Lambach P, et al
    Seasonal influenza vaccination in middle-income countries: Assessment of immunization practices in Belarus, Morocco, and Thailand.
    Vaccine. 2019 Nov 4. pii: S0264-410X(19)31401.
    PubMed     Abstract available

  519. CHEN W, Stoecker C
    Mass media coverage and influenza vaccine uptake.
    Vaccine. 2019 Nov 4. pii: S0264-410X(19)31382.
    PubMed     Abstract available

  520. SONG JY, Noh JY, Lee JS, Wie SH, et al
    Effectiveness of repeated influenza vaccination among the elderly population with high annual vaccine uptake rates during the three consecutive A/H3N2 epidemics.
    Vaccine. 2019 Nov 2. pii: S0264-410X(19)31375.
    PubMed     Abstract available

  521. PEBODY RG, Whitaker H, Ellis J, Andrews N, et al
    End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19.
    Vaccine. 2019 Nov 1. pii: S0264-410X(19)31460.
    PubMed     Abstract available

    October 2019
  522. OTTEN G, Matassa V, Ciarlet M, Leav B, et al
    A phase 1, randomized, observer blind, antigen and adjuvant dosage finding clinical trial to evaluate the safety and immunogenicity of an adjuvanted, trivalent subunit influenza vaccine in adults>/=65 years of age.
    Vaccine. 2019 Oct 31. pii: S0264-410X(19)31438.
    PubMed     Abstract available

  523. SHEN AK, Warnock R, Selna W, MaCurdy TE, et al
    Characteristics of vaccinating providers reported through Medicare claims in office-based settings: Volume of influenza and pneumococcal vaccinations.
    Vaccine. 2019 Oct 31. pii: S0264-410X(19)31402.
    PubMed     Abstract available

  524. STURKENBOOM M, Bahri P, Chiucchiuini A, Grove Krause T, et al
    Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines.
    Vaccine. 2019 Oct 31. pii: S0264-410X(19)31002.
    PubMed     Abstract available

  525. PALLAS SW, Ahmeti A, Morgan W, Preza I, et al
    Program cost analysis of influenza vaccination of health care workers in Albania.
    Vaccine. 2019 Oct 25. pii: S0264-410X(19)31400.
    PubMed     Abstract available

  526. KANG YM, Cho HK, Kim HM, Lee MH, et al
    Protective efficacy of vaccines of the Korea national antigen bank against the homologous H5Nx clade and clade highly pathogenic avian influenza viruses.
    Vaccine. 2019 Oct 25. pii: S0264-410X(19)31417.
    PubMed     Abstract available

  527. NG TWY, Cowling BJ, So HC, Ip DKM, et al
    Testing an integrative theory of health behavioural change for predicting seasonal influenza vaccination uptake among healthcare workers.
    Vaccine. 2019 Oct 24. pii: S0264-410X(19)31414.
    PubMed     Abstract available

  528. KOLB EA, Buterbaugh RE, Rinehart CL, Ensley D, et al
    Protection against bovine respiratory syncytial virus in calves vaccinated with adjuvanted modified live vaccine administered in the face of maternal antibody.
    Vaccine. 2019 Oct 24. pii: S0264-410X(19)31378.
    PubMed     Abstract available

  529. FRAWLEY JE, McManus K, McIntyre E, Seale H, et al
    Uptake of funded influenza vaccines in young Australian children in 2018; parental characteristics, information seeking and attitudes.
    Vaccine. 2019 Oct 23. pii: S0264-410X(19)31406.
    PubMed     Abstract available

  530. PEBODY R, Whitaker H, Zhao H, Andrews N, et al
    Protection provided by influenza vaccine against influenza-related hospitalisation in >/=65 year olds: Early experience of introduction of a newly licensed adjuvanted vaccine in England in 2018/19.
    Vaccine. 2019 Oct 22. pii: S0264-410X(19)31405.
    PubMed     Abstract available

  531. PEBODY RG, Zhao H, Whitaker HJ, Ellis J, et al
    Effectiveness of influenza vaccine in children in preventing influenza associated hospitalisation, 2018/19, England.
    Vaccine. 2019 Oct 21. pii: S0264-410X(19)31408.
    PubMed     Abstract available

  532. FRIEDMAN L, Renaud A, Hines D, Winter A, et al
    Exploring indirect protection associated with influenza immunization - A systematic review of the literature.
    Vaccine. 2019 Oct 21. pii: S0264-410X(19)31328.
    PubMed     Abstract available

  533. ESSINK B, Fierro C, Rosen J, Figueroa AL, et al
    Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults.
    Vaccine. 2019 Oct 18. pii: S0264-410X(19)31384.
    PubMed     Abstract available

  534. MANDON ED, Pizzorno A, Traversier A, Champagne A, et al
    Novel calixarene-based surfactant enables low dose split inactivated vaccine protection against influenza infection.
    Vaccine. 2019 Oct 17. pii: S0264-410X(19)31381.
    PubMed     Abstract available

  535. WOLFF GG
    Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season.
    Vaccine. 2019 Oct 10. pii: S0264-410X(19)31364.
    PubMed     Abstract available

    Respiratory syncytial virus suppression of the antiviral immune response: Implications for evaluation of candidate vaccines.
    Vaccine. 2019 Oct 10. pii: S0264-410X(19)31339.
    PubMed     Abstract available

  537. VAN AALST R, Gravenstein S, Mor V, Mahmud SM, et al
    Comparative effectiveness of high dose versus adjuvanted influenza vaccine: A retrospective cohort study.
    Vaccine. 2019 Oct 9. pii: S0264-410X(19)31349.
    PubMed     Abstract available

  538. BUFFIN S, Peubez I, Barriere F, Nicolai MC, et al
    Influenza A and B virus-like particles produced in mammalian cells are highly immunogenic and induce functional antibodies.
    Vaccine. 2019 Oct 4. pii: S0264-410X(19)31281.
    PubMed     Abstract available

  539. KOIKE ME, Gattas VL, Lucchesi MBB, Moura de Oliveira MM, et al
    Pharmacovigilance capacity strengthening for WHO prequalification: The case of the trivalent influenza vaccine manufactured by Instituto Butantan.
    Vaccine. 2019 Oct 4. pii: S0264-410X(19)31324.
    PubMed     Abstract available

    September 2019
  540. SMITH D, Streatfield SJ, Acosta H, Ganesan S, et al
    A nanoemulsion-adjuvanted intranasal H5N1 influenza vaccine protects ferrets against homologous and heterologous H5N1 lethal challenge.
    Vaccine. 2019;37:6162-6170.
    PubMed     Abstract available

  541. RUDICELL RS, Garinot M, Kanekiyo M, Kamp HD, et al
    Comparison of adjuvants to optimize influenza neutralizing antibody responses.
    Vaccine. 2019;37:6208-6220.
    PubMed     Abstract available

  542. BIGGERSTAFF M, Cohen C, Reed C, Tempia S, et al
    A cost-effectiveness analysis of antenatal influenza vaccination among HIV-infected and HIV-uninfected pregnant women in South Africa.
    Vaccine. 2019 Sep 28. pii: S0264-410X(19)31283.
    PubMed     Abstract available

  543. CUTRELL JB, Drechsler H, Bedimo R, Alvarez CA, et al
    Statin use and medically attended acute respiratory illness among influenza vaccine recipients.
    Vaccine. 2019 Sep 19. pii: S0264-410X(19)31224.
    PubMed     Abstract available

  544. GUCLU OA, Demirci H, Ocakoglu G, Guclu Y, et al
    Relationship of pneumococcal and influenza vaccination frequency with health literacy in the rural population in Turkey.
    Vaccine. 2019 Sep 18. pii: S0264-410X(19)31258.
    PubMed     Abstract available

  545. YITBAREK A, Astill J, Hodgins DC, Parkinson J, et al
    Commensal gut microbiota can modulate adaptive immune responses in chickens vaccinated with whole inactivated avian influenza virus subtype H9N2.
    Vaccine. 2019 Sep 18. pii: S0264-410X(19)31255.
    PubMed     Abstract available

  546. TEO LM, Smith HE, Lwin MO, Tang WE, et al
    Attitudes and perception of influenza vaccines among older people in Singapore: A qualitative study.
    Vaccine. 2019 Sep 18. pii: S0264-410X(19)31246.
    PubMed     Abstract available

  547. DONAHUE JG, Kieke BA, King JP, Mascola MA, et al
    Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15.
    Vaccine. 2019 Sep 17. pii: S0264-410X(19)31244.
    PubMed     Abstract available

  548. GILES ML, Buttery J, Davey MA, Wallace E, et al
    Pregnant women's knowledge and attitude to maternal vaccination including group B streptococcus and respiratory syncytial virus vaccines.
    Vaccine. 2019 Sep 17. pii: S0264-410X(19)31173.
    PubMed     Abstract available

  549. TAN HY, Lai E, Kunasekaran M, Chughtai AA, et al
    Prevalence and predictors of influenza vaccination among residents of long-term care facilities.
    Vaccine. 2019 Sep 13. pii: S0264-410X(19)31221.
    PubMed     Abstract available

  550. HONEMANN M, Martin D, Pietsch C, Maier M, et al
    Influenza B virus infections in Western Saxony, Germany in three consecutive seasons between 2015 and 2018: Analysis of molecular and clinical features.
    Vaccine. 2019 Sep 11. pii: S0264-410X(19)31091.
    PubMed     Abstract available

  551. COSTANTINO V, MacIntyre CR, Trent M
    Modelling of optimal timing for influenza vaccination as a function of intraseasonal waning of immunity and vaccine coverage.
    Vaccine. 2019 Sep 11. pii: S0264-410X(19)31145.
    PubMed     Abstract available

  552. QUATTROCCHI A, Mereckiene J, Fitzgerald M, Cotter S, et al
    Determinants of influenza and pertussis vaccine uptake in pregnant women in Ireland: A cross-sectional survey in 2017/18 influenza season.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31196.
    PubMed     Abstract available

  553. ARYA DP, Said MA, Izurieta HS, Perez-Vilar S, et al
    Surveillance for Guillain-Barre syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31109.
    PubMed     Abstract available

  554. ELAISH M, Xia M, Ngunjiri JM, Ghorbani A, et al
    Protective immunity against influenza virus challenge by norovirus P particle-M2e and HA2-AtCYN vaccines in chickens.
    Vaccine. 2019 Sep 7. pii: S0264-410X(19)31171.
    PubMed     Abstract available

  555. NAKAMURA K, Harada Y, Takahashi H, Trusheim H, et al
    Systematic evaluation of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for preparing influenza vaccine seed virus.
    Vaccine. 2019 Sep 6. pii: S0264-410X(19)31140.
    PubMed     Abstract available

  556. CHERIAN T, Morales KF, Mantel C, Lambach P, et al
    Factors and considerations for establishing and improving seasonal influenza vaccination of health workers: Report from a WHO meeting, January 16-17, Berlin, Germany.
    Vaccine. 2019 Sep 6. pii: S0264-410X(19)31000.
    PubMed     Abstract available

    August 2019
  557. BAR-PELED Y, Huang J, Nunez IA, Pierce SR, et al
    Structural and antigenic characterization of a computationally-optimized H5 hemagglutinin influenza vaccine.
    Vaccine. 2019 Aug 31. pii: S0264-410X(19)31138.
    PubMed     Abstract available

  558. RAJ SM, Chughtai AA, Sharma A, Tan TC, et al
    Cost-benefit analysis of a national influenza vaccination program in preventing hospitalisation costs in Australian adults aged 50-64years old.
    Vaccine. 2019 Aug 28. pii: S0264-410X(19)31092.
    PubMed     Abstract available

  559. CARLSON SJ, Scanlan C, Marshall HS, Blyth CC, et al
    Attitudes about and access to influenza vaccination experienced by parents of children hospitalised for influenza in Australia.
    Vaccine. 2019 Aug 27. pii: S0264-410X(19)31071.
    PubMed     Abstract available

  560. DORAIVELU K, Boulet SL, Biswas HH, Adams JC, et al
    Predictors of tetanus, diphtheria, acellular pertussis and influenza vaccination during pregnancy among full-term deliveries in a medically underserved population.
    Vaccine. 2019 Aug 27. pii: S0264-410X(19)31108.
    PubMed     Abstract available

  561. CHEN P, Ding L, Jiang Y, Zeng X, et al
    Protective efficacy in farmed ducks of a duck enteritis virus-vectored vaccine against H5N1, H5N6, and H5N8 avian influenza viruses.
    Vaccine. 2019 Aug 27. pii: S0264-410X(19)31088.
    PubMed     Abstract available

  562. BRUXVOORT KJ, Luo Y, Ackerson B, Tanenbaum HC, et al
    Comparison of vaccine effectiveness against influenza hospitalization of cell-based and egg-based influenza vaccines, 2017-2018.
    Vaccine. 2019 Aug 21. pii: S0264-410X(19)31074.
    PubMed     Abstract available

  563. CHANG LJ, Meng Y, Janosczyk H, Landolfi V, et al
    Safety and immunogenicity of high-dose quadrivalent influenza vaccine in adults >/=65years of age: A phase 3 randomized clinical trial.
    Vaccine. 2019 Aug 17. pii: S0264-410X(19)31066.
    PubMed     Abstract available

  564. COSTANTINO C, Restivo V, Amodio E, Colomba GME, et al
    A mid-term estimate of 2018/2019 vaccine effectiveness to prevent laboratory confirmed A(H1N1)pdm09 and A(H3N2) influenza cases in Sicily (Italy).
    Vaccine. 2019 Aug 16. pii: S0264-410X(19)31064.
    PubMed     Abstract available

  565. BELINGHERI M, De Vito G, Riva MA
    Italian midwives and influenza vaccination: problems in adherence and perception.
    Vaccine. 2019;37:4851.

  566. INNIS BL, Scorza FB, Blum JS, Jain VK, et al
    Convening on the influenza human viral challenge model for universal influenza vaccines, Part 2: Methodologic considerations.
    Vaccine. 2019;37:4830-4834.
    PubMed     Abstract available

  567. INNIS BL, Berlanda Scorza F, Blum JS, Jain VK, et al
    Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity.
    Vaccine. 2019;37:4823-4829.
    PubMed     Abstract available

  568. PATEL N, Massare MJ, Tian JH, Guebre-Xabier M, et al
    Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection.
    Vaccine. 2019 Aug 12. pii: S0264-410X(19)31010.
    PubMed     Abstract available

  569. ASTHAGIRI ARUNKUMAR G, McMahon M, Pavot V, Aramouni M, et al
    Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice.
    Vaccine. 2019 Aug 6. pii: S0264-410X(19)31016.
    PubMed     Abstract available

  570. GEBAUER M, Hurlimann HC, Behrens M, Wolff T, et al
    Subunit vaccines based on recombinant yeast protect against influenza A virus in a one-shot vaccination scheme.
    Vaccine. 2019 Aug 6. pii: S0264-410X(19)31015.
    PubMed     Abstract available

  571. STARK FC, Akache B, Ponce A, Dudani R, et al
    Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunization.
    Vaccine. 2019 Aug 2. pii: S0264-410X(19)30888.
    PubMed     Abstract available

  572. TZENG TT, Lai CC, Weng TC, Cyue MH, et al
    The stability and immunogenicity of inactivated MDCK cell-derived influenza H7N9 viruses.
    Vaccine. 2019 Aug 2. pii: S0264-410X(19)30346.
    PubMed     Abstract available

    July 2019
  573. NOH JY, Jang YS, Lee SN, Choi MJ, et al
    Randomized, single-blind, active-controlled phase I clinical trial to evaluate the immunogenicity and safety of GC3114 (high-dose, quadrivalent influenza vaccine) in healthy adults.
    Vaccine. 2019 Jul 31. pii: S0264-410X(19)30997.
    PubMed     Abstract available

  574. MUNOZ FM, Anderson EJ, Bernstein DI, Harrison CJ, et al
    Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents.
    Vaccine. 2019 Jul 30. pii: S0264-410X(19)31006.
    PubMed     Abstract available

  575. VENEREO-SANCHEZ A, Fulton K, Koczka K, Twine S, et al
    Characterization of influenza H1N1 Gag virus-like particles and extracellular vesicles co-produced in HEK-293SF.
    Vaccine. 2019 Jul 26. pii: S0264-410X(19)30955.
    PubMed     Abstract available

  576. ESTEBAN-VASALLO MD, Dominguez-Berjon MF, Garcia-Riolobos C, Zoni AC, et al
    Effect of mobile phone text messaging for improving the uptake of influenza vaccination in patients with rare diseases.
    Vaccine. 2019 Jul 25. pii: S0264-410X(19)30970.
    PubMed     Abstract available

  577. TATEISHI K, Fujihashi K, Yamamoto N, Hasegawa H, et al
    CpG ODN G9.1 as a novel nasal ODN adjuvant elicits complete protection from influenza virus infection without causing inflammatory immune responses.
    Vaccine. 2019 Jul 22. pii: S0264-410X(19)30923.
    PubMed     Abstract available

  578. LEMIEUX M, Lorbetskie B, Luebbert CC, Walrond L, et al
    The differential effect of sub-micron level HA aggregates on influenza potency assays.
    Vaccine. 2019 Jul 20. pii: S0264-410X(19)30948.
    PubMed     Abstract available

  579. FABIANI M, Volpe E, Faraone M, Bella A, et al
    Influenza vaccine uptake in the elderly population: Individual and general practitioner's determinants in Central Italy, Lazio region, 2016-2017 season.
    Vaccine. 2019 Jul 19. pii: S0264-410X(19)30952.
    PubMed     Abstract available

  580. SIMOES EAF, Nunes MC, Carosone-Link P, Madimabe R, et al
    Trivalent influenza vaccination randomized control trial of pregnant women and adverse fetal outcomes.
    Vaccine. 2019 Jul 19. pii: S0264-410X(19)30915.
    PubMed     Abstract available

  581. EICKHOFF CS, Terry FE, Peng L, Meza KA, et al
    Highly conserved influenza T cell epitopes induce broadly protective immunity.
    Vaccine. 2019 Jul 19. pii: S0264-410X(19)30924.
    PubMed     Abstract available

  582. GOCKO X, Poulteau S, Beyens MN, Bertholon P, et al
    Case report: Recurrent peripheral facial paralysis following two influenza vaccinations in 2009 and 2016.
    Vaccine. 2019 Jul 13. pii: S0264-410X(19)30916.
    PubMed     Abstract available

  583. SHELDENKAR A, Lim F, Yung CF, Lwin MO, et al
    Acceptance and uptake of influenza vaccines in Asia: A systematic review.
    Vaccine. 2019 Jul 10. pii: S0264-410X(19)30889.
    PubMed     Abstract available

  584. KINGSTAD-BAKKE BA, Chandrasekar SS, Phanse Y, Ross KA, et al
    Effective mosaic-based nanovaccines against avian influenza in poultry.
    Vaccine. 2019 Jul 9. pii: S0264-410X(19)30854.
    PubMed     Abstract available

  585. BRESEE JS, Lafond KE, McCarron M, Azziz-Baumgartner E, et al
    The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships.
    Vaccine. 2019 Jul 6. pii: S0264-410X(19)30811.
    PubMed     Abstract available

  586. MOSER MJ, Hatta Y, Gabaglia C, Sanchez A, et al
    Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice.
    Vaccine. 2019 Jul 4. pii: S0264-410X(19)30805.
    PubMed     Abstract available

  587. PARKER L, Ritter L, Wu W, Maeso R, et al
    Haemagglutinin stability was not the primary cause of the reduced effectiveness of live attenuated influenza vaccine against A/H1N1pdm09 viruses in the 2013-2014 and 2015-2016 seasons.
    Vaccine. 2019 Jul 3. pii: S0264-410X(19)30777.
    PubMed     Abstract available

  588. BRIGGS L, Fronek P, Quinn V, Wilde T, et al
    Perceptions of influenza and pneumococcal vaccine uptake by older persons in Australia.
    Vaccine. 2019 Jul 2. pii: S0264-410X(19)30856.
    PubMed     Abstract available

  589. DURALLIU A, Matejtschuk P, Dubey S, Koroma H, et al
    The influence of the closure format on the storage stability and moisture content of freeze-dried influenza antigen.
    Vaccine. 2019 Jul 2. pii: S0264-410X(19)30847.
    PubMed     Abstract available

    June 2019
  590. CORONEL J, Behrendt I, Burgin T, Anderlei T, et al
    Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems.
    Vaccine. 2019 Jun 29. pii: S0264-410X(19)30764.
    PubMed     Abstract available

  591. VAN AALST R, Russo EM, Neupane N, Mahmud SM, et al
    Economic assessment of a high-dose versus a standard-dose influenza vaccine in the US Veteran population: Estimating the impact on hospitalization cost for cardio-respiratory disease.
    Vaccine. 2019 Jun 28. pii: S0264-410X(19)30843.
    PubMed     Abstract available

  592. HAUSER MI, Muscatello DJ, Soh ACY, Dwyer DE, et al
    An indirect comparison meta-analysis of AS03 and MF59 adjuvants in pandemic influenza A(H1N1)pdm09 vaccines.
    Vaccine. 2019 Jun 25. pii: S0264-410X(19)30801.
    PubMed     Abstract available

  593. DE OLIVEIRA BERNARDO C, Gonzalez-Chica DA, Chilver M, Stocks N, et al
    Influenza immunisation coverage from 2015 to 2017: A national study of adult patients from Australian general practice.
    Vaccine. 2019 Jun 25. pii: S0264-410X(19)30819.
    PubMed     Abstract available

  594. SINGH G, Zholobko O, Pillatzki A, Webb B, et al
    An amphiphilic invertible polymer as a delivery vehicle for a M2e-HA2-HA1 peptide vaccine against an Influenza A virus in pigs.
    Vaccine. 2019 Jun 21. pii: S0264-410X(19)30792.
    PubMed     Abstract available

  595. MANARA C, Brazzoli M, Piccioli D, Taccone M, et al
    Co-administration of GM-CSF expressing RNA is a powerful tool to enhance potency of SAM-based vaccines.
    Vaccine. 2019 Jun 18. pii: S0264-410X(19)30479.
    PubMed     Abstract available

  596. KWONG JC, Buchan SA, Chung H, Campitelli MA, et al
    Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort.
    Vaccine. 2019 Jun 17. pii: S0264-410X(19)30772.
    PubMed     Abstract available

  597. MURTI M, Otterstatter M, Orth A, Balshaw R, et al
    Measuring the impact of influenza vaccination on healthcare worker absenteeism in the context of a province-wide mandatory vaccinate-or-mask policy.
    Vaccine. 2019 Jun 13. pii: S0264-410X(19)30775.
    PubMed     Abstract available

  598. DEMARCUS L, Shoubaki L, Federinko S
    Comparing influenza vaccine effectiveness between cell-derived and egg-derived vaccines, 2017-2018 influenza season.
    Vaccine. 2019 Jun 11. pii: S0264-410X(19)30763.
    PubMed     Abstract available

  599. NORDIN JD, Vazquez-Benitez G, Olsen A, Kuckler LC, et al
    Safety of guidelines recommending live attenuated influenza vaccine for routine use in children and adolescents with asthma.
    Vaccine. 2019 Jun 10. pii: S0264-410X(19)30718.
    PubMed     Abstract available

  600. SHINJOH M, Sugaya N, Furuichi M, Araki E, et al
    Effectiveness of inactivated influenza vaccine in children by vaccine dose, 2013-18.
    Vaccine. 2019 Jun 8. pii: S0264-410X(19)30747.
    PubMed     Abstract available

  601. LIAO Q, Lam WWT, Wong CKH, Lam C, et al
    The relative effects of determinants on Chinese adults' decision for influenza vaccination choice: What is the effect of priming?
    Vaccine. 2019 Jun 8. pii: S0264-410X(19)30709.
    PubMed     Abstract available

  602. MURALIDHARAN A, Russell MS, Larocque L, Gravel C, et al
    Chitosan alters inactivated respiratory syncytial virus vaccine elicited immune responses without affecting lung histopathology in mice.
    Vaccine. 2019 Jun 8. pii: S0264-410X(19)30753.
    PubMed     Abstract available

  603. BORG K, Sutton K, Beasley M, Tull F, et al
    Reply to letter to the editor in response to the article "Communication-based interventions for increasing influenza vaccination rates among Aboriginal children: A randomised controlled trial".
    Vaccine. 2019;37:3382.

    May 2019
  604. NG Y, Nandar K, Chua LAV, Mak TM, et al
    Evaluating the effectiveness of the influenza vaccine during respiratory outbreaks in Singapore's long term care facilities, 2017.
    Vaccine. 2019 May 31. pii: S0264-410X(19)30388.
    PubMed     Abstract available

  605. KEITEL WA, Voronca DC, Atmar RL, Paust S, et al
    Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A/H5N1 vaccines: A meta-analysis.
    Vaccine. 2019 May 31. pii: S0264-410X(19)30554.
    PubMed     Abstract available

  606. YAKUBOGULLARI N, Genc R, Coven F, Nalbantsoy A, et al
    Development of adjuvant nanocarrier systems for seasonal influenza A (H3N2) vaccine based on Astragaloside VII and gum tragacanth (APS).
    Vaccine. 2019 May 30. pii: S0264-410X(19)30662.
    PubMed     Abstract available

  607. NICOLODI C, Groiss F, Kiselev O, Wolschek M, et al
    Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1.
    Vaccine. 2019 May 30. pii: S0264-410X(19)30627.
    PubMed     Abstract available

  608. BA-NGUZ A, Shah A, Bresee JS, Lafond KE, et al
    Supporting national immunization technical advisory groups (NITAGs) in resource-constrained settings. New strategies and lessons learned from the Task Force for Global Health's Partnership for influenza vaccine introduction.
    Vaccine. 2019 May 23. pii: S0264-410X(19)30670.
    PubMed     Abstract available

  609. LAESTADIUS A, Ingelman-Sundberg HM, Myrberg IH, Verme A, et al
    Altered proportions of circulating CXCR5+ helper T cells do not dampen influenza vaccine responses in children with rheumatic disease.
    Vaccine. 2019 May 21. pii: S0264-410X(19)30661.
    PubMed     Abstract available

  610. PEREZ-VILAR S, Wernecke M, Arya D, Lo AC, et al
    Surveillance for Guillain-Barre syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017-2018 season.
    Vaccine. 2019 May 20. pii: S0264-410X(19)30665.
    PubMed     Abstract available

  611. KOUL PA, Bali NK, Koul HP
    Influenza vaccination for Hajj for the next decade: A case for quadrivalent SH vaccine.
    Vaccine. 2019 May 16. pii: S0264-410X(19)30602.

  612. MANNING J, Dunne EM, Wang N, Pedersen JS, et al
    Effect of a pneumococcal whole cell vaccine on influenza A-induced pneumococcal otitis media in infant mice.
    Vaccine. 2019 May 15. pii: S0264-410X(19)30324.
    PubMed     Abstract available

  613. O'LEARY ST, Pyrzanowski J, Brewer SE, Sevick C, et al
    Effectiveness of a multimodal intervention to increase vaccination in obstetrics/gynecology settings.
    Vaccine. 2019 May 15. pii: S0264-410X(19)30658.
    PubMed     Abstract available

  614. KO EJ, Lee Y, Lee YT, Jung YJ, et al
    Flagellin-expressing virus-like particles exhibit adjuvant effects on promoting IgG isotype-switched long-lasting antibody induction and protection of influenza vaccines in CD4-deficient mice.
    Vaccine. 2019 May 14. pii: S0264-410X(19)30632.
    PubMed     Abstract available

  615. FELDMAN RA, Fuhr R, Smolenov I, Mick Ribeiro A, et al
    mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials.
    Vaccine. 2019 May 9. pii: S0264-410X(19)30562.
    PubMed     Abstract available

  616. AWAD S, Abdo N, Yusef D, Jawarneh A, et al
    Knowledge, attitudes and practices related to influenza illness and vaccination in children: Role of awareness campaigns in changing parents' attitudes toward influenza vaccination in Jordan.
    Vaccine. 2019 May 6. pii: S0264-410X(19)30571.
    PubMed     Abstract available

  617. TORCEL-PAGNON L, Bauchau V, Mahy P, Tin Tin Htar M, et al
    Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe.
    Vaccine. 2019 May 6. pii: S0264-410X(19)30561.
    PubMed     Abstract available

  618. BONOMO ME, Kim RY, Deem MW
    Modular epitope binding predicts influenza quasispecies dominance and vaccine effectiveness: Application to 2018/19 season.
    Vaccine. 2019 May 3. pii: S0264-410X(19)30417.
    PubMed     Abstract available

    April 2019
  619. DOYON-PLOURDE P, Fakih I, Tadount F, Fortin E, et al
    Impact of influenza vaccination on healthcare utilization - A systematic review.
    Vaccine. 2019 Apr 29. pii: S0264-410X(19)30525.
    PubMed     Abstract available

  620. BISSINGER T, Fritsch J, Mihut A, Wu Y, et al
    Semi-perfusion cultures of suspension MDCK cells enable high cell concentrations and efficient influenza A virus production.
    Vaccine. 2019 Apr 29. pii: S0264-410X(19)30528.
    PubMed     Abstract available

  621. COHET C, van der Most R, Bauchau V, Bekkat-Berkani R, et al
    Safety of AS03-adjuvanted influenza vaccines: A review of the evidence.
    Vaccine. 2019 Apr 25. pii: S0264-410X(19)30522.
    PubMed     Abstract available

  622. XEUATVONGSA A, Mott JA, Khanthamaly V, Patthammavong C, et al
    Progress toward sustainable influenza vaccination in the Lao Peoples' Democratic Republic, 2012-2018.
    Vaccine. 2019 Apr 23. pii: S0264-410X(19)30511.
    PubMed     Abstract available

  623. HUERTAS-DIAZ MC, Phan S, Elson A, Nunez I, et al
    Parainfluenza virus 5 (PIV5) amplifying virus-like particles expressing respiratory syncytial virus (RSV) antigens protect mice against RSV infection.
    Vaccine. 2019 Apr 19. pii: S0264-410X(19)30506.
    PubMed     Abstract available

  624. GRANICHER G, Coronel J, Pralow A, Marichal-Gallardo P, et al
    Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1.
    Vaccine. 2019 Apr 17. pii: S0264-410X(19)30481.
    PubMed     Abstract available

  625. LEROUX-ROELS G, De Boever F, Maes C, Nguyen TL, et al
    Safety and immunogenicity of a respiratory syncytial virus fusion glycoprotein F subunit vaccine in healthy adults: Results of a phase 1, randomized, observer-blind, controlled, dosage-escalation study.
    Vaccine. 2019 Apr 12. pii: S0264-410X(19)30449.
    PubMed     Abstract available

  626. POLAND GA, Hall LL, Powell JA
    Effective and equitable influenza vaccine coverage in older and vulnerable adults: The need for evidence-based innovation and transformation.
    Vaccine. 2019;37:2167-2170.

  627. GORMAN DR, Bielecki K, Willocks LJ, Pollock KG, et al
    A qualitative study of vaccination behaviour amongst female Polish migrants in Edinburgh, Scotland.
    Vaccine. 2019 Apr 9. pii: S0264-410X(19)30422.
    PubMed     Abstract available

  628. GENTILE A, Paget J, Bellei N, Torres JP, et al
    Influenza in Latin America: A report from the Global Influenza Initiative (GII).
    Vaccine. 2019 Apr 8. pii: S0264-410X(19)30436.
    PubMed     Abstract available

  629. EL SAHLY HM, Atmar RL, Patel SM, Bellamy A, et al
    Safety and immunogenicity of an 8 year interval heterologous prime-boost influenza A/H7N7-H7N9 vaccination.
    Vaccine. 2019 Apr 4. pii: S0264-410X(19)30420.
    PubMed     Abstract available

  630. PADILLA-QUIRARTE HO, Badillo-Godinez O, Gutierrez-Xicotencatl L, Acevedo-Betancur Y, et al
    Targeting M2e to DEC-205 induces an enhanced serum antibody-dependent heterosubtypic protection against influenza A virus infection.
    Vaccine. 2019 Apr 4. pii: S0264-410X(19)30257.
    PubMed     Abstract available

  631. HAVERI A, Ikonen N, Kantele A, Anttila VJ, et al
    Seasonal influenza vaccines induced high levels of neutralizing cross-reactive antibody responses against different genetic group influenza A(H1N1)pdm09 viruses.
    Vaccine. 2019 Apr 3. pii: S0264-410X(19)30427.
    PubMed     Abstract available

  632. REGAN AK, Fielding JE, Chilver MB, Carville KS, et al
    Intraseason decline in influenza vaccine effectiveness during the 2016 southern hemisphere influenza season: A test-negative design study and phylogenetic assessment.
    Vaccine. 2019 Apr 2. pii: S0264-410X(19)30222.
    PubMed     Abstract available

    March 2019
  633. SAWLWIN DC, Graves Jones A, Albano FR
    Modification of the vaccine manufacturing process improves the pyrogenicity profile of inactivated influenza vaccines in young children.
    Vaccine. 2019 Mar 29. pii: S0264-410X(19)30390.
    PubMed     Abstract available

  634. CASHMAN P, Moberley S, Chee K, Stephenson J, et al
    Participant centred safety surveillance of health care workers receiving influenza vaccination.
    Vaccine. 2019 Mar 28. pii: S0264-410X(19)30320.
    PubMed     Abstract available

  635. ARNOLD LD, Luong L, Rebmann T, Chang JJ, et al
    Racial disparities in U.S. maternal influenza vaccine uptake: Results from analysis of Pregnancy Risk Assessment Monitoring System (PRAMS) data, 2012-2015.
    Vaccine. 2019 Mar 27. pii: S0264-410X(19)30208.
    PubMed     Abstract available

  636. ANDRES C, Peremiquel-Trillas P, Gimferrer L, Pinana M, et al
    Molecular influenza surveillance at a tertiary university hospital during four consecutive seasons (2012-2016) in Catalonia, Spain.
    Vaccine. 2019 Mar 27. pii: S0264-410X(19)30380.
    PubMed     Abstract available

  637. EVERETT HE, Aramouni M, Coward V, Ramsay A, et al
    Vaccine-mediated protection of pigs against infection with pandemic H1N1 2009 swine influenza A virus requires a close antigenic match between the vaccine antigen and challenge virus.
    Vaccine. 2019 Mar 23. pii: S0264-410X(19)30316.
    PubMed     Abstract available

  638. TING-HUI-LIN, Chia MY, Lin CY, Yeh YQ, et al
    Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development.
    Vaccine. 2019;37:1897-1903.
    PubMed     Abstract available

  639. CRIADO MF, Bertran K, Lee DH, Killmaster L, et al
    Efficacy of novel recombinant fowlpox vaccine against recent Mexican H7N3 highly pathogenic avian influenza virus.
    Vaccine. 2019 Mar 15. pii: S0264-410X(19)30314.
    PubMed     Abstract available

  640. NORMAN DA, Danchin M, Van Buynder P, Moore HC, et al
    Caregiver's attitudes, beliefs, and experiences for influenza vaccination in Australian children with medical comorbidities.
    Vaccine. 2019 Mar 15. pii: S0264-410X(19)30315.
    PubMed     Abstract available

  641. SCHAFFER SJ, Rand CM, Humiston SG, Concannon C, et al
    Practical considerations in developing a successful school-located influenza vaccination (SLIV) program.
    Vaccine. 2019 Mar 13. pii: S0264-410X(19)30290.

  642. THORRINGTON D, van Leeuwen E, Ramsay M, Pebody R, et al
    Assessing optimal use of the standard dose adjuvanted trivalent seasonal influenza vaccine in the elderly.
    Vaccine. 2019 Mar 11. pii: S0264-410X(19)30293.
    PubMed     Abstract available

  643. SEKIYA T, Mifsud EJ, Ohno M, Nomura N, et al
    Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza.
    Vaccine. 2019 Mar 8. pii: S0264-410X(19)30264.
    PubMed     Abstract available

  644. PAN SC, Hsieh SM, Lin CF, Hsu YS, et al
    A randomized, double-blind, controlled clinical trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with adjuvant LTh(alphaK): A phase I study.
    Vaccine. 2019 Mar 2. pii: S0264-410X(19)30189.
    PubMed     Abstract available

  645. AINSLIE KEC, Haber M, Orenstein WA
    Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic.
    Vaccine. 2019 Mar 1. pii: S0264-410X(19)30241.
    PubMed     Abstract available

    February 2019
  646. GIDUTHURI JG, Purohit V, Maire N, Kudale A, et al
    Influenza vaccination of pregnant women: Engaging clinicians to reduce missed opportunities for vaccination.
    Vaccine. 2019 Feb 28. pii: S0264-410X(19)30240.
    PubMed     Abstract available

  647. ZHANG D, Zhang Y, Wang Q, Lock J, et al
    The effectiveness of influenza vaccination in preventing hospitalizations in elderly in Beijing, 2016-18.
    Vaccine. 2019 Feb 28. pii: S0264-410X(19)30207.
    PubMed     Abstract available

  648. MEYER SB, Violette R, Aggarwal R, Simeoni M, et al
    Vaccine hesitancy and Web 2.0: Exploring how attitudes and beliefs about influenza vaccination are exchanged in online threaded user comments.
    Vaccine. 2019 Feb 27. pii: S0264-410X(19)30223.
    PubMed     Abstract available

  649. GETAHUN D, Fassett MJ, Peltier MR, Takhar HS, et al
    Association between seasonal influenza vaccination with pre- and postnatal outcomes.
    Vaccine. 2019 Feb 21. pii: S0264-410X(19)30214.
    PubMed     Abstract available

  650. WANG Z, Li Z, Su X, Qiao Y, et al
    Enhanced cross-lineage protection induced by recombinant H9N2 avian influenza virus inactivated vaccine.
    Vaccine. 2019 Feb 20. pii: S0264-410X(19)30206.
    PubMed     Abstract available

  651. WANG SH, Smith D, Cao Z, Chen J, et al
    Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge.
    Vaccine. 2019 Feb 19. pii: S0264-410X(19)30168.
    PubMed     Abstract available

  652. ABUBAKAR A, Melhem N, Malik M, Dbaibo G, et al
    Seasonal influenza vaccination policies in the Eastern Mediterranean Region: Current status and the way forward.
    Vaccine. 2019 Feb 19. pii: S0264-410X(19)30163.
    PubMed     Abstract available

  653. DUROUS L, Julien T, Padey B, Traversier A, et al
    SPRi-based hemagglutinin quantitative assay for influenza vaccine production monitoring.
    Vaccine. 2019 Feb 14. pii: S0264-410X(19)30181.
    PubMed     Abstract available

  654. ZENG Y, Yuan Z, Yin J, Han Y, et al
    Factors affecting parental intention to vaccinate kindergarten children against influenza: A cross-sectional survey in China.
    Vaccine. 2019 Feb 12. pii: S0264-410X(19)30156.
    PubMed     Abstract available

  655. CHAE W, Kim P, Hwang BJ, Seong BL, et al
    Universal monoclonal antibody-based influenza hemagglutinin quantitative enzyme-linked immunosorbent assay.
    Vaccine. 2019 Feb 11. pii: S0264-410X(19)30153.
    PubMed     Abstract available

  656. HERRERA-RODRIGUEZ J, Signorazzi A, Holtrop M, de Vries-Idema J, et al
    Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production.
    Vaccine. 2019 Feb 11. pii: S0264-410X(19)30184.
    PubMed     Abstract available

  657. PEPIN S, Samson SI, Alvarez FP, Dupuy M, et al
    Impact of a quadrivalent inactivated influenza vaccine on influenza-associated complications and health care use in children aged 6 to 35months: Analysis of data from a phase III trial in the Northern and Southern Hemispheres.
    Vaccine. 2019 Feb 8. pii: S0264-410X(19)30144.
    PubMed     Abstract available

  658. YOUNG-XU Y, Snider JT, van Aalst R, Mahmud SM, et al
    Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable method.
    Vaccine. 2019 Feb 8. pii: S0264-410X(19)30148.
    PubMed     Abstract available

  659. HABER P, Moro PL, Ng C, Dores GM, et al
    Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.
    Vaccine. 2019 Feb 7. pii: S0264-410X(19)30128.
    PubMed     Abstract available

  660. DOORNEKAMP L, de Jong W, Wagener MN, Goeijenbier M, et al
    Dutch healthcare professionals' opinion on vaccination and education to prevent infections in immunocompromised patients: A mixed-method study with recommendations for daily practice.
    Vaccine. 2019 Feb 7. pii: S0264-410X(19)30160.
    PubMed     Abstract available

  661. PETRIE JG, Martin ET, Truscon R, Johnson E, et al
    Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population.
    Vaccine. 2019 Feb 6. pii: S0264-410X(19)30131.
    PubMed     Abstract available

  662. BORGEY F, Henry L, Lebeltel J, Lescure P, et al
    Effectiveness of an intervention campaign on influenza vaccination of professionals in nursing homes: A cluster-randomized controlled trial.
    Vaccine. 2019 Feb 6. pii: S0264-410X(19)30151.
    PubMed     Abstract available

  663. RAO S, Alishahi M, De Crescenzo L, Dempsey AF, et al
    A population-based study of maternal and infant factors influencing influenza vaccination among young children born in Colorado from 2008 to 2016.
    Vaccine. 2019 Feb 2. pii: S0264-410X(19)30130.
    PubMed     Abstract available

    January 2019
  664. SHAPIRO JR, Hodgins B, Hendin HE, Patel A, et al
    Needle-free delivery of influenza vaccine using the Med-Jet(R) H4 is efficient and elicits the same humoral and cellular responses as standard IM injection: A randomized trial.
    Vaccine. 2019 Jan 29. pii: S0264-410X(19)30103.
    PubMed     Abstract available

  665. QUINN SC, Jamison AM, An J, Hancock GR, et al
    Measuring vaccine hesitancy, confidence, trust and flu vaccine uptake: Results of a national survey of White and African American adults.
    Vaccine. 2019 Jan 29. pii: S0264-410X(19)30096.
    PubMed     Abstract available

  666. GHORBANI A, Ngunjiri JM, Xia M, Elaish M, et al
    Heterosubtypic protection against avian influenza virus by live attenuated and chimeric norovirus P-particle-M2e vaccines in chickens.
    Vaccine. 2019 Jan 25. pii: S0264-410X(19)30100.
    PubMed     Abstract available

  667. SAHIN Z, Neeleman R, Haines J, Kayser V, et al
    Preparation-free method can enable rapid surfactant screening during industrial processing of influenza vaccines.
    Vaccine. 2019 Jan 23. pii: S0264-410X(19)30050.
    PubMed     Abstract available

  668. LU J, Luo M, Yee AZH, Sheldenkar A, et al
    Do superstitious beliefs affect influenza vaccine uptake through shaping health beliefs?
    Vaccine. 2019 Jan 22. pii: S0264-410X(19)30071.
    PubMed     Abstract available

  669. YUNG BS, Pugh H, Generotti AA, Phanhthilath N, et al
    Novel IFN-gamma ELISpot reveals robust T cell responses elicited after influenza nucleoprotein DNA vaccination in New Zealand White rabbits.
    Vaccine. 2019 Jan 17. pii: S0264-410X(19)30037.
    PubMed     Abstract available

  670. STRIJBOS E, Tannemaat MR, Alleman I, de Meel RHP, et al
    A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis.
    Vaccine. 2019 Jan 16. pii: S0264-410X(19)30038.
    PubMed     Abstract available

  671. BOCCALINI S, Tacconi FM, Lai PL, Bechini A, et al
    Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy.
    Vaccine. 2019 Jan 14. pii: S0264-410X(19)30026.
    PubMed     Abstract available

  672. MOOIJ P, Grodeland G, Koopman G, Andersen TK, et al
    Needle-free delivery of DNA: Targeting of hemagglutinin to MHC class II molecules protects rhesus macaques against H1N1 influenza.
    Vaccine. 2019 Jan 9. pii: S0264-410X(19)30005.
    PubMed     Abstract available

  673. MORAN A, Agaliotis M, Seale H
    The views of key stakeholders around mandatory influenza vaccination of hospital and aged care staff: Examining the current climate in Australia.
    Vaccine. 2019 Jan 6. pii: S0264-410X(18)31702.
    PubMed     Abstract available

  674. PRASERT K, Patumanond J, Praphasiri P, Siriluk S, et al
    Effectiveness of trivalent inactivated influenza vaccine among community-dwelling older adults in Thailand: A two-year prospective cohort study.
    Vaccine. 2019 Jan 4. pii: S0264-410X(19)30003.
    PubMed     Abstract available

  675. WEHBI NK, Wani RJ, Klepser DG, Murry J, et al
    Impact of implementing a technology platform in community pharmacies to increase adult immunizations rates.
    Vaccine. 2019;37:56-60.
    PubMed     Abstract available

    December 2018
  676. REGAN AK, Gibbs R, Bloomfield L, Effler PV, et al
    Estimating influenza vaccine effectiveness using data routinely available in electronic primary care records.
    Vaccine. 2018 Dec 29. pii: S0264-410X(18)31651.
    PubMed     Abstract available

  677. HURLEY LP, Allison MA, Kim L, O'Leary ST, et al
    Primary care physicians' perspectives on respiratory syncytial virus (RSV) disease in adults and a potential RSV vaccine for adults.
    Vaccine. 2018 Dec 28. pii: S0264-410X(18)31704.
    PubMed     Abstract available

  678. PEPIN S, Dupuy M, Borja-Tabora CFC, Montellano M, et al
    Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres.
    Vaccine. 2018 Dec 14. pii: S0264-410X(18)31637.
    PubMed     Abstract available

  679. MILLER PDE, de Silva TI, Leonard H, Anthias C, et al
    A comparison of viral microneutralization and haemagglutination inhibition assays as measures of seasonal inactivated influenza vaccine immunogenicity in the first year after reduced intensity conditioning, lymphocyte depleted allogeneic haematopoieti
    Vaccine. 2018 Dec 13. pii: S0264-410X(18)31586.
    PubMed     Abstract available

  680. KIMOTO T, Kim H, Sakai S, Takahashi E, et al
    Oral vaccination with influenza hemagglutinin combined with human pulmonary surfactant-mimicking synthetic adjuvant SF-10 induces efficient local and systemic immunity compared with nasal and subcutaneous vaccination and provides protective immunity i
    Vaccine. 2018 Dec 13. pii: S0264-410X(18)31647.
    PubMed     Abstract available

  681. OSHANSKY CM, Zhou J, Gao Y, Schweinle JE, et al
    Safety and immunogenicity of influenza A(H5N1) vaccine stored up to twelve years in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS).
    Vaccine. 2018 Dec 12. pii: S0264-410X(18)31632.
    PubMed     Abstract available

  682. CATTAPAN A, Browne K, Halperin DM, Di Castri A, et al
    Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial.
    Vaccine. 2018 Dec 6. pii: S0264-410X(18)31527.
    PubMed     Abstract available

  683. LEIDNER AJ, Murthy N, Chesson HW, Biggerstaff M, et al
    Cost-effectiveness of adult vaccinations: A systematic review.
    Vaccine. 2018 Dec 4. pii: S0264-410X(18)31581.
    PubMed     Abstract available

    November 2018
  684. BRESEE JS, McKinlay MA, Abramson J, Klugman KP, et al
    Global Funders Consortium for Universal Influenza Vaccine Development.
    Vaccine. 2018 Nov 29. pii: S0264-410X(18)31560.

  685. DAWA J, Chaves SS, Ba Nguz A, Kalani R, et al
    Developing a seasonal influenza vaccine recommendation in Kenya: Process and challenges faced by the National Immunization Technical Advisory Group (NITAG).
    Vaccine. 2018 Nov 27. pii: S0264-410X(18)31587.
    PubMed     Abstract available

  686. VAJO Z, Kalabay L, Vajo P, Balaton G, et al
    Licensing the first reduced, 6microg dose whole virion, aluminum adjuvanted seasonal influenza vaccine - A randomized-controlled multicenter trial.
    Vaccine. 2018 Nov 26. pii: S0264-410X(18)31562.
    PubMed     Abstract available

  687. RIDDELL CA, Bhat N, Bont LJ, Dupont WD, et al
    Informing randomized clinical trials of respiratory syncytial virus vaccination during pregnancy to prevent recurrent childhood wheezing: A sample size analysis.
    Vaccine. 2018 Nov 22. pii: S0264-410X(18)31407.
    PubMed     Abstract available

  688. MCMORROW ML, Tempia S, Walaza S, Treurnicht FK, et al
    Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa.
    Vaccine. 2018 Nov 21. pii: S0264-410X(18)31573.
    PubMed     Abstract available

  689. STEAD M, Critchlow N, Eadie D, Sullivan F, et al
    Mandatory policies for influenza vaccination: Views of managers and healthcare workers in England.
    Vaccine. 2018 Nov 20. pii: S0264-410X(18)31556.
    PubMed     Abstract available

  690. TUCKERMAN J, Misan S, Salih S, Joseph Xavier B, et al
    Influenza vaccination: Uptake and associations in a cross-sectional study of children with special risk medical conditions.
    Vaccine. 2018 Nov 16. pii: S0264-410X(18)31299.
    PubMed     Abstract available

  691. BIELECKI K, Kirolos A, Willocks LJ, Pollock KG, et al
    Low uptake of nasal influenza vaccine in polish and other ethnic minority children in Edinburgh, Scotland.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)31552.
    PubMed     Abstract available

  692. YUE X, Black CL, Williams WW, Lu PJ, et al
    Influenza vaccination among adults living with persons at high-risk for complications from influenza during early 2016-17 influenza season.
    Vaccine. 2018 Nov 14. pii: S0264-410X(18)31499.
    PubMed     Abstract available

  693. WON SY, Hunt K, Guak H, Hasaj B, et al
    Characterization of the innate stimulatory capacity of plant-derived virus-like particles bearing influenza hemagglutinin.
    Vaccine. 2018 Nov 14. pii: S0264-410X(18)31496.
    PubMed     Abstract available

  694. KAHN KE, Santibanez TA, Zhai Y, Bridges CB, et al
    Association between patient reminders and influenza vaccination status among children.
    Vaccine. 2018 Nov 14. pii: S0264-410X(18)31395.
    PubMed     Abstract available

  695. SHANG M, Chung JR, Jackson ML, Jackson LA, et al
    Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016.
    Vaccine. 2018 Nov 9. pii: S0264-410X(18)31490.
    PubMed     Abstract available

  696. MUNOZ FM, Jackson LA, Swamy GK, Edwards KM, et al
    Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women.
    Vaccine. 2018 Nov 8. pii: S0264-410X(18)31475.
    PubMed     Abstract available

  697. WILCOX CR, Bottrell K, Paterson P, Schulz WS, et al
    Influenza and pertussis vaccination in pregnancy: Portrayal in online media articles and perceptions of pregnant women and healthcare professionals.
    Vaccine. 2018 Nov 3. pii: S0264-410X(18)31489.
    PubMed     Abstract available

    October 2018
  698. AHMED N, Quinn SC, Hancock GR, Freimuth VS, et al
    Social media use and influenza vaccine uptake among White and African American adults.
    Vaccine. 2018 Oct 30. pii: S0264-410X(18)31415.
    PubMed     Abstract available

  699. GILBERT BE, Patel N, Lu H, Liu Y, et al
    Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
    Vaccine. 2018 Oct 30. pii: S0264-410X(18)31458.
    PubMed     Abstract available

  700. KRAMER R, Duclos A, Lina B, Casalegno JS, et al
    Cost and burden of RSV related hospitalisation from 2012 to 2017 in the first year of life in Lyon, France.
    Vaccine. 2018;36:6591-6593.
    PubMed     Abstract available

  701. BEKKAT-BERKANI R, Romano-Mazzotti L
    Understanding the unique characteristics of seasonal influenza illness to improve vaccine uptake in the US.
    Vaccine. 2018 Oct 23. pii: S0264-410X(18)31393.
    PubMed     Abstract available

  702. ZHAI Y, Santibanez TA, Kahn KE, Black CL, et al
    Paid sick leave benefits, influenza vaccination, and taking sick days due to influenza-like illness among U.S. workers.
    Vaccine. 2018 Oct 22. pii: S0264-410X(18)31405.
    PubMed     Abstract available

  703. DANCHIN MH, Costa-Pinto J, Attwell K, Willaby H, et al
    Vaccine decision-making begins in pregnancy: Correlation between vaccine concerns, intentions and maternal vaccination with subsequent childhood vaccine uptake.
    Vaccine. 2018;36:6473-6479.
    PubMed     Abstract available

  704. VAUGHN AR, Johnson ML
    Communicating and enhancing teachers' attitudes and understanding of influenza using refutational text.
    Vaccine. 2018 Oct 17. pii: S0264-410X(18)31406.
    PubMed     Abstract available

  705. WANG Q, Yue N, Zheng M, Wang D, et al
    Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: A meta-analysis.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31411.
    PubMed     Abstract available

  706. D'ALESSIO F, Koopman G, Houard S, Remarque EJ, et al
    Workshop report: Experimental animal models for universal influenza vaccines.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31390.
    PubMed     Abstract available

  707. SANTIBANEZ TA, Kahn KE, Bridges CB
    Do parents prefer inactivated or live attenuated influenza vaccine for their children?
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31408.
    PubMed     Abstract available

  708. ZHANG L, Durr E, Galli JD, Cosmi S, et al
    Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability.
    Vaccine. 2018 Oct 16. pii: S0264-410X(18)31398.
    PubMed     Abstract available

  709. THANG HV, Huong VM, Victor JC, Van CB, et al
    Safety and immunogenicity of inactivated monovalent influenza A/H1N1 vaccine candidate manufactured in Vietnam.
    Vaccine. 2018 Oct 15. pii: S0264-410X(18)31365.
    PubMed     Abstract available

  710. TOKARS JI, Rolfes MA, Foppa IM, Reed C, et al
    An evaluation and update of methods for estimating the number of influenza cases averted by vaccination in the United States.
    Vaccine. 2018 Oct 13. pii: S0264-410X(18)31392.
    PubMed     Abstract available

  711. YEOLEKAR LR, Ganguly M, Tyagi P, Ingle NB, et al
    Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains.
    Vaccine. 2018 Oct 12. pii: S0264-410X(18)31354.
    PubMed     Abstract available

  712. GERRETSEN HE, Capone S, Vitelli A, Reyes LS, et al
    Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infection.
    Vaccine. 2018 Oct 11. pii: S0264-410X(18)31351.
    PubMed     Abstract available

  713. BARTSCH SM, Taitel MS, DePasse JV, Cox SN, et al
    Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic.
    Vaccine. 2018 Oct 5. pii: S0264-410X(18)31300.
    PubMed     Abstract available

  714. TSUZUKI S, Schwehm M, Eichner M
    Corrigendum to "Simulation studies to assess the long-term effects of Japan's change from trivalent to quadrivalent influenza vaccination" [Vaccine 36 (2018) 624-630].
    Vaccine. 2018 Oct 3. pii: S0264-410X(18)31315.

  715. ROBISON SG, Thomas AR
    Assessing the effectiveness of high-dose influenza vaccine in preventing hospitalization among seniors, and observations on the limitations of effectiveness study design.
    Vaccine. 2018 Oct 1. pii: S0264-410X(18)31319.
    PubMed     Abstract available

  716. GREEN CA, Sande CJ, de Lara C, Thompson AJ, et al
    Humoral and cellular immunity to RSV in infants, children and adults.
    Vaccine. 2018;36:6183-6190.
    PubMed     Abstract available

    September 2018
  717. BORG K, Sutton K, Beasley M, Tull F, et al
    Communication-based interventions for increasing influenza vaccination rates among Aboriginal children: A randomised controlled trial.
    Vaccine. 2018 Sep 29. pii: S0264-410X(18)31269.
    PubMed     Abstract available

  718. HAYASHI T, Lynch HE, Geyer S, Yoshida K, et al
    Impact of early life exposure to ionizing radiation on influenza vaccine response in an elderly Japanese cohort.
    Vaccine. 2018 Sep 28. pii: S0264-410X(18)31323.
    PubMed     Abstract available

  719. MOMOSE H, Sasaki E, Kuramitsu M, Hamaguchi I, et al
    Gene expression profiling toward the next generation safety control of influenza vaccines and adjuvants in Japan.
    Vaccine. 2018 Sep 19. pii: S0264-410X(18)31270.
    PubMed     Abstract available

  720. BERTRAN K, Lee DH, Criado MF, Balzli CL, et al
    Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
    Vaccine. 2018 Sep 18. pii: S0264-410X(18)31264.
    PubMed     Abstract available

  721. DEDIEGO ML, Chiem K, Topham DJ
    Directed selection of amino acid changes in the influenza hemagglutinin and neuraminidase affecting protein antigenicity.
    Vaccine. 2018 Sep 14. pii: S0264-410X(18)31240.
    PubMed     Abstract available

  722. DIALLO A, Victor JC, Feser J, Ortiz JR, et al
    Immunogenicity and safety of MF59-adjuvanted and full-dose unadjuvanted trivalent inactivated influenza vaccines among vaccine-naive children in a randomized clinical trial in rural Senegal.
    Vaccine. 2018 Sep 14. pii: S0264-410X(18)31158.
    PubMed     Abstract available

  723. GAGNON A, Acosta E, Miller MS
    Reporting and evaluating influenza virus surveillance data: An argument for incidence by single year of age.
    Vaccine. 2018 Sep 12. pii: S0264-410X(18)31227.

  724. MCGRATH LJ, Layton JB, Krueger WS, Kshirsagar AV, et al
    High-dose influenza vaccine use among patients receiving hemodialysis in the United States, 2010-2013.
    Vaccine. 2018 Sep 5. pii: S0264-410X(18)31229.
    PubMed     Abstract available

  725. WESTRICK SC, Patterson BJ, Kader MS, Rashid S, et al
    National survey of pharmacy-based immunization services.
    Vaccine. 2018;36:5657-5664.
    PubMed     Abstract available

  726. MORGENSTERN K, Xie Y, Palladino G, Barr JR, et al
    Reference antigen-free and antibody-free LTD-IDMS assay for influenza H7N9 vaccine in vitro potency determination.
    Vaccine. 2018 Sep 4. pii: S0264-410X(18)31204.
    PubMed     Abstract available

  727. TAM YH, Ng TWY, Chu DKW, Fang VJ, et al
    The effectiveness of influenza vaccination against medically-attended illnesses in Hong Kong across three years with different degrees of vaccine match, 2014-17.
    Vaccine. 2018 Sep 3. pii: S0264-410X(18)31215.
    PubMed     Abstract available

  728. SOUZA CK, Rajao DS, Sandbulte MR, Lopes S, et al
    The type of adjuvant in whole inactivated influenza a virus vaccines impacts vaccine-associated enhanced respiratory disease.
    Vaccine. 2018 Sep 1. pii: S0264-410X(18)31212.
    PubMed     Abstract available

  729. MOMBELLI M, Rettby N, Perreau M, Pascual M, et al
    Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial.
    Vaccine. 2018 Sep 1. pii: S0264-410X(18)31186.
    PubMed     Abstract available

    August 2018
  730. CHIU HT, Shen LJ, Chen YC, Lin JH, et al
    Effect of statin use on the risk of medically attended acute respiratory illness among influenza vaccinated elderly.
    Vaccine. 2018 Aug 30. pii: S0264-410X(18)31206.
    PubMed     Abstract available

  731. WHITAKER JA, von Itzstein MS, Poland GA
    Strategies to maximize influenza vaccine impact in older adults.
    Vaccine. 2018 Aug 25. pii: S0264-410X(18)31169.
    PubMed     Abstract available

  732. STONE K, Akpalu Y, Horney J
    Use of the Community Assessment for Public Health Response (CASPER) method to assess influenza vaccination and activity in Brazos County, Texas.
    Vaccine. 2018 Aug 24. pii: S0264-410X(18)31139.
    PubMed     Abstract available

  733. NEWALL AT, Chen C, Wood JG, Stockwell MS, et al
    Within-season influenza vaccine waning suggests potential net benefits to delayed vaccination in older adults in the United States.
    Vaccine. 2018 Aug 23. pii: S0264-410X(18)31114.
    PubMed     Abstract available

  734. WEIBEL D, Sturkenboom M, Black S, de Ridder M, et al
    Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment.
    Vaccine. 2018 Aug 16. pii: S0264-410X(18)31115.
    PubMed     Abstract available

  735. PRICE GE, Lo CY, Misplon JA, Epstein SL, et al
    Reduction of influenza virus transmission from mice immunized against conserved viral antigens is influenced by route of immunization and choice of vaccine antigen.
    Vaccine. 2018;36.
    PubMed     Abstract available

  736. SHINJOH M, Sugaya N, Yamaguchi Y, Iibuchi N, et al
    Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016/17 season.
    Vaccine. 2018 Aug 6. pii: S0264-410X(18)31074.
    PubMed     Abstract available

  737. WU S, Pan Y, Zhang X, Zhang L, et al
    Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
    Vaccine. 2018 Aug 4. pii: S0264-410X(18)31097.
    PubMed     Abstract available

  738. YEUNG KHT, Tarrant M, Chan KCC, Tam WH, et al
    Increasing influenza vaccine uptake in children: A randomised controlled trial.
    Vaccine. 2018 Aug 2. pii: S0264-410X(18)31075.
    PubMed     Abstract available

  739. THOMPSON MG, Pierse N, Sue Huang Q, Prasad N, et al
    Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015.
    Vaccine. 2018 Aug 1. pii: S0264-410X(18)30997.
    PubMed     Abstract available

    July 2018
  740. ORTQVIST A, Brytting M, Leval A, Hergens MP, et al
    Impact of repeated influenza vaccinations in persons over 65years of age: A large population-based cohort study of severe influenza over six consecutive seasons, 2011/12-2016/17.
    Vaccine. 2018 Jul 31. pii: S0264-410X(18)31046.
    PubMed     Abstract available

  741. NOH JY, Choi WS, Song JY, Lee HS, et al
    Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007-2014.
    Vaccine. 2018 Jul 26. pii: S0264-410X(18)30987.
    PubMed     Abstract available

  742. STATLER VA, Albano FR, Airey J, Sawlwin DC, et al
    Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6-59months of age: A phase 3, randomized, noninferiority study.
    Vaccine. 2018 Jul 26. pii: S0264-410X(18)31005.
    PubMed     Abstract available

  743. FORD AJ, Alwan NA
    Use of social networking sites and women's decision to receive vaccinations during pregnancy: A cross-sectional study in the UK.
    Vaccine. 2018 Jul 25. pii: S0264-410X(18)30988.
    PubMed     Abstract available

  744. FERDMAN J, Palladino G, Liao HX, Moody MA, et al
    Intra-seasonal antibody repertoire analysis of a subject immunized with an MF59(R)-adjuvanted pandemic 2009 H1N1 vaccine.
    Vaccine. 2018 Jul 25. pii: S0264-410X(18)30895.
    PubMed     Abstract available

  745. MACHADO A, Kislaya I, Santos AJ, Gaio V, et al
    Factors associated to repeated influenza vaccination in the Portuguese adults with chronic conditions.
    Vaccine. 2018 Jul 24. pii: S0264-410X(18)31010.
    PubMed     Abstract available

  746. KASPER AK, Pallotta AM, Kovacs CS, Spinner ML, et al
    Infectious diseases consult improves vaccination adherence in kidney transplant candidates.
    Vaccine. 2018 Jul 23. pii: S0264-410X(18)30899.
    PubMed     Abstract available

  747. MAKARKOV AI, Patel AR, Bainov V, Ward BJ, et al
    A novel serological assay for influenza based on DiD fluorescence dequenching that is free from observer bias and potentially automatable - A proof of concept study.
    Vaccine. 2018;36:4485-4493.
    PubMed     Abstract available

  748. ZHANG L, Pan Y, Hackert V, van der Hoek W, et al
    The 2015-2016 influenza epidemic in Beijing, China: Unlike elsewhere, circulation of influenza A(H3N2) with moderate vaccine effectiveness.
    Vaccine. 2018 Jul 14. pii: S0264-410X(18)30947.
    PubMed     Abstract available

  749. HATTA Y, Boltz D, Sarawar S, Kawaoka Y, et al
    Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity.
    Vaccine. 2018 Jul 12. pii: S0264-410X(18)30894.
    PubMed     Abstract available

  750. HARRISON N, Poeppl W, Miksch M, Machold K, et al
    Predictors for influenza vaccine acceptance among patients with inflammatory rheumatic diseases.
    Vaccine. 2018 Jul 3. pii: S0264-410X(18)30906.
    PubMed     Abstract available

    June 2018
  751. BRADY RC, Jackson LA, Frey SE, Shane AL, et al
    Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women.
    Vaccine. 2018 Jun 28. pii: S0264-410X(18)30864.
    PubMed     Abstract available

  752. PING X, Hu W, Xiong R, Zhang X, et al
    Generation of a broadly reactive influenza H1 antigen using a consensus HA sequence.
    Vaccine. 2018 Jun 27. pii: S0264-410X(18)30889.
    PubMed     Abstract available

  753. SCHLAUDECKER EP, Ambroggio L, McNeal MM, Finkelman FD, et al
    Declining responsiveness to influenza vaccination with progression of human pregnancy.
    Vaccine. 2018 Jun 22. pii: S0264-410X(18)30796.
    PubMed     Abstract available

  754. SCHELTEMA NM, Kavelaars XM, Thorburn K, Hennus MP, et al
    Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancy.
    Vaccine. 2018 Jun 22. pii: S0264-410X(18)30837.
    PubMed     Abstract available

  755. DAI X, Li N, Roller RJ
    Peroxiredoxin 1 protein interacts with influenza virus ribonucleoproteins and is required for efficient virus replication.
    Vaccine. 2018 Jun 16. pii: S0264-410X(18)30823.
    PubMed     Abstract available

  756. ORTIZ JR
    Implementation of maternal influenza immunization programs.
    Vaccine. 2018;36:3571.

  757. KOUL PA, Mir H
    The biggest barrier to influenza vaccination in pregnant females in India: Poor sensitization of the care providers.
    Vaccine. 2018;36:3569-3570.

  758. SHEN AK, Warnock R, Chu S, Kelman JA, et al
    Receipt of other routinely recommended vaccines relative to receipt of seasonal influenza vaccines: Trends from medicare administrative data, 2013-2015.
    Vaccine. 2018 Jun 13. pii: S0264-410X(18)30836.
    PubMed     Abstract available

  759. STRASSBERG ER, Power M, Schulkin J, Stark LM, et al
    Patient attitudes toward influenza and tetanus, diphtheria and acellular pertussis vaccination in pregnancy.
    Vaccine. 2018 Jun 12. pii: S0264-410X(18)30800.
    PubMed     Abstract available

  760. ENGELHARDT OG, Edge C, Dunleavy U, Guilfoyle K, et al
    Comparison of single radial immunodiffusion, SDS-PAGE and HPLC potency assays for inactivated influenza vaccines shows differences in ability to predict immunogenicity of haemagglutinin antigen.
    Vaccine. 2018 Jun 9. pii: S0264-410X(18)30742.
    PubMed     Abstract available

  761. JOYCE C, Scallan CD, Mateo R, Belshe RB, et al
    Orally administered adenoviral-based vaccine induces respiratory mucosal memory and protection against RSV infection in cotton rats.
    Vaccine. 2018 Jun 9. pii: S0264-410X(18)30789.
    PubMed     Abstract available

  762. VALKENBURG SA, Li OTW, Li A, Bull M, et al
    Protection by universal influenza vaccine is mediated by memory CD4 T cells.
    Vaccine. 2018 Jun 7. pii: S0264-410X(18)30818.
    PubMed     Abstract available

  763. FAN X, Su Q, Qiu F, Yi Y, et al
    Intranasal inoculate of influenza virus vaccine against lethal virus challenge.
    Vaccine. 2018 Jun 4. pii: S0264-410X(18)30739.
    PubMed     Abstract available

  764. HENDRIKS J, Hutubessy RCW, Grohmann G, Torelli G, et al
    Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availability.
    Vaccine. 2018 Jun 1. pii: S0264-410X(18)30766.
    PubMed     Abstract available

    May 2018
  765. GARRETSON TA, Petrie JG, Martin ET, Monto AS, et al
    Identification of human vaccinees that possess antibodies targeting the egg-adapted hemagglutinin receptor binding site of an H1N1 influenza vaccine strain.
    Vaccine. 2018 May 31. pii: S0264-410X(18)30752.
    PubMed     Abstract available

  766. FLEMING JA, Baltrons R, Rowley E, Quintanilla I, et al
    Implementation of maternal influenza immunization in El Salvador: Experiences and lessons learned from a mixed-methods study.
    Vaccine. 2018 May 30. pii: S0264-410X(18)30762.
    PubMed     Abstract available

  767. ZHANG W, Sun H, Atiquzzaman M, Sou J, et al
    Influenza vaccination for HIV-positive people: Systematic review and network meta-analysis.
    Vaccine. 2018 May 30. pii: S0264-410X(18)30743.
    PubMed     Abstract available

  768. ASTILL J, Alkie T, Yitbarek A, Abdelaziz KTA, et al
    Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.
    Vaccine. 2018 May 28. pii: S0264-410X(18)30759.
    PubMed     Abstract available

  769. PUTRI WCWS, Muscatello DJ, Stockwell MS, Newall AT, et al
    Economic burden of seasonal influenza in the United States.
    Vaccine. 2018 May 22. pii: S0264-410X(18)30677.
    PubMed     Abstract available

  770. LOGAN J, Nederhoff D, Koch B, Griffith B, et al
    'What have you HEARD about the HERD?' Does education about local influenza vaccination coverage and herd immunity affect willingness to vaccinate?
    Vaccine. 2018 May 19. pii: S0264-410X(18)30657.
    PubMed     Abstract available

  771. YANG YT, Silverman RD
    Mandatory influenza vaccination and religious accommodation for healthcare workers: Lessons from recent legal challenges.
    Vaccine. 2018 May 19. pii: S0264-410X(18)30714.

  772. FERNANDO GJP, Hickling J, Jayashi Flores CM, Griffin P, et al
    Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch).
    Vaccine. 2018 May 17. pii: S0264-410X(18)30673.
    PubMed     Abstract available

  773. GRIEVES JL, Yin Z, Garcia-Sastre A, Mena I, et al
    A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats.
    Vaccine. 2018 May 17. pii: S0264-410X(18)30609.
    PubMed     Abstract available

  774. JAIN S, George PJ, Deng W, Koussa J, et al
    The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4(+) T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathway.
    Vaccine. 2018 May 12. pii: S0264-410X(18)30636.
    PubMed     Abstract available

  775. KAHN KE, Santibanez TA, Zhai Y, Bridges CB, et al
    Association between provider recommendation and influenza vaccination status among children.
    Vaccine. 2018 May 12. pii: S0264-410X(18)30584.
    PubMed     Abstract available

  776. HARRISON SM, Wei MY, Lamerato LE, Petrie JG, et al
    Multimorbidity is associated with uptake of influenza vaccination.
    Vaccine. 2018 May 7. pii: S0264-410X(18)30628.
    PubMed     Abstract available

  777. ARRIOLA CS, Vasconez N, Bresee J, Ropero AM, et al
    "Knowledge, attitudes and practices about influenza vaccination among pregnant women and healthcare providers serving pregnant women in Managua, Nicaragua".
    Vaccine. 2018 May 7. pii: S0264-410X(18)30620.
    PubMed     Abstract available

  778. SEO J, Lim J
    Trends in influenza vaccination coverage rates in South Korea from 2005 to 2014: Effect of public health policies on vaccination behavior.
    Vaccine. 2018 May 5. pii: S0264-410X(18)30631.
    PubMed     Abstract available

  779. YEUNG KHT, Chan KCC, Chan PKS, Lam DSY, et al
    Influenza vaccine effectiveness in hospitalised Hong Kong children: Feasibility of estimates from routine surveillance data.
    Vaccine. 2018 May 5. pii: S0264-410X(18)30588.
    PubMed     Abstract available

  780. BARTOSZKO JJ, McNamara IF, Aras OAZ, Hylton DA, et al
    Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis.
    Vaccine. 2018 May 1. pii: S0264-410X(18)30546.
    PubMed     Abstract available

    April 2018
  781. BOEY L, Bral C, Roelants M, De Schryver A, et al
    Attitudes, believes, determinants and organisational barriers behind the low seasonal influenza vaccination uptake in healthcare workers - A cross-sectional survey.
    Vaccine. 2018 Apr 28. pii: S0264-410X(18)30539.
    PubMed     Abstract available

  782. TESSIER E, Warburton F, Tsang C, Rafeeq S, et al
    Population-level factors predicting variation in influenza vaccine uptake among adults and young children in England, 2015/16 and 2016/17.
    Vaccine. 2018 Apr 28. pii: S0264-410X(18)30581.
    PubMed     Abstract available

  783. REGAN AK, Gibbs RA, Effler PV
    An audit of the reliability of influenza vaccination and medical information extracted from eHealth records in general practice.
    Vaccine. 2018 Apr 28. pii: S0264-410X(18)30583.
    PubMed     Abstract available

  784. SOMES MP, Turner RM, Dwyer LJ, Newall AT, et al
    Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: A systematic review and meta-analysis.
    Vaccine. 2018 Apr 28. pii: S0264-410X(18)30560.
    PubMed     Abstract available

  785. VAN DE WITTE S, Nauta J, Montomoli E, Weckx J, et al
    A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses.
    Vaccine. 2018 Apr 27. pii: S0264-410X(18)30538.
    PubMed     Abstract available

  786. LI R, Xie R, Yang C, Rainey J, et al
    Identifying ways to increase seasonal influenza vaccine uptake among pregnant women in China: A qualitative investigation of pregnant women and their obstetricians.
    Vaccine. 2018 Apr 26. pii: S0264-410X(18)30557.
    PubMed     Abstract available

  787. HJERTNER B, Bengtsson T, Morein B, Paulie S, et al
    A novel adjuvant G3 induces both Th1 and Th2 related immune responses in mice after immunization with a trivalent inactivated split-virion influenza vaccine.
    Vaccine. 2018 Apr 26. pii: S0264-410X(18)30551.
    PubMed     Abstract available

  788. OHLROGGE AW, Suggs LS
    Flu vaccination communication in Europe: What does the government communicate and how?
    Vaccine. 2018 Apr 24. pii: S0264-410X(18)30525.
    PubMed     Abstract available

  789. KUCK LR, Byrne-Nash R, Gillis J, Bueter K, et al
    VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
    Vaccine. 2018 Apr 23. pii: S0264-410X(18)30545.
    PubMed     Abstract available

  790. DALE LP, White L, Mitchell M, Faulkner G, et al
    Smartphone app uses loyalty point incentives and push notifications to encourage influenza vaccine uptake.
    Vaccine. 2018 Apr 23. pii: S0264-410X(18)30487.
    PubMed     Abstract available

  791. VERHEES RAF, Dondorp W, Thijs C, Dinant GJ, et al
    Influenza vaccination in the elderly: Is a trial on mortality ethically acceptable?
    Vaccine. 2018 Apr 21. pii: S0264-410X(18)30510.
    PubMed     Abstract available

  792. SUZUKI M, Katsurada N, Le MN, Kaneko N, et al
    Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza pneumonia among adults aged >/=65years in Japan.
    Vaccine. 2018 Apr 20. pii: S0264-410X(18)30520.
    PubMed     Abstract available

  793. Response to three Letters to the Editor regarding: Donahue JG, et al. "Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12". Vaccine 35 (2017) 5314-5322.
    Vaccine. 2018;36:2231-2232.

  794. SARKAR I, Garg R, van Drunen Littel-van den Hurk S
    The respiratory syncytial virus fusion protein formulated with a polymer-based adjuvant induces multiple signaling pathways in macrophages.
    Vaccine. 2018;36:2326-2336.
    PubMed     Abstract available

  795. AULT KA, Riley LE
    Response to Donahue et al. 2017 in press article.
    Vaccine. 2018;36:2230.

  796. WEN Y, Palladino G, Xie Y, Ferrari A, et al
    Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity.
    Vaccine. 2018 Apr 18. pii: S0264-410X(18)30490.
    PubMed     Abstract available

  797. HOSCHLER K, Southern J, Thompson C, Warburton F, et al
    Responses to live attenuated influenza vaccine in children vaccinated previously with Pandemrix (ASO3B adjuvanted pandemic A/H1N1pdm09).
    Vaccine. 2018 Apr 18. pii: S0264-410X(18)30486.
    PubMed     Abstract available

  798. SZILAGYI PG, Schaffer S, Rand CM, Goldstein NPN, et al
    Impact of elementary school-located influenza vaccinations: A stepped wedge trial across a community.
    Vaccine. 2018 Apr 17. pii: S0264-410X(18)30403.
    PubMed     Abstract available

  799. SHIBATA N, Kimura S, Hoshino T, Takeuchi M, et al
    Effectiveness of influenza vaccination for children in Japan: Four-year observational study using a large-scale claims database.
    Vaccine. 2018 Apr 13. pii: S0264-410X(18)30460.
    PubMed     Abstract available

  800. BISSET KA, Paterson P
    Strategies for increasing uptake of vaccination in pregnancy in high-income countries: A systematic review.
    Vaccine. 2018 Apr 13. pii: S0264-410X(18)30482.
    PubMed     Abstract available

  801. HOFFMANN A, Dumke C, Hanschmann KO, Wicker S, et al
    Local thermal reaction after influenza vaccination: Quantification by infrared imaging and biometric considerations.
    Vaccine. 2018 Apr 10. pii: S0264-410X(18)30467.
    PubMed     Abstract available

  802. LAPUENTE D, Ruzsics Z, Thirion C, Tenbusch M, et al
    Evaluation of adenovirus 19a as a novel vector for mucosal vaccination against influenza A viruses.
    Vaccine. 2018 Apr 5. pii: S0264-410X(18)30262.
    PubMed     Abstract available

  803. DABAGHIAN M, Latifi AM, Tebianian M, NajmiNejad H, et al
    Nasal vaccination with r4M2e.HSP70c antigen encapsulated into N-trimethyl chitosan (TMC) nanoparticulate systems: Preparation and immunogenicity in a mouse model.
    Vaccine. 2018 Apr 4. pii: S0264-410X(18)30259.
    PubMed     Abstract available

  804. CONLIN AMS, Bukowinski AT, Levine JA, Khodr ZG, et al
    A follow-up comparative safety analysis of pandemic H1N1 vaccination during pregnancy and risk of infant birth defects among U.S. military mothers.
    Vaccine. 2018 Apr 3. pii: S0264-410X(18)30417.
    PubMed     Abstract available

    March 2018
  805. ESPOSITO S, Franco E, Gavazzi G, de Miguel AG, et al
    The public health value of vaccination for seniors in Europe.
    Vaccine. 2018 Mar 31. pii: S0264-410X(18)30409.
    PubMed     Abstract available

  806. WENDLANDT R, Cowling BJ, Chen Y, Havers F, et al
    Knowledge, attitudes and practices related to the influenza virus and vaccine among older adults in Eastern China.
    Vaccine. 2018 Mar 29. pii: S0264-410X(18)30408.
    PubMed     Abstract available

  807. KASSIANOS G, Kuchar E, Nitsch-Osuch A, Kyncl J, et al
    Motors of influenza vaccination uptake and vaccination advocacy in healthcare workers: A comparative study in six European countries.
    Vaccine. 2018 Mar 28. pii: S0264-410X(18)30205.
    PubMed     Abstract available

  808. MUFLIHAH H, Florido M, Lin LCW, Xia Y, et al
    Sequential pulmonary immunization with heterologous recombinant influenza A virus tuberculosis vaccines protects against murine M. tuberculosis infection.
    Vaccine. 2018 Mar 27. pii: S0264-410X(18)30382.
    PubMed     Abstract available

  809. CITRON MP, Patel M, Purcell M, Lin SA, et al
    A novel method for strict intranasal delivery of non-replicating RSV vaccines in cotton rats and non-human primates.
    Vaccine. 2018 Mar 26. pii: S0264-410X(18)30320.
    PubMed     Abstract available

  810. KRETZSCHMAR E, Muckenfuss H, Pfleiderer M
    Official batch control of influenza vaccines: Is it still useful?
    Vaccine. 2018 Mar 23. pii: S0264-410X(18)30275.
    PubMed     Abstract available

  811. WANG Y, Chen L, Yu J, Pang Y, et al
    The effectiveness of influenza vaccination among nursery school children in China during the 2016/17 influenza season.
    Vaccine. 2018 Mar 23. pii: S0264-410X(18)30384.
    PubMed     Abstract available

  812. ALFELALI M, Barasheed O, Badahdah AM, Bokhary H, et al
    Influenza vaccination among Saudi Hajj pilgrims: Revealing the uptake and vaccination barriers.
    Vaccine. 2018 Mar 16. pii: S0264-410X(18)30343.
    PubMed     Abstract available

  813. SOEDJATMIKO S, Medise BE, Gunardi H, Sekartini R, et al
    Immunogenicity and safety of a Trivalent Influenza HA vaccine in Indonesian infants and children.
    Vaccine. 2018 Mar 15. pii: S0264-410X(18)30324.
    PubMed     Abstract available

  814. LINDSAY BJ, Bonar MM, Costas-Cancelas IN, Hunt K, et al
    Morphological characterization of a plant-made virus-like particle vaccine bearing influenza virus hemagglutinins by electron microscopy.
    Vaccine. 2018 Mar 14. pii: S0264-410X(18)30316.
    PubMed     Abstract available

  815. NICHOLS MK, Andrew MK, Hatchette TF, Ambrose A, et al
    Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious
    Vaccine. 2018 Mar 13. pii: S0264-410X(18)30292.
    PubMed     Abstract available

  816. KESHTKAR-JAHROMI M, Ouyang M, Keshtkarjahromi M, Almed S, et al
    Effect of influenza vaccine on tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in older adults.
    Vaccine. 2018 Mar 13. pii: S0264-410X(17)31609.
    PubMed     Abstract available

  817. TETE SM, Jul-Larsen A, Rostami S, Lunde THF, et al
    Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Vaccine. 2018 Mar 13. pii: S0264-410X(18)30196.
    PubMed     Abstract available

  818. RIKIN S, Jia H, Vargas CY, Castellanos de Belliard Y, et al
    Assessment of temporally-related acute respiratory illness following influenza vaccination.
    Vaccine. 2018 Mar 7. pii: S0264-410X(18)30315.
    PubMed     Abstract available

  819. SUNDARAM N, Duckett K, Yung CF, Thoon KC, et al
    "I wouldn't really believe statistics" - Challenges with influenza vaccine acceptance among healthcare workers in Singapore.
    Vaccine. 2018 Mar 5. pii: S0264-410X(18)30312.
    PubMed     Abstract available

  820. SURTEES TC, Teh BW, Slavin MA, Worth LJ, et al
    Factors contributing to declination of annual influenza vaccination by healthcare workers caring for cancer patients: An Australian experience.
    Vaccine. 2018 Mar 1. pii: S0264-410X(18)30297.
    PubMed     Abstract available

  821. CZAKO R, Vogel L, Sutton T, Matsuoka Y, et al
    H5N2 vaccine viruses on Russian and US live attenuated influenza virus backbones demonstrate similar infectivity, immunogenicity and protection in ferrets.
    Vaccine. 2018 Mar 1. pii: S0264-410X(18)30248.
    PubMed     Abstract available

    February 2018
  822. ARMITAGE EP, Camara J, Bah S, Forster AS, et al
    Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia.
    Vaccine. 2018 Feb 23. pii: S0264-410X(18)30211.
    PubMed     Abstract available

  823. WESTCOTT MM, Clemens EA, Holbrook BC, King SB, et al
    The choice of linker for conjugating R848 to inactivated influenza virus determines the stimulatory capacity for innate immune cells.
    Vaccine. 2018;36:1174-1182.
    PubMed     Abstract available

  824. KING JP, McLean HQ, Meece JK, Levine MZ, et al
    Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season.
    Vaccine. 2018;36:1214-1219.
    PubMed     Abstract available

  825. WHITE KM, Ayllon J, Mena I, Potenski A, et al
    Influenza B virus reverse genetic backbones with improved growth properties in the EB66(R) cell line as basis for vaccine seed virus generation.
    Vaccine. 2018;36:1146-1153.
    PubMed     Abstract available

  826. IBANEZ LI, Caldevilla CA, Paredes Rojas Y, Mattion N, et al
    Genetic and subunit vaccines based on the stem domain of the equine influenza hemagglutinin provide homosubtypic protection against heterologous strains.
    Vaccine. 2018 Feb 15. pii: S0264-410X(18)30193.
    PubMed     Abstract available

  827. SYCHEVA AL, Pogorelyy MV, Komech EA, Minervina AA, et al
    Quantitative profiling reveals minor changes of T cell receptor repertoire in response to subunit inactivated influenza vaccine.
    Vaccine. 2018 Feb 15. pii: S0264-410X(18)30201.
    PubMed     Abstract available

  828. DJAGBARE MD, Yu L, Parupudi A, Sun J, et al
    Monoclonal antibody based in vitro potency assay as a predictor of antigenic integrity and in vivo immunogenicity of a Respiratory Syncytial Virus post-fusion F-protein based vaccine.
    Vaccine. 2018 Feb 15. pii: S0264-410X(18)30115.
    PubMed     Abstract available

  829. MAGIRI R, Lai K, Chaffey A, Zhou Y, et al
    Intradermal immunization with inactivated swine influenza virus and adjuvant polydi(sodium carboxylatoethylphenoxy)phosphazene (PCEP) induced humoral and cell-mediated immunity and reduced lung viral titres in pigs.
    Vaccine. 2018 Feb 14. pii: S0264-410X(18)30200.
    PubMed     Abstract available

  830. BAYER L, Fertey J, Ulbert S, Grunwald T, et al
    Immunization with an adjuvanted low-energy electron irradiation inactivated respiratory syncytial virus vaccine shows immunoprotective activity in mice.
    Vaccine. 2018 Feb 10. pii: S0264-410X(18)30188.
    PubMed     Abstract available

  831. PANDO R, Sharabi S, Mandelboim M
    Exceptional influenza morbidity in summer season of 2017 in Israel may predict the vaccine efficiency in the coming winter.
    Vaccine. 2018 Feb 8. pii: S0264-410X(18)30158.
    PubMed     Abstract available

  832. DE BEKKER-GROB EW, Veldwijk J, Jonker M, Donkers B, et al
    The impact of vaccination and patient characteristics on influenza vaccination uptake of elderly people: A discrete choice experiment.
    Vaccine. 2018 Feb 6. pii: S0264-410X(18)30103.
    PubMed     Abstract available

  833. RUSSELL K, Chung JR, Monto AS, Martin ET, et al
    Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.
    Vaccine. 2018 Feb 2. pii: S0264-410X(18)30094.
    PubMed     Abstract available

    January 2018
  834. VEKEMANS J, Moorthy V, Giersing B, Friede M, et al
    Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics.
    Vaccine. 2018 Jan 25. pii: S0264-410X(17)31364.
    PubMed     Abstract available

  835. KAPLAN BS, Souza CK, Gauger PC, Stauft CB, et al
    Vaccination of pigs with a codon-pair bias de-optimized live attenuated influenza vaccine protects from homologous challenge.
    Vaccine. 2018 Jan 20. pii: S0264-410X(18)30061.
    PubMed     Abstract available

  836. DE BOER PT, Kelso JK, Halder N, Nguyen TP, et al
    The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia.
    Vaccine. 2018 Jan 17. pii: S0264-410X(17)31836.
    PubMed     Abstract available

  837. MORIMOTO N, Takeishi K
    Change in the efficacy of influenza vaccination after repeated inoculation under antigenic mismatch: A systematic review and meta-analysis.
    Vaccine. 2018 Jan 17. pii: S0264-410X(18)30057.
    PubMed     Abstract available

  838. SUGAYA N, Shinjoh M, Nakata Y, Tsunematsu K, et al
    Three-season effectiveness of inactivated influenza vaccine in preventing influenza illness and hospitalization in children in Japan, 2013-2016.
    Vaccine. 2018 Jan 17. pii: S0264-410X(18)30058.
    PubMed     Abstract available

  839. LU PJ, Srivastav A, Amaya A, Dever JA, et al
    Association of provider recommendation and offer and influenza vaccination among adults aged >/=18years - United States.
    Vaccine. 2018 Jan 9. pii: S0264-410X(17)31759.
    PubMed     Abstract available

  840. SHIM E, Smith KJ, Nowalk MP, Raviotta JM, et al
    Impact of seasonal influenza vaccination in the presence of vaccine interference.
    Vaccine. 2018 Jan 9. pii: S0264-410X(17)31830.
    PubMed     Abstract available

  841. BIEZEN R, Grando D, Mazza D, Brijnath B, et al
    Why do we not want to recommend influenza vaccination to young children? A qualitative study of Australian parents and primary care providers.
    Vaccine. 2018 Jan 5. pii: S0264-410X(17)31828.
    PubMed     Abstract available

    Cardioprotective effect of influenza and pneumococcal vaccination in patients with cardiovascular diseases.
    Vaccine. 2018;36:202-206.
    PubMed     Abstract available

  843. RAMIREZ A, Morris S, Maucourant S, D'Ascanio I, et al
    A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles.
    Vaccine. 2018 Jan 3. pii: S0264-410X(17)31814.
    PubMed     Abstract available

    December 2017
  844. TSUZUKI S, Schwehm M, Eichner M
    Simulation studies to assess the long-term effects of Japan's change from trivalent to quadrivalent influenza vaccination.
    Vaccine. 2017 Dec 29. pii: S0264-410X(17)31819.
    PubMed     Abstract available

  845. JORGENSEN P, Mereckiene J, Cotter S, Johansen K, et al
    How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015.
    Vaccine. 2017 Dec 26. pii: S0264-410X(17)31762.
    PubMed     Abstract available

  846. ROECA C, Polotsky AJ
    Influenza vaccination in early pregnancy.
    Vaccine. 2017 Dec 21. pii: S0264-410X(17)31785.

  847. GALLAGHER N, Jessop L, Sartaj M, Johnston J, et al
    Impact of live attenuated influenza vaccination programme for healthy children in Northern Ireland: A comparison of seven influenza seasons, 2010/11-2016/17.
    Vaccine. 2017 Dec 21. pii: S0264-410X(17)31730.
    PubMed     Abstract available

  848. REGAN AK, Moore HC, Sullivan SG
    Does influenza vaccination during early pregnancy really increase the risk of miscarriage?
    Vaccine. 2017 Dec 20. pii: S0264-410X(17)31786.

  849. MELIDOU A, Broberg E
    Erratum to "Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European region to the WHO vaccine composition cons
    Vaccine. 2017 Dec 20. pii: S0264-410X(17)31792.

  850. JACKSON ML, Phillips CH, Benoit J, Kiniry E, et al
    The impact of selection bias on vaccine effectiveness estimates from test-negative studies.
    Vaccine. 2017 Dec 15. pii: S0264-410X(17)31775.
    PubMed     Abstract available

  851. JACKSON ML, Phillips CH, Benoit J, Jackson LA, et al
    Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons.
    Vaccine. 2017 Dec 14. pii: S0264-410X(17)31755.
    PubMed     Abstract available

  852. FLOREK NW, Campos LM, Braun KM, McLean HQ, et al
    An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children.
    Vaccine. 2017 Dec 14. pii: S0264-410X(17)31777.
    PubMed     Abstract available

  853. ROWELL J, Lo CY, Price GE, Misplon JA, et al
    Conventional influenza vaccines influence the performance of a universal influenza vaccine in mice.
    Vaccine. 2017 Dec 14. pii: S0264-410X(17)31676.
    PubMed     Abstract available

  854. WU S, Su J, Yang P, Zhang H, et al
    Willingness to accept a future influenza A(H7N9) vaccine in Beijing, China.
    Vaccine. 2017 Dec 12. pii: S0264-410X(17)31746.
    PubMed     Abstract available

  855. RABENSTEINER A, Buja A, Regele D, Fischer M, et al
    Healthcare worker's attitude to seasonal influenza vaccination in the South Tyrolean province of Italy: barriers and facilitators.
    Vaccine. 2017 Dec 11. pii: S0264-410X(17)31734.
    PubMed     Abstract available

  856. NUNN A, Campbell AC, Naus M, Kwong JC, et al
    Implementing a province-wide mandatory vaccinate-or-mask policy at healthcare facilities in British Columbia, Canada.
    Vaccine. 2017 Dec 6. pii: S0264-410X(17)31713.
    PubMed     Abstract available

  857. ORTIZ JR, Hickling J, Jones R, Donabedian A, et al
    Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016.
    Vaccine. 2017 Dec 5. pii: S0264-410X(17)31645.
    PubMed     Abstract available

    November 2017
  858. RUSSELL KE, Bresee JS, Katz JM, Olsen SJ, et al
    Evaluating interest in an influenza A(H5N1) vaccine among laboratory workers who work with highly-pathogenic avian influenza viruses in the United States.
    Vaccine. 2017 Nov 30. pii: S0264-410X(17)31536.
    PubMed     Abstract available

  859. BALZLI CL, Bertran K, Lee DH, Killmaster L, et al
    The efficacy of recombinant turkey herpesvirus vaccines targeting the H5 of highly pathogenic avian influenza virus from the 2014-2015 North American outbreak.
    Vaccine. 2017 Nov 24. pii: S0264-410X(17)31590.
    PubMed     Abstract available

  860. LAPINSCKI B, Pereira LA, Nogueira MB, Vidal LR, et al
    Molecular epidemiology of influenza B virus and implications in immunization strategy, Southern Brazil.
    Vaccine. 2017 Nov 22. pii: S0264-410X(17)31597.
    PubMed     Abstract available

  861. SHIN HY, Chung JH, Hwang HJ, Kim TH, et al
    Factors influencing on influenza vaccination and its trends of coverage in patients with diabetes in Korea: A population-based cross-sectional study.
    Vaccine. 2017 Nov 21. pii: S0264-410X(17)31599.
    PubMed     Abstract available

  862. BOONNAK K, Dhitavat J, Thantamnu N, Kosoltanapiwat N, et al
    Immune responses to intradermal and intramuscular inactivated influenza vaccine among older age group.
    Vaccine. 2017 Nov 17. pii: S0264-410X(17)31538.
    PubMed     Abstract available

  863. MALOSH RE, Martin ET, Ortiz JR, Monto AS, et al
    The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review.
    Vaccine. 2017 Nov 17. pii: S0264-410X(17)31577.
    PubMed     Abstract available

  864. GARG R, Brownlie R, Latimer L, Gerdts V, et al
    Vaccination with a human parainfluenza virus type 3 chimeric FHN glycoprotein formulated with a combination adjuvant induces protective immunity.
    Vaccine. 2017 Nov 16. pii: S0264-410X(17)31524.
    PubMed     Abstract available

  865. AINSLIE KEC, Shi M, Haber M, Orenstein WA, et al
    On the bias of estimates of influenza vaccine effectiveness from test-negative studies.
    Vaccine. 2017 Nov 13. pii: S0264-410X(17)31539.
    PubMed     Abstract available

  866. COLE KS, Martin JM, Horne WT, Lin CJ, et al
    Differential gene expression elicited by children in response to the 2015-16 live attenuated versus inactivated influenza vaccine.
    Vaccine. 2017 Nov 10. pii: S0264-410X(17)31235.
    PubMed     Abstract available

  867. ALBRIGHT K, Hurley LP, Lockhart S, Gurfinkel D, et al
    Attitudes about adult vaccines and reminder/recall in a safety net population.
    Vaccine. 2017 Nov 10. pii: S0264-410X(17)31543.
    PubMed     Abstract available

  868. PAN Y, Wang Q, Yang P, Zhang L, et al
    Influenza vaccination in preventing outbreaks in schools: A long-term ecological overview.
    Vaccine. 2017 Nov 8. pii: S0264-410X(17)31525.
    PubMed     Abstract available

  869. PUIG-BARBERA J, Guglieri-Lopez B, Tortajada-Girbes M, Lopez-Labrador FX, et al
    Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
    Vaccine. 2017 Nov 8. pii: S0264-410X(17)31529.
    PubMed     Abstract available

  870. PILLSBURY A, Quinn H, Cashman P, Leeb A, et al
    Active SMS-based influenza vaccine safety surveillance in Australian children.
    Vaccine. 2017 Nov 8. pii: S0264-410X(17)31499.
    PubMed     Abstract available

  871. CROUSE QUINN S, Jamison AM, Freimuth VS, An J, et al
    Determinants of influenza vaccination among high-risk Black and White adults.
    Vaccine. 2017 Nov 7. pii: S0264-410X(17)31491.
    PubMed     Abstract available

  872. DIOS-GUERRA C, Carmona-Torres JM, Lopez-Soto PJ, Morales-Cane I, et al
    Prevalence and factors associated with influenza vaccination of persons over 65 years old in Spain (2009-2014).
    Vaccine. 2017 Nov 6. pii: S0264-410X(17)31494.
    PubMed     Abstract available

  873. MCELHANEY JE, Andrew MK, McNeil SA
    Estimating influenza vaccine effectiveness: Evolution of methods to better understand effects of confounding in older adults.
    Vaccine. 2017;35:6269-6274.
    PubMed     Abstract available

    October 2017
  874. KATZ J, Englund JA, Steinhoff MC, Khatry SK, et al
    Nutritional status of infants at six months of age following maternal influenza immunization: A randomized placebo-controlled trial in rural Nepal.
    Vaccine. 2017 Oct 31. pii: S0264-410X(17)31372.
    PubMed     Abstract available

  875. ROLFES MA, Goswami D, Sharmeen AT, Yeasmin S, et al
    Efficacy of trivalent influenza vaccine against laboratory-confirmed influenza among young children in a randomized trial in Bangladesh.
    Vaccine. 2017 Oct 31. pii: S0264-410X(17)31482.
    PubMed     Abstract available

  876. YAN J, Morrow MP, Chu JS, Racine T, et al
    Broad cross-protective anti-hemagglutination responses elicited by influenza microconsensus DNA vaccine.
    Vaccine. 2017 Oct 31. pii: S0264-410X(17)31358.
    PubMed     Abstract available

  877. STOCKWELL MS, Marchant CD, Wodi AP, Barnett ED, et al
    A multi-site feasibility study to assess fever and wheezing in children after influenza vaccines using text messaging.
    Vaccine. 2017 Oct 28. pii: S0264-410X(17)31481.
    PubMed     Abstract available

  878. NG S, Saborio S, Kuan G, Gresh L, et al
    Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015.
    Vaccine. 2017;35:6202-6207.
    PubMed     Abstract available

  879. NI Y, Guo J, Turner D, Tizard I, et al
    Development of a novel dual-domain nanoparticle antigen construct for universal influenza vaccine.
    Vaccine. 2017 Oct 25. pii: S0264-410X(17)31459.
    PubMed     Abstract available

  880. MORIYAMA M, Takeyama H, Hasegawa H, Ichinohe T, et al
    Induction of lung CD8+ T cell responses by consecutive inoculations of a poly(I:C) influenza vaccine.
    Vaccine. 2017 Oct 24. pii: S0264-410X(17)31446.
    PubMed     Abstract available

  881. WOHLGEMUTH N, Ye Y, Fenstermacher KJ, Liu H, et al
    The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells.
    Vaccine. 2017 Oct 24. pii: S0264-410X(17)31414.
    PubMed     Abstract available

  882. WALTER EB, Hornik CP, Grohskopf L, McGee CE, et al
    The effect of antipyretics on immune response and fever following receipt of inactivated influenza vaccine in young children.
    Vaccine. 2017 Oct 19. pii: S0264-410X(17)31416.
    PubMed     Abstract available

  883. HU Z, Liu X, Jiao X, Liu X, et al
    Newcastle disease virus (NDV) recombinant expressing the hemagglutinin of H7N9 avian influenza virus protects chickens against NDV and highly pathogenic avian influenza A (H7N9) virus challenges.
    Vaccine. 2017 Oct 14. pii: S0264-410X(17)31375.
    PubMed     Abstract available

  884. ORTIZ JR, Hombach J
    Announcing the publication of the WHO immunological basis for immunization series module on influenza vaccines.
    Vaccine. 2017 Oct 14. pii: S0264-410X(17)31226.
    PubMed     Abstract available

  885. PUIG-BARBERA J, Mira-Iglesias A, Tortajada-Girbes M, Lopez-Labrador FX, et al
    Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015.
    Vaccine. 2017;35:5799-5807.
    PubMed     Abstract available

  886. OLATUNBOSUN OD, Esterhuizen TM, Wiysonge CS
    A cross sectional survey to evaluate knowledge, attitudes and practices regarding seasonal influenza and influenza vaccination among diabetics in Pretoria, South Africa.
    Vaccine. 2017 Oct 13. pii: S0264-410X(17)31370.
    PubMed     Abstract available

  887. HO HJ, Chan YY, Ibrahim MAB, Wagle AA, et al
    A formative research-guided educational intervention to improve the knowledge and attitudes of seniors towards influenza and pneumococcal vaccinations.
    Vaccine. 2017 Oct 11. pii: S0264-410X(17)31369.
    PubMed     Abstract available

  888. ANA-SOSA-BATIZ F, Johnston APR, Hogarth PM, Wines BD, et al
    Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults.
    Vaccine. 2017 Oct 10. pii: S0264-410X(17)31315.
    PubMed     Abstract available

  889. OFORI-ANYINAM O, Leroux-Roels G, Drame M, Aerssens A, et al
    Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults >/=50years of age: Results from a phase III, randomized, non-i
    Vaccine. 2017 Oct 5. pii: S0264-410X(17)31228.
    PubMed     Abstract available

  890. SUN P, Crum-Cianflone NF, Defang G, Williams M, et al
    Evaluation of T and B memory cell responses elicited by the pandemic H1N1 vaccine in HIV-infected and HIV-uninfected individuals.
    Vaccine. 2017 Oct 4. pii: S0264-410X(17)31307.
    PubMed     Abstract available

    September 2017
  891. FORERO A, Fenstermacher K, Wohlgemuth N, Nishida A, et al
    Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells.
    Vaccine. 2017 Sep 28. pii: S0264-410X(17)31306.
    PubMed     Abstract available

  892. HOLBROOK BC, D'Agostino RB Jr, Tyler Aycock S, Jorgensen MJ, et al
    Adjuvanting an inactivated influenza vaccine with conjugated R848 improves the level of antibody present at 6months in a nonhuman primate neonate model.
    Vaccine. 2017 Sep 26. pii: S0264-410X(17)31302.
    PubMed     Abstract available

  893. HOGAN AB, Campbell PT, Blyth CC, Lim FJ, et al
    Potential impact of a maternal vaccine for RSV: A mathematical modelling study.
    Vaccine. 2017 Sep 26. pii: S0264-410X(17)31272.
    PubMed     Abstract available

  894. CHAMBERS CD, Xu R, Mitchell AA
    Commentary on: "Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12".
    Vaccine. 2017;35:5323-5324.

  895. DONAHUE JG, Kieke BA, King JP, DeStefano F, et al
    Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12.
    Vaccine. 2017;35:5314-5322.
    PubMed     Abstract available

  896. VALLEE-TOURANGEAU G, Promberger M, Moon K, Wheelock A, et al
    Motors of influenza vaccination uptake and vaccination advocacy in healthcare workers: Development and validation of two short scales.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31092.
    PubMed     Abstract available

  897. KANDEIL A, Mostafa A, El-Shesheny R, El-Taweel AN, et al
    Avian influenza H5N1 vaccination efficacy in Egyptian backyard poultry.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31269.
    PubMed     Abstract available

  898. HALSEY NA, Proveaux T
    Value of an in-depth analysis of unpublished data on the safety of influenza vaccines in pregnant women.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31297.
    PubMed     Abstract available

  899. LOW MSF, Tan H, Hartman M, Tam CC, et al
    Parental perceptions of childhood seasonal influenza vaccination in Singapore: A cross-sectional survey.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31308.
    PubMed     Abstract available

  900. ZIMMERMAN RK, Raviotta JM, Nowalk MP, Moehling KK, et al
    Using the 4 Pillars Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination.
    Vaccine. 2017 Sep 22. pii: S0264-410X(17)31268.
    PubMed     Abstract available

  901. PRINCIPI N, Esposito S
    Influenza vaccine use to protect healthy children: A debated topic.
    Vaccine. 2017 Sep 16. pii: S0264-410X(17)31232.
    PubMed     Abstract available

  902. EATON A, Lewis N, Fireman B, Hansen J, et al
    Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009-2010.
    Vaccine. 2017 Sep 13. pii: S0264-410X(17)31180.
    PubMed     Abstract available

  903. TAN S, Zhang S, Wu B, Zhao Y, et al
    Hemagglutinin-specific CD4+ T-cell responses following 2009-pH1N1 inactivated split-vaccine inoculation in humans.
    Vaccine. 2017 Sep 13. pii: S0264-410X(17)31159.
    PubMed     Abstract available

  904. ISLAM S, Mohn KG, Krammer F, Sanne M, et al
    Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination.
    Vaccine. 2017 Sep 9. pii: S0264-410X(17)31132.
    PubMed     Abstract available

  905. NEUZIL KM, Bresee JS, de la Hoz F, Johansen K, et al
    Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines.
    Vaccine. 2017 Sep 8. pii: S0264-410X(17)31188.
    PubMed     Abstract available

  906. RAVIOTTA JM, Smith KJ, DePasse J, Brown ST, et al
    Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults.
    Vaccine. 2017 Sep 7. pii: S0264-410X(17)30977.
    PubMed     Abstract available

  907. LUZ PM, Johnson RE, Brown HE
    Workplace availability, risk group and perceived barriers predictive of 2016-17 influenza vaccine uptake in the United States: A cross-sectional study.
    Vaccine. 2017 Sep 7. pii: S0264-410X(17)31178.
    PubMed     Abstract available

  908. VICKERS ER, McClure DL, Naleway AL, Jacobsen SJ, et al
    Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink.
    Vaccine. 2017 Sep 6. pii: S0264-410X(17)31186.
    PubMed     Abstract available

  909. ADAMSON PJ, Al Kindi MA, Wang JJ, Colella AD, et al
    Proteomic analysis of influenza haemagglutinin-specific antibodies following vaccination reveals convergent immunoglobulin variable region signatures.
    Vaccine. 2017 Sep 6. pii: S0264-410X(17)31151.
    PubMed     Abstract available

  910. WOO EJ, Moro PL, Cano M, Jankosky C, et al
    Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System.
    Vaccine. 2017 Sep 5. pii: S0264-410X(17)31135.
    PubMed     Abstract available

  911. SANTOS JJS, Obadan AO, Garcia SC, Carnaccini S, et al
    Short- and long-term protective efficacy against clade H5N2 highly pathogenic avian influenza virus following prime-boost vaccination in turkeys.
    Vaccine. 2017 Sep 5. pii: S0264-410X(17)31157.
    PubMed     Abstract available

    August 2017
  912. FELL DB, Azziz-Baumgartner E, Baker MG, Batra M, et al
    Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group.
    Vaccine. 2017 Aug 31. pii: S0264-410X(17)31125.
    PubMed     Abstract available

  913. SANO K, Ainai A, Suzuki T, Hasegawa H, et al
    The road to a more effective influenza vaccine: Up to date studies and future prospects.
    Vaccine. 2017 Aug 30. pii: S0264-410X(17)31118.
    PubMed     Abstract available

  914. WATKINS HC, Pagan CL, Childs HR, Posada S, et al
    A single dose and long lasting vaccine against pandemic influenza through the controlled release of a heterospecies tandem M2 sequence embedded within detoxified bacterial outer membrane vesicles.
    Vaccine. 2017 Aug 30. pii: S0264-410X(17)31080.
    PubMed     Abstract available

  915. FUKUSHIMA W, Ozasa K, Okumura A, Mori M, et al
    Oseltamivir use and severe abnormal behavior in Japanese children and adolescents with influenza: Is a self-controlled case series study applicable?
    Vaccine. 2017;35:4817-4824.
    PubMed     Abstract available

  916. OHFUJI S, Deguchi M, Tachibana D, Koyama M, et al
    Estimating influenza disease burden among pregnant women: Application of self-control method.
    Vaccine. 2017;35:4811-4816.
    PubMed     Abstract available

  917. KONDO K, Suzuki K, Washio M, Ohfuji S, et al
    Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study.
    Vaccine. 2017;35:4806-4810.
    PubMed     Abstract available

  918. FUKUSHIMA W, Hirota Y
    Basic principles of test-negative design in evaluating influenza vaccine effectiveness.
    Vaccine. 2017;35:4796-4800.
    PubMed     Abstract available

  919. HARA M, Hirota Y
    Basic principle of population-based cohort study to evaluate influenza vaccine effectiveness among elderly Japanese.
    Vaccine. 2017;35:4791-4795.
    PubMed     Abstract available

  920. HIROTA Y, Ozasa K, Nakano T
    Vaccine epidemiology: Its role in promoting sound immunization programs in Japan.
    Vaccine. 2017;35:4787-4790.
    PubMed     Abstract available

  921. LEVIN MJ, Buchwald UK, Gardner J, Martin J, et al
    Immunogenicity and safety of zoster vaccine live administered with quadrivalent influenza virus vaccine.
    Vaccine. 2017 Aug 19. pii: S0264-410X(17)31096.
    PubMed     Abstract available

  922. SMITH G, Liu Y, Flyer D, Massare MJ, et al
    Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes.
    Vaccine. 2017 Aug 18. pii: S0264-410X(17)31088.
    PubMed     Abstract available

  923. MCHUGH L, Andrews RM, Ware RS
    Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy 2012-2014: The FluMum study.
    Vaccine. 2017;35.

  924. HUTCHEON J, Ortiz J
    Re: Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy 2012-2014: The FluMum study.
    Vaccine. 2017;35.

  925. PATERSON P, Chantler T, Larson HJ
    Reasons for non-vaccination: Parental vaccine hesitancy and the childhood influenza vaccination school pilot programme in England.
    Vaccine. 2017 Aug 14. pii: S0264-410X(17)31083.
    PubMed     Abstract available

  926. D'ANGIO CT, Wyman CP, Misra RS, Halliley JL, et al
    Plasma cell and serum antibody responses to influenza vaccine in preterm and full-term infants.
    Vaccine. 2017 Aug 11. pii: S0264-410X(17)31068.
    PubMed     Abstract available

  927. GOEIJENBIER M, van Sloten TT, Slobbe L, Mathieu C, et al
    Benefits of flu vaccination for persons with diabetes mellitus: A review.
    Vaccine. 2017 Aug 11. pii: S0264-410X(17)31021.
    PubMed     Abstract available

  928. ALLEN JD, Owino SO, Carter DM, Crevar CJ, et al
    Broadened immunity and protective responses with emulsion-adjuvanted H5 COBRA-VLP vaccines.
    Vaccine. 2017 Aug 5. pii: S0264-410X(17)31043.
    PubMed     Abstract available

  929. OHFUJI S, Kobayashi M, Ide Y, Egawa Y, et al
    Key points in evaluating immunogenicity of pandemic influenza vaccines: A lesson from immunogenicity studies of influenza A(H1N1)pdm09 vaccine.
    Vaccine. 2017 Aug 4. pii: S0264-410X(17)31018.
    PubMed     Abstract available

  930. SUZUKI T, Ainai A, Hasegawa H
    Functional and structural characteristics of secretory IgA antibodies elicited by mucosal vaccines against influenza virus.
    Vaccine. 2017 Aug 3. pii: S0264-410X(17)31019.
    PubMed     Abstract available

  931. MELIDOU A, Broberg E
    Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European Region to the WHO vaccine composition consultation for
    Vaccine. 2017 Aug 3. pii: S0264-410X(17)30965.
    PubMed     Abstract available

  932. VILLANUEVA-CABEZAS JP, Coppo MJC, Durr PA, McVernon J, et al
    Vaccine efficacy against Indonesian Highly Pathogenic Avian Influenza H5N1: systematic review and meta-analysis.
    Vaccine. 2017 Aug 2. pii: S0264-410X(17)30967.
    PubMed     Abstract available

    July 2017
  933. PIERCE CL, Williams TL, Santana WI, Levine M, et al
    Immunocapture isotope dilution mass spectrometry in response to a pandemic influenza threat.
    Vaccine. 2017 Jul 31. pii: S0264-410X(17)30957.
    PubMed     Abstract available

  934. BOIKOS C, Joseph L, Scheifele D, Lands LC, et al
    Adverse events following live-attenuated intranasal influenza vaccination of children with cystic fibrosis: Results from two influenza seasons.
    Vaccine. 2017 Jul 31. pii: S0264-410X(17)30976.
    PubMed     Abstract available

  935. YOON IS, Park H, Kwak HW, Woo Jung Y, et al
    Macrophage-derived insulin-like growth factor-1 affects influenza vaccine efficacy through the regulation of immune cell homeostasis.
    Vaccine. 2017 Jul 28. pii: S0264-410X(17)30945.
    PubMed     Abstract available

  936. FOGEL B, Hicks S
    Influenza vaccination rates in children decline when the live attenuated influenza vaccine is not recommended.
    Vaccine. 2017 Jul 28. pii: S0264-410X(17)30975.
    PubMed     Abstract available

  937. AYORA-TALAVERA G, Flores GM, Gomez-Carballo J, Gonzalez-Losa R, et al
    Influenza seasonality goes south in the Yucatan Peninsula: The case for a different influenza vaccine calendar in this Mexican region.
    Vaccine. 2017 Jul 26. pii: S0264-410X(17)30916.
    PubMed     Abstract available

  938. PALACHE A, Abelin A, Hollingsworth R, Cracknell W, et al
    Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004-2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving infl
    Vaccine. 2017 Jul 25. pii: S0264-410X(17)30961.
    PubMed     Abstract available

  939. HOFSTETTER AM, Barrett A, Camargo S, Rosenthal SL, et al
    Text message reminders for vaccination of adolescents with chronic medical conditions: A randomized clinical trial.
    Vaccine. 2017 Jul 20. pii: S0264-410X(17)30920.
    PubMed     Abstract available

  940. FISCHER LM, Wolff MW, Reichl U
    Purification of cell culture-derived influenza A virus via continuous anion exchange chromatography on monoliths.
    Vaccine. 2017 Jul 17. pii: S0264-410X(17)30894.
    PubMed     Abstract available

  941. MADAN A, Collins H, Sheldon E, Frenette L, et al
    Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trial.
    Vaccine. 2017 Jul 15. pii: S0264-410X(17)30909.
    PubMed     Abstract available

  942. MORCL T, Hurst BL, Tarbet EB
    Calcium phosphate nanoparticle (CaPNP) for dose-sparing of inactivated whole virus pandemic influenza A (H1N1) 2009 vaccine in mice.
    Vaccine. 2017 Jul 14. pii: S0264-410X(17)30912.
    PubMed     Abstract available

  943. MAKARKOV AI, Chierzi S, Pillet S, Murai KK, et al
    Plant-made virus-like particles bearing influenza hemagglutinin (HA) recapitulate early interactions of native influenza virions with human monocytes/macrophages.
    Vaccine. 2017 Jul 13. pii: S0264-410X(17)30908.
    PubMed     Abstract available

  944. FAGERLIN A, Valley TS, Scherer AM, Knaus M, et al
    Communicating infectious disease prevalence through graphics: Results from an international survey.
    Vaccine. 2017;35:4041-4047.
    PubMed     Abstract available

  945. RODRIGUEZ L, Nogales A, Murcia PR, Parrish CR, et al
    A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses.
    Vaccine. 2017 Jul 11. pii: S0264-410X(17)30857.
    PubMed     Abstract available

  946. RONDY M, Launay O, Castilla J, Costanzo S, et al
    Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.
    Vaccine. 2017 Jul 11. pii: S0264-410X(17)30896.
    PubMed     Abstract available

  947. GOLDECK D, Theeten H, Hassouneh F, Oettinger L, et al
    Frequencies of peripheral immune cells in older adults following seasonal influenza vaccination with an adjuvanted vaccine.
    Vaccine. 2017 Jul 6. pii: S0264-410X(17)30879.
    PubMed     Abstract available

  948. BELONGIA EA, Karron RA, Reingold A, Walter EB, et al
    The Advisory Committee on Immunization Practices recommendation regarding the use of live influenza vaccine: A rejoinder.
    Vaccine. 2017 Jul 3. pii: S0264-410X(17)30794.

  949. LU PJ, Srivastav A, Santibanez TA, Christopher Stringer M, et al
    Knowledge of influenza vaccination recommendation and early vaccination uptake during the 2015-16 season among adults aged >/=18years - United States.
    Vaccine. 2017 Jul 1. pii: S0264-410X(17)30871.
    PubMed     Abstract available

    June 2017
  950. VALDIN HL, Begue RE
    Influenza vaccines effectiveness 2013-14 through 2015-16, a test-negative study in children.
    Vaccine. 2017 Jun 29. pii: S0264-410X(17)30847.
    PubMed     Abstract available

  951. SHI CR, Nambudiri VE
    Widespread psoriasis flare following influenza vaccination.
    Vaccine. 2017 Jun 29. pii: S0264-410X(17)30864.

  952. KIM SH, Samal SK
    Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses.
    Vaccine. 2017 Jun 28. pii: S0264-410X(17)30852.
    PubMed     Abstract available

  953. WU UI, Hsieh SM, Lee WS, Wang NC, et al
    Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: A phase I/II, prospective, randomized, open-label trial.
    Vaccine. 2017 Jun 28. pii: S0264-410X(17)30831.
    PubMed     Abstract available

  954. SONG Y, Zhang T, Chen L, Yi B, et al
    Increasing seasonal influenza vaccination among high risk groups in China: Do community healthcare workers have a role to play?
    Vaccine. 2017 Jun 28. pii: S0264-410X(17)30851.
    PubMed     Abstract available

  955. HATTA Y, Boltz D, Sarawar S, Kawaoka Y, et al
    M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
    Vaccine. 2017 Jun 28. pii: S0264-410X(17)30826.
    PubMed     Abstract available

  956. BEYER WEP, Palache AM, Boulfich M, Osterhaus ADME, et al
    Rationale for two influenza B lineages in seasonal vaccines: A meta-regression study on immunogenicity and controlled field trials.
    Vaccine. 2017 Jun 24. pii: S0264-410X(17)30825.
    PubMed     Abstract available

  957. VENEREO-SANCHEZ A, Simoneau M, Lanthier S, Chahal P, et al
    Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line.
    Vaccine. 2017 Jun 22. pii: S0264-410X(17)30801.
    PubMed     Abstract available

  958. EL OMEIRI N, Azziz-Baumgartner E, Thompson MG, Clara W, et al
    Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations - Latin America, 2013.
    Vaccine. 2017 Jun 22. pii: S0264-410X(17)30823.
    PubMed     Abstract available

  959. REPERANT LA, Osterhaus ADME
    AIDS, Avian flu, SARS, MERS, Ebola, Zika... what next?
    Vaccine. 2017 Jun 17. pii: S0264-410X(17)30583.
    PubMed     Abstract available

  960. CHRISTIAN LM, Beverly C, Mitchell AM, Karlsson E, et al
    Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns.
    Vaccine. 2017 Jun 14. pii: S0264-410X(17)30686.
    PubMed     Abstract available

  961. BLANCO JCG, Pletneva LM, Otoa RO, Patel MC, et al
    Preclinical assessment of safety of maternal vaccination against respiratory syncytial virus (RSV) in cotton rats.
    Vaccine. 2017 Jun 14. pii: S0264-410X(17)30786.
    PubMed     Abstract available

  962. DEPASSE JV, Nowalk MP, Smith KJ, Raviotta JM, et al
    Does cost-effectiveness of influenza vaccine choice vary across the U.S.? An agent-based modeling study.
    Vaccine. 2017 Jun 9. pii: S0264-410X(17)30763.
    PubMed     Abstract available

  963. WESTON D, Blackburn R, Potts HWW, Hayward AC, et al
    Predictors of self and parental vaccination decisions in England during the 2009 H1N1 pandemic: Analysis of the Flu Watch pandemic cohort data.
    Vaccine. 2017 Jun 7. pii: S0264-410X(17)30720.
    PubMed     Abstract available

  964. KURUPATI RK, Kossenkoff A, Kannan S, Haut LH, et al
    The effect of timing of influenza vaccination and sample collection on antibody titers and responses in the aged.
    Vaccine. 2017 Jun 2. pii: S0264-410X(17)30733.
    PubMed     Abstract available

  965. AUGUST A, Glenn GM, Kpamegan E, Hickman SP, et al
    A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age.
    Vaccine. 2017 Jun 1. pii: S0264-410X(17)30681.
    PubMed     Abstract available

    May 2017
  966. HILGERS LAT, Platenburg PPLI, Bajramovic J, Veth J, et al
    Carbohydrate fatty acid monosulphate esters are safe and effective adjuvants for humoral responses.
    Vaccine. 2017;35:3249-3255.
    PubMed     Abstract available

  967. SHIM SM, Song EJ, Song D, Lee TY, et al
    Nontoxic outer membrane vesicles efficiently increase the efficacy of an influenza vaccine in mice and ferrets.
    Vaccine. 2017 May 30. pii: S0264-410X(17)30689.
    PubMed     Abstract available

  968. PETIOT E, Proust A, Traversier A, Durous L, et al
    Influenza viruses production: Evaluation of a novel avian cell line DuckCelt(R)-T17.
    Vaccine. 2017 May 29. pii: S0264-410X(17)30502.
    PubMed     Abstract available

  969. BOES L, Boedeker B, Schmich P, Wetzstein M, et al
    Factors associated with parental acceptance of seasonal influenza vaccination for their children - A telephone survey in the adult population in Germany.
    Vaccine. 2017 May 27. pii: S0264-410X(17)30623.
    PubMed     Abstract available

  970. BERTRAN K, Balzli C, Lee DH, Suarez DL, et al
    Protection of White Leghorn chickens by U.S. emergency H5 vaccination against clade H5N2 high pathogenicity avian influenza virus.
    Vaccine. 2017 May 26. pii: S0264-410X(17)30687.
    PubMed     Abstract available

  971. LONE NA, Spackman E, Kapczynski D
    Immunologic evaluation of 10 different adjuvants for use in vaccines for chickens against highly pathogenic avian influenza virus.
    Vaccine. 2017 May 13. pii: S0264-410X(17)30608.
    PubMed     Abstract available

  972. SEALY RE, Surman SL, Hurwitz JL
    CD4(+) T cells support establishment of RSV-specific IgG and IgA antibody secreting cells in the upper and lower murine respiratory tract following RSV infection.
    Vaccine. 2017;35:2617-2621.
    PubMed     Abstract available

  973. DIAZ A, Romero M, Vazquez T, Lechner S, et al
    Metformin improves in vivo and in vitro B cell function in individuals with obesity and Type-2 Diabetes.
    Vaccine. 2017;35:2694-2700.
    PubMed     Abstract available

  974. MILIAN E, Julien T, Biaggio R, Venereo-Sanchez A, et al
    Accelerated mass production of influenza virus seed stocks in HEK-293 suspension cell cultures by reverse genetics.
    Vaccine. 2017 May 8. pii: S0264-410X(17)30557.
    PubMed     Abstract available

  975. CHADA KE, Forshee R, Golding H, Anderson S, et al
    A systematic review and meta-analysis of cross-reactivity of antibodies induced by oil-in-water emulsion adjuvanted influenza H5N1 virus monovalent vaccines.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30507.
    PubMed     Abstract available

  976. ZERBO O, Modaressi S, Chan B, Goddard K, et al
    No association between influenza vaccination during pregnancy and adverse birth outcomes.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30575.
    PubMed     Abstract available

  977. HENDIN HE, Pillet S, Lara AN, Wu CY, et al
    Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro.
    Vaccine. 2017;35:2592-2599.
    PubMed     Abstract available

  978. SAHIN Z, Akkoc S, Neeleman R, Haines J, et al
    Nile Red fluorescence spectrum decomposition enables rapid screening of large protein aggregates in complex biopharmaceutical formulations like influenza vaccines.
    Vaccine. 2017 May 2. pii: S0264-410X(17)30558.
    PubMed     Abstract available

  979. WONG CKH, Liao Q, Guo VYW, Xin Y, et al
    Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review.
    Vaccine. 2017 May 2. pii: S0264-410X(17)30542.
    PubMed     Abstract available

    April 2017
  980. ARRIOLA CS, Vasconez N, Thompson MG, Olsen SJ, et al
    Association of influenza vaccination during pregnancy with birth outcomes in Nicaragua.
    Vaccine. 2017 Apr 29. pii: S0264-410X(17)30536.
    PubMed     Abstract available

  981. BAXTER R, Eaton A, Hansen J, Aukes L, et al
    Corrigendum to "Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years" [Vaccine 35 (2017) 1254-1258].
    Vaccine. 2017 Apr 27. pii: S0264-410X(17)30553.

  982. ZHANG Y, Wu P, Feng L, Yang P, et al
    Influenza vaccine effectiveness against influenza-associated hospitalization in 2015/16 season, Beijing, China.
    Vaccine. 2017 Apr 26. pii: S0264-410X(17)30436.
    PubMed     Abstract available

  983. KAPCZYNSKI DR, Pantin-Jackwood MJ, Spackman E, Chrzastek K, et al
    Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade highly pathogenic avian influenza viruses.
    Vaccine. 2017 Apr 26. pii: S0264-410X(17)30520.
    PubMed     Abstract available

  984. DOMBKOWSKI KJ, Cowan AE, Reeves SL, Foley MR, et al
    The impacts of email reminder/recall on adolescent influenza vaccination.
    Vaccine. 2017 Apr 25. pii: S0264-410X(17)30511.
    PubMed     Abstract available

  985. SANDHU SK, Hua W, MaCurdy TE, Franks RL, et al
    Near real-time surveillance for Guillain-Barre syndrome after influenza vaccination among the Medicare population, 2010/11 to 2013/14.
    Vaccine. 2017 Apr 24. pii: S0264-410X(17)30439.
    PubMed     Abstract available

  986. BAZAN M, Villacorta E, Barbagelatta G, Jimenez MM, et al
    Health workers' attitudes, perceptions and knowledge of influenza immunization in Lima, Peru: A mixed methods study.
    Vaccine. 2017 Apr 21. pii: S0264-410X(17)30485.
    PubMed     Abstract available

  987. WILKINSON K, Wei Y, Szwajcer A, Rabbani R, et al
    Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis.
    Vaccine. 2017 Apr 18. pii: S0264-410X(17)30444.
    PubMed     Abstract available

  988. NAKATSUKASA A, Kuruma K, Okamatsu M, Hiono T, et al
    Potency of whole virus particle and split virion vaccines using dissolving microneedle against challenges of H1N1 and H5N1 influenza viruses in mice.
    Vaccine. 2017 Apr 18. pii: S0264-410X(17)30469.
    PubMed     Abstract available

  989. SUH J, Kim B, Yang Y, Suh DC, et al
    Cost effectiveness of influenza vaccination in patients with acute coronary syndrome in Korea.
    Vaccine. 2017 Apr 17. pii: S0264-410X(17)30480.
    PubMed     Abstract available

  990. DAUNER A, Agrawal P, Salvatico J, Tapia T, et al
    The in vitro MIMIC(R) platform reflects age-associated changes in immunological responses after influenza vaccination.
    Vaccine. 2017 Apr 13. pii: S0264-410X(17)30451.
    PubMed     Abstract available

  991. SMITH TRF, Schultheis K, Morrow MP, Kraynyak KA, et al
    Development of an intradermal DNA vaccine delivery strategy to achieve single-dose immunity against respiratory syncytial virus.
    Vaccine. 2017 Apr 13. pii: S0264-410X(17)30468.
    PubMed     Abstract available

  992. VAN DOORN E, Darvishian M, Dijkstra F, Donker GA, et al
    Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups.
    Vaccine. 2017 Apr 12. pii: S0264-410X(17)30476.
    PubMed     Abstract available

    Advancing new vaccines against pandemic influenza in low-resource countries.
    Vaccine. 2017 Apr 11. pii: S0264-410X(17)30446.
    PubMed     Abstract available

  994. MCLEAN HQ, Caspard H, Griffin MR, Poehling KA, et al
    Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season.
    Vaccine. 2017 Apr 10. pii: S0264-410X(17)30437.
    PubMed     Abstract available

  995. RAY GT, Lewis N, Goddard K, Ross P, et al
    Asthma exacerbations among asthmatic children receiving live attenuated versus inactivated influenza vaccines.
    Vaccine. 2017 Apr 9. pii: S0264-410X(17)30434.
    PubMed     Abstract available

  996. HOFSTETTER AM, Robinson JD, Lepere K, Cunningham M, et al
    Clinician-parent discussions about influenza vaccination of children and their association with vaccine acceptance.
    Vaccine. 2017 Apr 6. pii: S0264-410X(17)30411.
    PubMed     Abstract available

  997. AIREY J, Albano FR, Sawlwin DC, Jones AG, et al
    Immunogenicity and safety of a quadrivalent inactivated influenza virus vaccine compared with a comparator quadrivalent inactivated influenza vaccine in a pediatric population: A phase 3, randomized noninferiority study.
    Vaccine. 2017 Apr 5. pii: S0264-410X(17)30334.
    PubMed     Abstract available

  998. LEUNG VK, Carolan LA, Worth LJ, Harper SA, et al
    Influenza vaccination responses: Evaluating impact of repeat vaccination among health care workers.
    Vaccine. 2017 Apr 3. pii: S0264-410X(17)30390.
    PubMed     Abstract available

    March 2017
  999. IMBURGIA TM, Hendrix KS, Donahue KL, Sturm LA, et al
    Predictors of influenza vaccination in the U.S. among children 9-13years of age.
    Vaccine. 2017 Mar 27. pii: S0264-410X(17)30387.
    PubMed     Abstract available

  1000. OFSTEAD CL, Amelang MR, Wetzler HP, Tan L, et al
    Moving the needle on nursing staff influenza vaccination in long-term care: Results of an evidence-based intervention.
    Vaccine. 2017 Mar 25. pii: S0264-410X(17)30357.
    PubMed     Abstract available

  1001. HELLFRITZSCH M, Thomsen RW, Baggesen LM, Larsen FB, et al
    Lifestyle, socioeconomic characteristics, and medical history of elderly persons who receive seasonal influenza vaccination in a tax-supported healthcare system.
    Vaccine. 2017 Mar 23. pii: S0264-410X(17)30356.
    PubMed     Abstract available

  1002. FELL DB, Bhutta ZA, Hutcheon JA, Karron RA, et al
    Report of the WHO technical consultation on the effect of maternal influenza and influenza vaccination on the developing fetus: Montreal, Canada, September 30-October 1, 2015.
    Vaccine. 2017 Mar 23. pii: S0264-410X(17)30373.
    PubMed     Abstract available

  1003. TSENG YF, Weng TC, Lai CC, Chen PL, et al
    A fast and efficient purification platform for cell-based influenza viruses by flow-through chromatography.
    Vaccine. 2017 Mar 22. pii: S0264-410X(17)30322.
    PubMed     Abstract available

  1004. KOEPKE R, Schauer SL, Davis JP
    Measuring maternal Tdap and influenza vaccination rates: Comparison of two population-based methods.
    Vaccine. 2017 Mar 21. pii: S0264-410X(17)30330.
    PubMed     Abstract available

  1005. KANG GJ, Culp RK, Abbas KM
    Facilitators and barriers of parental attitudes and beliefs toward school-located influenza vaccination in the United States: Systematic review.
    Vaccine. 2017 Mar 17. pii: S0264-410X(17)30320.
    PubMed     Abstract available

  1006. GUIOMAR R, Pereira da Silva S, Conde P, Cristovao P, et al
    Cross-protection to new drifted influenza A(H3) viruses and prevalence of protective antibodies to seasonal influenza, during 2014 in Portugal.
    Vaccine. 2017 Mar 15. pii: S0264-410X(17)30213.
    PubMed     Abstract available

  1007. LANSBURY LE, Smith S, Beyer W, Karamehic E, et al
    Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis.
    Vaccine. 2017 Mar 14. pii: S0264-410X(17)30272.
    PubMed     Abstract available

  1008. TREANOR JT, Albano FR, Sawlwin DC, Graves Jones A, et al
    Immunogenicity and safety of a quadrivalent inactivated influenza vaccine compared with two trivalent inactivated influenza vaccines containing alternate B strains in adults: A phase 3, randomized noninferiority study.
    Vaccine. 2017 Mar 13. pii: S0264-410X(17)30291.
    PubMed     Abstract available

  1009. TROGSTAD L, Bakken IJ, Gunnes N, Ghaderi S, et al
    Narcolepsy and hypersomnia in Norwegian children and young adults following the influenza A(H1N1) 2009 pandemic.
    Vaccine. 2017 Mar 13. pii: S0264-410X(17)30266.
    PubMed     Abstract available

  1010. SEQUEIRA DP, Correia R, Carrondo MJ, Roldao A, et al
    Combining stable insect cell lines with baculovirus-mediated expression for multi-HA influenza VLP production.
    Vaccine. 2017 Mar 10. pii: S0264-410X(17)30246.
    PubMed     Abstract available

  1011. MOSNIER A, Daviaud I, Caini S, Berche H, et al
    Does seasonal vaccination affect the clinical presentation of influenza among the elderly? A cross-sectional analysis in the outpatient setting in France, 2003-2014.
    Vaccine. 2017 Mar 10. pii: S0264-410X(17)30292.
    PubMed     Abstract available

  1012. UI H, Yamayoshi S, Uraki R, Kiso M, et al
    Evaluation of seasonal influenza vaccines for H1N1pdm09 and type B viruses based on a replication-incompetent PB2-KO virus.
    Vaccine. 2017 Mar 9. pii: S0264-410X(17)30244.
    PubMed     Abstract available

  1013. KURZ X, Bauchau V, Mahy P, Glismann S, et al
    The ADVANCE Code of Conduct for collaborative vaccine studies.
    Vaccine. 2017 Mar 9. pii: S0264-410X(17)30242.
    PubMed     Abstract available

  1014. TING EE, Sander B, Ungar WJ
    Systematic review of the cost-effectiveness of influenza immunization programs.
    Vaccine. 2017 Mar 8. pii: S0264-410X(17)30247.
    PubMed     Abstract available

  1015. PROBST P, Grigg JB, Wang M, Munoz E, et al
    A small-molecule IRF3 agonist functions as an influenza vaccine adjuvant by modulating the antiviral immune response.
    Vaccine. 2017 Mar 6. pii: S0264-410X(17)30118.
    PubMed     Abstract available

  1016. GERSHWIN LJ, Behrens NE, McEligot HA, Carvallo-Chaigneau FR, et al
    A recombinant subunit vaccine for bovine RSV and Histophilus somni protects calves against dual pathogen challenge.
    Vaccine. 2017 Mar 5. pii: S0264-410X(17)30125.
    PubMed     Abstract available

  1017. KUCK LR, Saye S, Loob S, Roth-Eichhorn S, et al
    VaxArray assessment of influenza split vaccine potency and stability.
    Vaccine. 2017 Mar 2. pii: S0264-410X(17)30222.
    PubMed     Abstract available

    February 2017
  1018. SMITH LE, Webster RK, Weinman J, Amlot R, et al
    Psychological factors associated with uptake of the childhood influenza vaccine and perception of post-vaccination side-effects: A cross-sectional survey in England.
    Vaccine. 2017 Feb 24. pii: S0264-410X(17)30225.
    PubMed     Abstract available

  1019. CHEUNG K, Ho SM, Lam W
    Factors affecting the willingness of nursing students to receive annual seasonal influenza vaccination: A large-scale cross-sectional study.
    Vaccine. 2017 Feb 14. pii: S0264-410X(17)30164.
    PubMed     Abstract available

  1020. MEIJER WJ, Wensing AM, Bos AA, Kuiphuis JC, et al
    Influenza vaccination in healthcare workers; comparison of side effects and preferred route of administration of intradermal versus intramuscular administration.
    Vaccine. 2017 Feb 10. pii: S0264-410X(17)30145.
    PubMed     Abstract available

  1021. MCHUGH L, Andrews RM, Lambert SB, Viney KA, et al
    Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy, 2012-2014: The FluMum study.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30155.
    PubMed     Abstract available

  1022. LENNY BJ, Sonnberg S, Danner AF, Friedman K, et al
    Evaluation of multivalent H2 influenza pandemic vaccines in mice.
    Vaccine. 2017 Feb 8. pii: S0264-410X(17)30061.
    PubMed     Abstract available

  1023. MADAN A, Ferguson M, Sheldon E, Segall N, et al
    Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in healthy adults: A phase I/II, observer-blind, randomized, controlled trial.
    Vaccine. 2017 Feb 7. pii: S0264-410X(17)30119.
    PubMed     Abstract available

  1024. WUMKES ML, van der Velden AM, de Bruin E, Meerveld-Eggink A, et al
    Microarray profile of the humoral immune response to influenza vaccination in breast cancer patients treated with chemotherapy.
    Vaccine. 2017 Feb 3. pii: S0264-410X(17)30088.
    PubMed     Abstract available

  1025. YUK SS, Erdene-Ochir TO, Kwon JH, Noh JY, et al
    Efficacy of clade 2.3.2 H5 commercial vaccines in protecting chickens from clade H5N8 highly pathogenic avian influenza infection.
    Vaccine. 2017 Feb 3. pii: S0264-410X(17)30082.
    PubMed     Abstract available

  1026. BAXTER R, Eaton A, Hansen J, Aukes L, et al
    Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30128.
    PubMed     Abstract available

  1027. SANCHEZ-RAMOS EL, Monarrez-Espino J, Noyola DE
    Impact of vaccination on influenza mortality in children <5years old in Mexico.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30087.
    PubMed     Abstract available

  1028. BARMAN S, Krylov PS, Turner JC, Franks J, et al
    Manipulation of neuraminidase packaging signals and hemagglutinin residues improves the growth of A/Anhui/1/2013 (H7N9) influenza vaccine virus yield in eggs.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30127.
    PubMed     Abstract available

    January 2017
  1029. ALAN H, Ian B, Nancy C, Ruben O D, et al
    Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015.
    Vaccine. 2017 Jan 25. pii: S0264-410X(17)30037.
    PubMed     Abstract available

  1030. SMALL PA JR, Cronin BJ
    The Advisory Committee on Immunization Practices' controversial recommendation against the use of live attenuated influenza vaccine is based on a biased study design that ignores secondary protection.
    Vaccine. 2017 Jan 21. pii: S0264-410X(17)30041.

  1031. DHAKAL S, Goodman J, Bondra K, Lakshmanappa YS, et al
    Polyanhydride nanovaccine against swine influenza virus in pigs.
    Vaccine. 2017 Jan 20. pii: S0264-410X(17)30038.
    PubMed     Abstract available

  1032. MORIYAMA M, Chino S, Ichinohe T
    Consecutive inoculations of influenza virus vaccine and poly(I:C) protects mice against homologous and heterologous virus challenge.
    Vaccine. 2017 Jan 19. pii: S0264-410X(17)30046.
    PubMed     Abstract available

  1033. DAVID SC, Lau J, Singleton EV, Babb R, et al
    The effect of gamma-irradiation conditions on the immunogenicity of whole-inactivated Influenza A virus vaccine.
    Vaccine. 2017 Jan 18. pii: S0264-410X(16)31269.
    PubMed     Abstract available

  1034. NAKAYAMA M, Itoh Y, Shichinohe S, Nakabayashi R, et al
    Potential risk of repeated nasal vaccination that induces allergic reaction with mucosal IgE and airway eosinophilic infiltration in cynomolgus macaques infected with H5N1 highly pathogenic avian influenza virus.
    Vaccine. 2017 Jan 18. pii: S0264-410X(17)30013.
    PubMed     Abstract available

  1035. YANG L, Nan H, Liang J, Chan YH, et al
    Influenza vaccination in older people with diabetes and their household contacts.
    Vaccine. 2017 Jan 13. pii: S0264-410X(17)30007.
    PubMed     Abstract available

  1036. QUINN SC, Jamison A, Freimuth VS, An J, et al
    Exploring racial influences on flu vaccine attitudes and behavior: Results of a national survey of White and African American adults.
    Vaccine. 2017 Jan 13. pii: S0264-410X(16)31271.
    PubMed     Abstract available

  1037. TREANOR JJ, Chu L, Essink B, Muse D, et al
    Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial.
    Vaccine. 2017 Jan 11. pii: S0264-410X(16)31286.
    PubMed     Abstract available

  1038. TAYLOR G
    Animal models of respiratory syncytial virus infection.
    Vaccine. 2017;35:469-480.
    PubMed     Abstract available

  1039. HABIBI MS, Chiu C
    Controlled human infection with RSV: The opportunities of experimental challenge.
    Vaccine. 2017;35:489-495.
    PubMed     Abstract available

  1040. MEJIAS A, Garcia-Maurino C, Rodriguez-Fernandez R, Peeples ME, et al
    Development and clinical applications of novel antibodies for prevention and treatment of respiratory syncytial virus infection.
    Vaccine. 2017;35:496-502.
    PubMed     Abstract available

  1041. CHIU C
    Novel immunological insights in accelerating RSV vaccine development.
    Vaccine. 2017;35:459-460.

  1042. ZHANG W, Hirve S, Kieny MP
    Seasonal vaccines - Critical path to pandemic influenza response.
    Vaccine. 2017 Jan 10. pii: S0264-410X(16)31289.

  1043. COWLING BJ, Caini S, Chotpitayasunondh T, Djauzi S, et al
    Influenza in the Asia-Pacific region: Findings and recommendations from the Global Influenza Initiative.
    Vaccine. 2017 Jan 9. pii: S0264-410X(16)31298.
    PubMed     Abstract available

  1044. NEROME K, Matsuda S, Maegawa K, Sugita S, et al
    Quantitative analysis of the yield of avian H7 influenza virus haemagglutinin protein produced in silkworm pupae with the use of the codon-optimized DNA: A possible oral vaccine.
    Vaccine. 2017 Jan 5. pii: S0264-410X(16)31291.
    PubMed     Abstract available

  1045. LOWELL GH, Ziv S, Bruzil S, Babecoff R, et al
    Back to the future: Immunization with M-001 prior to trivalent influenza vaccine in 2011/12 enhanced protective immune responses against 2014/15 epidemic strain.
    Vaccine. 2017 Jan 5. pii: S0264-410X(16)31297.
    PubMed     Abstract available

  1046. CESPEDES PF, Rey-Jurado E, Espinoza JA, Rivera CA, et al
    A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice.
    Vaccine. 2017 Jan 5. pii: S0264-410X(16)31273.
    PubMed     Abstract available

  1047. LIN J, Xia J, Chen YT, Zhang KY, et al
    H9N2 avian influenza virus enhances the immune responses of BMDCs by down-regulating miR29c.
    Vaccine. 2017 Jan 4. pii: S0264-410X(16)31287.
    PubMed     Abstract available

  1048. YUDIN MH, Mistry N, De Souza LR, Besel K, et al
    Text messages for influenza vaccination among pregnant women: A randomized controlled trial.
    Vaccine. 2017 Jan 3. pii: S0264-410X(16)31195.
    PubMed     Abstract available

    December 2016
  1049. SAITO N, Komori K, Suzuki M, Morimoto K, et al
    Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan.
    Vaccine. 2016 Dec 30. pii: S0264-410X(16)31071.
    PubMed     Abstract available

  1050. MILLMAN AJ, Reynolds S, Duffy J, Chen J, et al
    Hospitalizations within 14days of vaccination among pediatric recipients of the live attenuated influenza vaccine, United States 2010-2012.
    Vaccine. 2016 Dec 29. pii: S0264-410X(16)31258.
    PubMed     Abstract available

  1051. LEE TY, Kim CU, Bae EH, Seo SH, et al
    Outer membrane vesicles harboring modified lipid A moiety augment the efficacy of an influenza vaccine exhibiting reduced endotoxicity in a mouse model.
    Vaccine. 2016 Dec 23. pii: S0264-410X(16)31232.
    PubMed     Abstract available

  1052. DOMNICH A, Arata L, Amicizia D, Puig-Barbera J, et al
    Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis.
    Vaccine. 2016 Dec 23. pii: S0264-410X(16)31218.
    PubMed     Abstract available

  1053. MERTZ D, Geraci J, Winkup J, Gessner BD, et al
    Pregnancy as a risk factor for severe outcomes from influenza virus infection: A systematic review and meta-analysis of observational studies.
    Vaccine. 2016 Dec 23. pii: S0264-410X(16)31219.
    PubMed     Abstract available

  1054. POWELL AM, Luo Z, Martin L, Wan Z, et al
    The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31233.
    PubMed     Abstract available

  1055. FUENTES S, Arenas D, Moore MM, Golding H, et al
    Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
    Vaccine. 2016 Dec 15. pii: S0264-410X(16)31105.
    PubMed     Abstract available

  1056. YOUNG B, Zhao X, Cook AR, Parry CM, et al
    Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis.
    Vaccine. 2016 Dec 7. pii: S0264-410X(16)31044.
    PubMed     Abstract available

  1057. PILKINTON MA, Nicholas KJ, Warren CM, Smith RM, et al
    Greater activation of peripheral T follicular helper cells following high dose influenza vaccine in older adults forecasts seroconversion.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31121.
    PubMed     Abstract available

  1058. SONG JY, Cheong HJ, Hyun HJ, Seo YB, et al
    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine and an MF59-adjuvanted influenza vaccine after concomitant vaccination in 60-year-old adults.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31109.
    PubMed     Abstract available

  1059. CHONG Y, Ikematsu H
    Effect of seasonal vaccination on the selection of influenza A/H3N2 epidemic variants.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31156.
    PubMed     Abstract available

  1060. HULO S, Nuvoli A, Sobaszek A, Salembier-Trichard A, et al
    Knowledge and attitudes towards influenza vaccination of health care workers in emergency services.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31158.
    PubMed     Abstract available

    November 2016
  1061. ZHOU H, Huang Y, Yuan S, Li Y, et al
    Sequential immunization with consensus influenza hemagglutinins raises cross-reactive neutralizing antibodies against various heterologous HA strains.
    Vaccine. 2016 Nov 30. pii: S0264-410X(16)31113.
    PubMed     Abstract available

  1062. DE VRIES RD, Nieuwkoop NJ, Pronk M, de Bruin E, et al
    Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection.
    Vaccine. 2016 Nov 30. pii: S0264-410X(16)31154.
    PubMed     Abstract available

  1063. PAN-NGUM W, Kinyanjui T, Kiti M, Taylor S, et al
    Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach.
    Vaccine. 2016 Nov 28. pii: S0264-410X(16)31023.
    PubMed     Abstract available

  1064. VAN BAALEN CA, Jeeninga RE, Penders GH, van Gent B, et al
    ViroSpot microneutralization assay for antigenic characterization of human influenza viruses.
    Vaccine. 2016 Nov 26. pii: S0264-410X(16)31122.
    PubMed     Abstract available

  1065. WANEESORN J, Wibowo N, Bingham J, Middelberg AP, et al
    Structural-based designed modular capsomere comprising HA1 for low-cost poultry influenza vaccination.
    Vaccine. 2016 Nov 25. pii: S0264-410X(16)31120.
    PubMed     Abstract available

  1066. JIMENEZ-GARCIA R, Lopez-de-Andres A, Hernandez-Barrera V, Gomez-Campelo P, et al
    Influenza vaccination in people with type 2 diabetes, coverage, predictors of uptake, and perceptions. Result of the MADIABETES cohort a 7years follow up study.
    Vaccine. 2016 Nov 24. pii: S0264-410X(16)31100.
    PubMed     Abstract available

  1067. SHEN Z, Bowen RA, Ge P, Yu J, et al
    Evaluation of a candidate live attenuated influenza vaccine prepared in Changchun BCHT (China) for safety and efficacy in ferrets.
    Vaccine. 2016;34:5953-5958.
    PubMed     Abstract available

  1068. ZHENG D, Chen S, Qu D, Chen J, et al
    Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)31073.
    PubMed     Abstract available

  1069. KANG J, Song YM
    Factors associated with vaccination status among Korean submariners who are eligible for free non-mandatory influenza vaccination.
    Vaccine. 2016 Nov 10. pii: S0264-410X(16)31027.
    PubMed     Abstract available

  1070. WALKER L, Newall A, Heywood AE
    Knowledge, attitudes and practices of Australian medical students towards influenza vaccination.
    Vaccine. 2016 Nov 8. pii: S0264-410X(16)31024.
    PubMed     Abstract available

  1071. HUANG CH, Chao DY, Wu CC, Hsu SY, et al
    Influenza vaccination and the endurance against air pollution among elderly with acute coronary syndrome.
    Vaccine. 2016 Nov 4. pii: S0264-410X(16)30989.
    PubMed     Abstract available

  1072. PIELER MM, Frentzel S, Bruder D, Wolff MW, et al
    A cell culture-derived whole virus influenza A vaccine based on magnetic sulfated cellulose particles confers protection in mice against lethal influenza A virus infection.
    Vaccine. 2016 Nov 2. pii: S0264-410X(16)30976.
    PubMed     Abstract available

    October 2016
  1073. LIU H, Frijlink HW, Huckriede A, van Doorn E, et al
    Influenza Vaccine Research funded by the European Commission FP7-Health-2013-Innovation-1 project.
    Vaccine. 2016 Oct 25. pii: S0264-410X(16)30975.
    PubMed     Abstract available

  1074. MANENTI A, Tete SM, Mohn KG, Jul-Larsen A, et al
    Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination.
    Vaccine. 2016 Oct 24. pii: S0264-410X(16)30940.
    PubMed     Abstract available

  1075. DVALISHVILI M, Mesxishvili D, Butsashvili M, Kamkamidze G, et al
    Knowledge, attitudes, and practices of healthcare providers in the country of Georgia regarding influenza vaccinations for pregnant women.
    Vaccine. 2016 Oct 20. pii: S0264-410X(16)30954.
    PubMed     Abstract available

  1076. ISENOR JE, Edwards NT, Alia TA, Slayter KL, et al
    Impact of pharmacists as immunizers on vaccination rates: A systematic review and meta-analysis.
    Vaccine. 2016 Oct 17. pii: S0264-410X(16)30792.
    PubMed     Abstract available

  1077. YANG J, Atkins KE, Feng L, Pang M, et al
    Seasonal influenza vaccination in China: Landscape of diverse regional reimbursement policy, and budget impact analysis.
    Vaccine. 2016 Oct 13. pii: S0264-410X(16)30911.
    PubMed     Abstract available

  1078. KARKI S, Dyda A, Newall A, Heywood A, et al
    Comparison of influenza vaccination coverage between immigrant and Australian-born adults.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30910.
    PubMed     Abstract available

  1079. MAERTENS K, Braeckman T, Top G, Van Damme P, et al
    Maternal pertussis and influenza immunization coverage and attitude of health care workers towards these recommendations in Flanders, Belgium.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30882.
    PubMed     Abstract available

  1080. SITARAS I, Rousou X, Peeters B, de Jong MC, et al
    Mutations in the haemagglutinin protein and their effect in transmission of highly pathogenic avian influenza (HPAI) H5N1 virus in sub-optimally vaccinated chickens.
    Vaccine. 2016 Oct 8. pii: S0264-410X(16)30894.
    PubMed     Abstract available

  1081. ABADOM TR, Smith AD, Tempia S, Madhi SA, et al
    Risk factors associated with hospitalisation for influenza-associated severe acute respiratory illness in South Africa: A case-population study.
    Vaccine. 2016 Oct 6. pii: S0264-410X(16)30824.
    PubMed     Abstract available

    September 2016
  1082. FITZGERALD TJ, Kang Y, Bridges CB, Talbert T, et al
    Integrating pharmacies into public health program planning for pandemic influenza vaccine response.
    Vaccine. 2016 Sep 26. pii: S0264-410X(16)30833.
    PubMed     Abstract available

  1083. GELLIN BG, Qadri F
    Preparing for the unpredictable: The continuing need for pandemic influenza preparedness.
    Vaccine. 2016 Sep 24. pii: S0264-410X(16)30836.

  1084. LIN X, Fiebelkorn AP, Pabst LJ
    Trends in compliance with two-dose influenza vaccine recommendations in children aged 6 months through 8 years, 2010-2015.
    Vaccine. 2016 Sep 23. pii: S0264-410X(16)30850.
    PubMed     Abstract available

  1085. WILLIS E, Parkhouse K, Krammer F, Hensley SE, et al
    Canine H3N8 influenza vaccines partially protect mice against the canine H3N2 strain currently circulating in the United States.
    Vaccine. 2016 Sep 23. pii: S0264-410X(16)30830.
    PubMed     Abstract available

  1086. LEVIN Y, Kochba E, Shukarev G, Rusch S, et al
    A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly.
    Vaccine. 2016 Sep 22. pii: S0264-410X(16)30804.
    PubMed     Abstract available

  1087. WONG VW, Fong DY, Lok KY, Wong JY, et al
    Brief education to promote maternal influenza vaccine uptake: A randomized controlled trial.
    Vaccine. 2016 Sep 22. pii: S0264-410X(16)30832.
    PubMed     Abstract available

  1088. SLAUNWHITE JM, Smith SM, Halperin BA, Langley JM, et al
    The role of healthcare provider attitudes in increasing willingness to accept seasonal influenza vaccine policy changes.
    Vaccine. 2016 Sep 21. pii: S0264-410X(16)30790.
    PubMed     Abstract available

  1089. PUSHKO P, Sun X, Tretyakova I, Hidajat R, et al
    Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model.
    Vaccine. 2016 Sep 20. pii: S0264-410X(16)30825.
    PubMed     Abstract available

  1090. ORTIZ JR, Perut M, Dumolard L, Wijesinghe PR, et al
    A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization.
    Vaccine. 2016 Sep 16. pii: S0264-410X(16)30643.
    PubMed     Abstract available

  1091. NANNEI C, Goldin S, Torelli G, Fatima H, et al
    Stakeholders' perceptions of 10years of the Global Action Plan for Influenza Vaccines (GAP) - Results from a survey.
    Vaccine. 2016 Sep 16. pii: S0264-410X(16)30712.
    PubMed     Abstract available

  1092. SPARROW E, Friede M, Sheikh M, Torvaldsen S, et al
    Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications.
    Vaccine. 2016 Sep 9. pii: S0264-410X(16)30744.
    PubMed     Abstract available

  1093. SCHMIDT R, Holznagel E, Neumann B, Alex N, et al
    Squalene-containing licensed adjuvants enhance strain-specific antibody responses against the influenza hemagglutinin and induce subtype-specific antibodies against the neuraminidase.
    Vaccine. 2016 Sep 8. pii: S0264-410X(16)30789.
    PubMed     Abstract available

  1094. NANNEI C, Chadwick C, Fatima H, Goldin S, et al
    Considerations for sustainable influenza vaccine production in developing countries.
    Vaccine. 2016 Sep 7. pii: S0264-410X(16)30743.
    PubMed     Abstract available

  1095. CASPARD H, Coelingh KL, Mallory RM, Ambrose CS, et al
    Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States.
    Vaccine. 2016 Sep 6. pii: S0264-410X(16)30786.
    PubMed     Abstract available

    August 2016
  1096. ROBERTS JN, Graham BS, Karron RA, Munoz FM, et al
    Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop.
    Vaccine. 2016 Aug 23. pii: S0264-410X(16)30655.
    PubMed     Abstract available

  1097. OHANNESSIAN R, Yaghobian S, Verger P, Vanhems P, et al
    A systematic review of serious video games used for vaccination.
    Vaccine. 2016 Aug 3. pii: S0264-410X(16)30646.
    PubMed     Abstract available

    May 2016
  1098. GRAHAM BS
    Vaccines against respiratory syncytial virus: The time has finally come.
    Vaccine. 2016 May 13. pii: S0264-410X(16)30257.
    PubMed     Abstract available

  1099. MOWBRAY F, Marcu A, Godinho CA, Michie S, et al
    Communicating to increase public uptake of pandemic flu vaccination in the UK: Which messages work?
    Vaccine. 2016 May 8. pii: S0264-410X(16)30278.
    PubMed     Abstract available

    February 2016
  1100. TUCKERMAN J, Thomas N, Marshall HS
    Should professionals caring for children be vaccinated? Community perspectives on health care and child care worker immunisation.
    Vaccine. 2016 Feb 5. pii: S0264-410X(16)00122.
    PubMed     Abstract available

    January 2016
  1101. BATES JT, Pickens JA, Schuster JE, Johnson M, et al
    Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates.
    Vaccine. 2016 Jan 7. pii: S0264-410X(15)01842.
    PubMed     Abstract available

  1102. ZHANG Y, Qiao L, Hu X, Zhao K, et al
    Baculovirus vectors expressing F proteins in combination with virus-induced signaling adaptor (VISA) molecules confer protection against respiratory syncytial virus infection.
    Vaccine. 2016;34:252-60.
    PubMed     Abstract available

  1103. GARG R, Latimer L, Wang Y, Simko E, et al
    Maternal immunization with respiratory syncytial virus fusion protein formulated with a novel combination adjuvant provides protection from RSV in newborn lambs.
    Vaccine. 2016;34:261-9.
    PubMed     Abstract available

  1104. KRISTENSEN M, van Lier A, Eilers R, McDonald SA, et al
    Burden of four vaccine preventable diseases in older adults.
    Vaccine. 2016 Jan 2. pii: S0264-410X(15)01863.
    PubMed     Abstract available

    December 2015
  1105. DETERMANN D, de Bekker-Grob EW, French J, Voeten HA, et al
    Future pandemics and vaccination: Public opinion and attitudes across three European countries.
    Vaccine. 2015 Dec 28. pii: S0264-410X(15)01832.
    PubMed     Abstract available

    October 2015
  1106. MAUNDER HE, Taylor G, Leppard KN, Easton AJ, et al
    Intranasal immunisation with recombinant adenovirus vaccines protects against a lethal challenge with pneumonia virus of mice.
    Vaccine. 2015 Oct 31. pii: S0264-410X(15)01561.
    PubMed     Abstract available

  1107. ALQAHTANI AS, Alfelali M, Arbon P, Booy R, et al
    Burden of vaccine preventable diseases at large events.
    Vaccine. 2015 Oct 2. pii: S0264-410X(15)01352.
    PubMed     Abstract available

    June 2015
  1108. MODJARRAD K, Giersing B, Kaslow DC, Smith PG, et al
    WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015.
    Vaccine. 2015 Jun 19. pii: S0264-410X(15)00767.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.